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1. Introduction 
 
The temporal and spatial control of gene expression is one of the most fundamental processes 
in biology. The transcription of genes constitutes an important medium for the regulation of gene 
expression. Although very basic principles of transcription are similar in prokaryotes and 
eukaryotes, eukaryotic transcription is distinguished by having multiple RNA polymerases and by 
highly more complicated control DNA sequences. The way how eukaryotic cells manage their 
genetic information with their much larger amounts of DNA that is packaged in a seemingly 
inaccessible structure called chromatin, requires regulatory machinery consisting of a 
conglomerate of protein factors, like the transcription factor TFIID. These factors function 
coordinately and in combinatorial fashion to switch the expression of genes on or off. In 
multicellular organisms, it is this selective expression of gene products in individual cell types 
that leads to the rich diversity of cells and tissues, which have evolved to perform highly 
specialized functions. The regulation of eukaryotic transcription of genes occurs on two levels: 
the level of the initiation of transcription at the DNA and the level of chromatin-dynamics (Lemon 
and Tjian 2000, Lee and Young 2000, Näär et al. 2001).  
 
1.1 The complexity of transcription regulation 
1.1.1 Regulatory DNA sequences 
 
Eukaryotic genes consist of cis-regulatory regions (“enhancer” or “silencer”), the promoter and 
the protein-coding sequence. The core promoter is very compact and can contain at least one of 
three different sequence elements that contact the TBP-containing TFIID initiation complex 
(Smale and Kadonaga 2003): TATA box, initiator element (INR) and the downstream promoter 
element (DPE).  
The TATA box is a DNA sequence found in the promoter region of many genes. It is the binding 
site for TBP (TATA-binding protein) of transcription factors like TFIID and is involved in the 
process of transcription by the RNA polymerase. Many genes lack a TATA box and use an INR 
and DPE instead. The INR is a conserved sequence element that encompasses the start site of 
transcription and can direct accurate transcription initiation in the absence of a TATA box (Smale 
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1997). It can also be represented in TATA-containing promoters where it leads to an increase in 
the strength of expression of the promoter (Lo and Smale 1996). The DPE was found only in 
TATA-less but INR-containing promoters and is responsible for the precise initiation of 
transcription through the INR (Burke and Kadonaga 1997).  
The complexity of the eukaryotic promoter region seems to increase with the diversity of its 
correlating organism (Figure 1): The regulatory DNAs of unicellular eukaryotes are often 
composed of short sequences, which are located immediately adjacent to the core promoter 
(Wyrick and Young 2002). These enhancer/silencer sequences are usually composed of two to 
three linked binding sites for one or two different sequence-specific transcription factors (de 
Bruin et al. 2001).  
The regulatory region of higher eukaryotes likely contains several enhancers in 5’ and 3’ 
regulatory regions or even in introns, adding complexity to the level of transcription-regulation 
since silencers/enhancers present target sites for transcription factors.  
 
Figure 1. Comparison of a simple eukaryotic promoter and extensively diversified metazoan
regulatory modules: 
a Basic eukaryotic transcriptional promoter unit: a simple core promoter (TATA), upstream activator
sequence (UAS) and silencer element spaced within 100-200 bp of the TATA box, typically for
unicellular eukaryotes. 
b Complex metazoan transcriptional control modules: Multiple clustered enhancer modules
interspersed with silencer and insulator elements, located 10-50 kb up- or downstream of a composite
core promoter containing TATA box (TATA), initiator sequences (INR) and downstream promoter
elements (DPE) (Levine and Tjian 2003).
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Examples among the known enhancers, for example in the upstream region of a gene, are the 
GC box, the CAAT box and the octamer element. The GC box is recognized by the transcription 
factor SP1 (Kadonaga et al. 1987, Pugh and Tjian 1990). The CAAT box is recognized by a 
variety of factors depending on the specific promoter, which it is part of. The octamer is also 
recognized by more than one factor, for example the ubiquitous transcription factor Oct-1 and 
the lymphoid specific Oct-2 (Lewin 1997).  
Additional DNAs play an important role in enhancer function: They might serve as “tethering 
elements” (Figure 2) that recruit distal enhancers to the core promoter and insulator DNA-
sequences prevent gene-associated enhancers from inappropriately regulating neighboring 
genes (Calhoun et al. 2002, Burgess-Beusse et al. 2002). 
 
1.1.2 Promoter recognition and the basal transcription apparatus 
 
RNA polymerase II (Pol II) cannot initiate transcription itself, but is absolutely dependent on the 
auxiliary general transcription factors (GTFs) that bind to the specific regions of the gene 
(Roeder 1996, Woychik and Hampsey 2002). At least six GTFs (TFIIA, -B, -D, -E, -F and -H) are 
necessary to direct accurate and regulated initiation of transcription (Hampsey 1998, Hampsey 
and Reinberg 1999, Lemon and Tjian 2000, Lee and Young 2000, Näär et al. 2001). 
Pol II, together with the GTFs, constitutes the basal transcription apparatus that is needed to 
initiate transcription of Pol II dependent genes and consists of more than 50 polypeptides that 
Figure 2. Function of a promoter proximal tethering 
element.  
Given a promoter-close tethering sequence and the 
specific proteins, a loop in the DNA can form, bringing 
a distal enhancer (enhancer A) close to a proximal 
promoter A to activate transcription (Dorsett 1999). 
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must be assembled at promoter sequences upon activation of gene expression (Zawel and 
Reinberg 1993, Tjian and Maniatis 1994, Orphanides et al. 1996).  
The current model for activation of transcription postulates, that in the first step transcription-
factors bind specific DNA-sequences in the enhancer regions of their target genes (Figure 3) 
following by the recruitment of one or more components of the basal transcription apparatus 
and/or cofactors (Ptashne and Gann 1997, Struhl 1996, Lemon and Tjian 2000, Näär et al. 
2001). These interactions between enhancer-bound transcription-factors and components of the 
transcription apparatus probably stabilize the assembly of the apparatus to the promoter of the 
target gene and induce an increase in the rate of initiation of transcription (Tjian and Maniatis 
1994, Roeder 1996, Ptashne and Gann 1997).  
 
Figure 3. The transcription apparatus: a multi-subunit complex 
(Levine and Tjian 2003). 
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1.2 TFIID and TAFs 
 
The GTF TFIID consists of TBP and, depending on the organism, 8-14 TBP-associated factors 
(TAFs) (Woychik and Hampsey 2002). Originally each TAF was named according to its relative 
weight (kD), but the names of the TAF-genes have been changed to reflect guidelines recently 
endorsed to avoid confusion (Tora 2002). An overview of the changes from old to new gene 
names for S. cerevisiae, H. sapiens, D. melanogaster, C. elegans, and S. pombe is shown in 
Figure 4. 
 
1.2.1 Function of TFIID in transcription 
 
The inability of GTFs to access chromatin, DNA wrapped around core histones H2A, H2B, H3 
and H4 in repeating subunits called nucleosomes, implies that a requisite step in transcription 
Figure 4. New Pol II TAF nomenclature including the corresponding known orthologs and paralogs
(Tora 2002). 
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initiation is the alteration of chromatin structure (Wolffe, 1998). TFIID, along with TFIIB, are the 
only components of the preinitiation complex (PIC) that can bind specifically to core promoters 
(Lagrange et al. 1998, Cosma et al. 1999, Krebs et al. 1999, Agalioti et al. 2000). 
The binding of TFIID to a core promoter surrounding the transcription start site of a gene 
nucleates assembly of the PIC, which contains Pol II and the GTFs TFIIA, TFIIB, TFIIE, TFIIF 
and TFIIH (Orphanides et al. 1996; Hampsey 1998). The nucleating function of TFIID is thought 
to comprise several distinct activities, which are given to the TFIID complex by its TAF subunits 
(Wassarman and Sauer 2001). These are: 
  
(1) Binding of TFIID to DNA sequence elements.  
(2) The posttranslational modification of histones and GTFs.  
(3) The recruitment to other GTFs via TAF-GTF interactions. 
(4) The recruitment of TFIID to activators via TAF-activator interactions. 
(5) Forming the scaffold for a stable TFIID complex via TAF-TAF and TAF-TBP interactions. 
 
1.2.2 DNA binding of TFIID  
 
Several TAFs contribute to the nucleating functions of TFIID by their structure. For example, 
Drosophila and human TAF12 are homologous to histone H2B and TAF6 and TAF9 are 
homologous to histone H4 and H3 respectively. In solution and in the crystalline state, the 
dTAF9/dTAF6 complex exists as a heterotetramer, resembling the (H3/H4)2 heterotetrameric 
core of the histone octamer and suggesting that TFIID contains a histone octamer-like 
substructure and binds DNA in an octamer-like manner (Burley and Roeder 1996). 
Early studies of Pol II transcription revealed, that TBP is sufficient for basal transcription in vitro, 
but that TFIID is required for the response to activators in vivo, indicating that TAFs play an 
important role in transcriptional activation (Näär et al. 2001). The binding of TFIID to the 
promoter constitutes a critical rate-limiting step of transcription (Orphanides et al. 1996, 
Hampsey and Reinberg 1997).  
Activators directly bind TAFs, which is consistent with the idea that TAFs may function as 
conduits for the flow of transcriptional regulatory information between activators and the core 
transcriptional machinery. Numerous activators such as NTF-1, SP1, Bicoid, Hunchback and 
p53 cannot stimulate transcription in vitro unless their target TAFs are present in the TBP-TAF 
complex (Chen et al. 1994, Sauer et al. 1995, Thut et al. 1995). 
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In yeast, TAF-dependent promoters exhibit differential TAF-dependence, with some TAFs being 
required for activation while others are dispensable and TAF-dependence seems to be specified 
by core promoter elements (Green 2000). Human and Drosophila TAF subunits of TFIID have 
been identified as sequence-specific DNA binding proteins that recognize either the downstream 
promoter element (DPE) or the initiator (Smale 2001, Shen and Green 1997). Additionally, TAF-
dependent transcription was found to correlate with promoter occupancy by TAFs, leading to the 
definition of two classes of promoters, TAF-independent and TAF-dependent promoters, to 
which TAFs are recruited with TBP, presumably as TFIID complex (Kuras et al. 2000, Li et al. 
2000). Experiments with chimeric promoters using upstream activation sequences (UASs) and 
TAF-dependent and independent core-promoters showed that transcription from a TAF-
dependent promoter but not TAF-independent promoter required both UAS and core promoter 
elements (Li et al. 2002).  
TAFs mediate the activation of transcription of genes with TATA-less promoters and thus play a 
role in the TBP-independent activation of transcription by recruiting the TFIID complex to such 
core promoters (Chen and Hampsey 2002). TFIID might play a key regulatory role in the 
coordinate expression of the ribosomal protein gene regulon, where most ribosomal protein 
genes lack a canonical TATA element (Mencia et al. 2002). The suggestion that TAFs play a 
central role within the TBP-independent activation of transcription is supported by the 
identification of the TBP-less complex TFTC (TBP-free TAF-containing complex) in mammalian 
cells, which is similar to TFIID (Wieczorek et al. 1998).  
TFIID was thought to be the only sequence-specific initiation factor recognising a Pol II promoter 
and thus to direct PIC assembly on all promoters.  It has been widely believed that a PIC is 
composed of the same set of GTFs at every protein-coding gene promoter. However, recent 
findings show that initiation of transcription is also regulated at the level of PIC-formation at core 
promoters in form of distinct PICs with varying composition and with distinct promoter recognition 
factors (Müller and Tora 2004). 
The observation that Pol II can initiate transcription using only a partial set of the GTFs has 
challenged the definition of GTFs (Parvin et al. 1994, Usheva and Shenk 1994). Additionally, 
database searches for paralogue genes encoding GTF subunits revealed that single-copy genes 
encode the components of TFIIB, -E, -F, -H and Pol II but TFIIA subunits which are not essential 
for transcription in vitro, are encoded by paralogue genes in Drosophila and humans (Aoyagi and 
Wassarman 2000).  
TFIID might play a key regulatory role in the coordinate expression of the ribosomal protein gene 
regulon, where most ribosomal protein genes lack a canonical TATA element (Mencia et al. 
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2002). The suggestion that TAFs play a central role within the TBP-independent activation of 
transcription is supported by the identification of the TBP-less complex TFTC (TBP-free TAF-
containing complex) in mammalian cells, which is similar to TFIID (Wieczorek et al. 1998). In 
contrast to the GTFs mentioned above, discoveries in the last years showed the TFIID complex 
in various compositions, with the rather diverse spectrum of TBP- and TAF-type factors allowing 
eukaryotic cells to form multiple promoter recognition complexes, differing in composition and 
function (see Figure 5). 
 
1.2.3 Different TFIID complexes 
 
TAFs also have paralogue genes, which are often expressed in a cell type- or tissue-specific 
pattern. In yeast, two genes encode TAF5 homologues that are both present in the same TFIID 
complex (Mitsuzawa et al. 2001). Drosophila melanogaster has homologues of TAF4 (Nohitter, 
Nht) and TAF5 (Cannonball, Can), which are expressed only in testis and regulate the 
expression of specific target genes (Hiller et al. 2001). Additionally, Drosophila TAF10 and 
TAF10b have been shown to be differentially expressed during embryogenesis (Georgieva et al. 
2000). In humans, TAF1L, a retroposed copy of TAF1 and TAF7L are specifically expressed 
during male germ-cell differentiation (Wang and Page 2002, Pointud et al. 2003). TAF1L lacks 
introns and evidently arose by retroposition of a processed TAF1 mRNA during primate evolution 
(Wang and Page 2002).  
A tissue specific homologue of TAF4 in mammalians, TAF4b, is expressed in B-lymphocytes and 
in the granulosa cells of the ovary and testis (Dikstein et al. 1996b, Freiman et al. 2001, see 
Figure 5). TAFs have also been described in complexes other than TFIID: yeast SAGA and 
Drosophila TFTC, human PCAF/GCN5 and STAGA complexes (Martinez 2002, Muratoglu et al. 
Figure 5. Metazoan gene-selective and tissue-specific TFIID-like
complexes by using alternate TAFs and TRFs: An Ovarian-
specific complex using TAF4b (TafII105) (Levine and Tjian
2003). 
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2003). TFTC can replace TFIID or TBP both on TATA-containing and TATA-less promoters in in 
vitro transcription assays (Wieczorek et al. 1998, Brand et al. 1999). 
 
1.2.4 TAF1 is essential for the nucleating function of TFIID 
 
TAF1 interacts directly with TBP and other TAF subunits, is the scaffold for an assembly of the 
TFIID complex and a broadly acting regulator of transcription (Chen et al. 1994, Weinzierl et al. 
1993, Verrijzer and Tjian 1996). Supporting the fact that TAF1 is an essential protein within 
TFIID is the observation that it is not possible to create mitotic and germ line TAF1-clones and 
null alleles of TAF1 are recessive larval lethal (Wassarman et al. 2000). 
TAF1 engages in strong interactions with TBP, TAF12, TAF11, TAF6, TAF5, TAF4 and TAF2 
(Chen et al. 1994). Immobilized TAF1 can serve as a scaffold for assembly of TFIID sub 
complexes and holo-TFIID from recombinant subunits, which suggests that assembly and 
integrity of TFIID are dependent on TAF1. Inactivation of TAF1 in yeast leads to degradation of 
other TFIID subunits and inactivation of all yeast TAFs tested to date results in degradation of 
other TAFs, which suggests that every TAF is necessary for the integrity of TFIID in vivo in yeast 
(Walker et al. 1996, Michel et al. 1998, Moqtaderi et al. 1998). 
Defects in TAF1 result in the down regulation of key cell cycle proteins: TAF1 is identical to 
CCG1, a cell cycle regulatory protein found to be important for G1 cell cycle progression 
(Sekiguchi et al. 1991, Wassarman et al. 2000). The hamster ts13 cell line contains a single 
base pair substitution in the hamster gene encoding TAF1 (ts form of TAF1, glycine to aspartatic 
acid at position 690), which results in cell cycle arrest in G1 phase, followed by apoptosis of the 
cells at the restrictive temperature (Hayashida et al. 1994, Sekiguchi et al. 1995). Transcription 
from cyclin A and cyclin D promoters is reduced when the ts13 cells are shifted from permissive 
to the restrictive temperature, due to the defects in the transcription properties of TFIID 
containing the mutant form of TAF1 (Wang et al. 1997). Transient expression of human TAF1 in 
ts13 cells rescued the G1-specific cell cycle arrest (Wang and Tjian 1994). DNA microarray gene 
expression profiling in the ts13 cell line showed that the transcription of 18% of all protein-coding 
genes transcribed by Pol II is affected more than twofold at the non-permissive temperature 
(O’Brien and Tjian 2000).  
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TAF1 in yeast consists of two proteins (Figure 6): yTAF1 contains the NH2-terminal kinase 
domain (NTK) and bromodomain factor 1 and 2 (Bdf1, Bdf2) contain the COOH-terminal kinase 
domain (CTK, Matangkasombut et al. 2000). Both of them can interact with the TFIID-specific 
component yTAF7, which underlines that yTAF1 and Bdf1/2 represent the functional equivalent 
of TAF1 in higher eukaryotes. All TAF1 proteins contain a “high mobility group” (HMG) domain, 
called HMG-box that is involved in DNA-binding and protein-protein interactions. The HMG-box 
domain consists of three helices in an irregular array. HMG-box domains are found in one or 
multiple copies in "HMG motif proteins" which form a large, diverse protein family involved in the 
regulation of DNA-dependent processes such as transcription, DNA-replication, and DNA-repair. 
The HMG-box proteins are divided into three sub-families: HMGB, HMGN and the HMGA 
family.  Each family has a characteristic functional sequence motif: the motif of the HMGB family 
is termed "HMG-box;" that of the HMGN family "nucleosomal binding domain" and that of the 
HMGA family "AT-hook." The functional motifs, which are characteristic of these canonical 
HMGs, are widespread among nuclear proteins in a variety of organisms. 
 
 
Figure 6. Bdf1 corresponds to the carboxy-terminal region of TAF1. Schematic 
alignment of yeast Taf1/Bdf1&2 and human/dTAF1 (Matangkasombut et al.
2000). 
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1.2.5 Activators regulate the function of TAF1 
 
Enhancer-bound aactivator interactions increase promoter occupancy of TFIID (i.e. recruitment) 
and modulate TAF1 regulatory and enzymatic activities (i.e. regulation, Wassarman and Sauer 
2001). Physical interactions between TAF1 and activators are a critical component of these 
mechanisms (Figure 7). TAF1 binds activators like the HIV transactivator of viral transcription Tat 
(Weissman et al. 1998) or the viral activator protein ICP4 of the herpes simplex virus type 1 
(Carrozza and DeLuca 1996), transcriptional repressors such as the retinoblastoma tumor 
suppressor protein RB (Siegert and Robbins 1999) and other proteins such as Cyclin D (Siegert 
et al. 2000). 
Several lines of evidence support a model in which TAF1-activator interactions contribute to 
recruitment of TFIID to promoters:  
1.) The activation domain of ICP4 binds TAF, indicating that TAF1-activator interactions 
contribute in recruiting TAF1 to promoters.  
2.) Gene-specific promoter occupancy of yeast TAF1 is elevated in response to an 
activation signal and is reduced after removal of enhancer sites (Kuras et al. 2000, Li et 
al. 2000).  
3.) Enhancers can confer TAF1 dependence on promoters that are normally TAF1 
independent (Wang et al. 1997).  
Figure 7. Schematic diagram of metazoan TAF1. Locations of enzymatic domains [NH2-terminal
kinase domain (NTK), COOH-terminal kinase domain (CTK), histone acetyltransferase domain
(HAT), and ubiquitin-activating/conjugating domain (E1/E2)] and bromodomains (Bromo) are
indicated within the linear TAF1 protein. Substrates for the enzymatic activities are indicated above
the TAF1 protein, and interacting proteins are indicated below. Substrates and interacting partners are
abbreviated as follows: TFIIA (A), TFIIE (E), TFIIF (F), TATAbinding protein (TBP), retinoblastoma
protein (RB), HIV Tat (TAT) and TFIIFα (RAP74) (Wassarman and Sauer 2000). 
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Once recruited to a promoter, TAF1 could participate in PIC assembly by binding to the RAP74 
subunit (TFIIFα) of TFIIF, as suggested by the finding that TAF1 mutants that fail to interact with 
RAP74 are unable to rescue the ts13 cell cycle defect (Ruppert and Tjian 1995). The importance 
of TAF1 interactions with both activators and GTFs argues that TAF1 functions as a classically 
defined coactivator that bridges activators to PIC assembly. 
Activators regulate transcription by modifying TAF1 activities to enhance formation or stability of 
the PIC on promoter-DNA. Binding of HIV Tat, an activator and repressor of viral gene 
transcription, to TAF1 inhibits TAF1 HAT activity (Weissman et al. 1998). Similarly, binding of RB 
to TAF1 inhibits TAF1 kinase activity (Siegert and Robbins 1999, Solow et al. 2001). In contrast, 
cyclin D1 suppresses the TAF1-kinase-inhibitory effect of RB (Siegert et al. 2000). This shows 
that regulation of TAF1 activities by interactions with activators, repressors and cell cycle 
regulators is an integral part to the process of transcriptional activation. 
 
1.2.6 TAF1 plays an essential role in promoter recognition 
 
It was shown that TAF1 contacts the INR, thus activating transcription on TATA-box- as well as 
TATA-less-promoters (Wu et al. 2001). A role for TAFs in recognizing the INR as start site for 
transcription was suggested by the finding that TFIID containing a TBP subunit that cannot bind 
to DNA can also not function on TATA-only promoters but can support transcription from TATA-
less, INR-containing promoters (Martinez et al. 1994).  
A minimal complex containing TBP and TAF1 directs basal but not activator-responsive 
transcription (Chen et al. 1994). A recombinant TBP-TAF1-TAF2 complex efficiently binds INR-
containing promoters in vitro (Verrijzer et al. 1995). Moreover, a TAF1-TAF2 complex can 
support INR-mediated transcription and specifically binds sequences that match the INR 
consensus sequence from a pool of random sequence oligonucleotides (Verrijzer et al. 1995, 
Chalkley and Verrijzer 1999), indicating that TAF1, together with TAF2, mediates binding of 
TFIID to the INR. 
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1.2.7 TAF1 modifies GTFs and other proteins 
 
TAF1 has intrinsic protein kinase activity (Dikstein et al. 1996a), histone acetyltransferase 
activity (Mizzen et al. 1996) and ubiquitin-activating and conjugating activity E1/E2 (Pham and 
Sauer 2000). 
TAF1 is a bipartite kinase and contains terminal kinase domains at both ends of the protein (NTK 
and CTK, Figure 7). Interestingly, the kinase domains do not show high similarities to other 
known kinases, suggesting that they might belong to a novel class (Dikstein et al. 1996a). The 
transcription regulator RB, which binds to the NTK-domain and thus inhibits its catalytic activity, 
regulates the activity of the NTK. However, transcription regulators EA1 and Cyclin D1 can 
suppress the RB-induced inhibition of the NTK (Shao et al. 1995, Siegert and Robbins 1999, 
Siegert et al. 2000). 
The NTK phosphorylates the 74 kDa subunit (RAP74) of GTF TFIIF, the β-subunit of TFIIA or 
tumor suppressor p53 (Dikstein et al. 1996a, Solow et al. 2001, Li et al. 2004).  
Dephosphorylation facilitates the ability of RAP74 to support transcription in vivo, thus 
implicating that phosphorylation of RAP74 by TAF1 may be an important mechanism for 
regulating transcription (Ruppert and Tjian 1995, Kitajima et al. 1994). RAP74 and TFIIA appear 
to represent reasonable candidate substrates for TAF1 kinase activity in vivo: endogenous 
RAP74 is hyperphosphorylated; dephosphorylation of RAP74 reduces its ability to support 
transcription elongation in vitro and phosphorylation of TFIIA stimulates TFIIA-TBP-TATA-
element complex formation in vitro (Kitajima et al. 1994, Solow et al. 2001).  
NTK-activity is required for TAF1-activity in vivo, because a recombinant TAF1 protein that lacks 
the NTK domain can not rescue the cell-cycle-arrest phenotype of ts13 cells, suggesting that the 
kinase activity is important for the progression through G1 (O’Brien and Tjian 1998, O’Brien and 
Tjian 2000). 
Both human and Drosophila TAF1 contain a histone acetyl transferase (HAT) domain that 
acetylates not only histones H3 and H4, but also TFIIEβ, the smaller subunit of the GTF TFIIE, in 
vitro (Imhof et al. 1997). Additionally, cells expressing HAT-inactive TAF1 mutants arrest in the 
late G1-phase of the cell cycle, suggesting that TAF1 HAT-activity regulates the expression of 
genes involved in cell cycle progression (Dunphy et al. 2000). 
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TAF1 has also been demonstrated to mediate monoubiquitination of histone H1, a linker histone 
that binds to DNA between adjacent nucleosomes, via its E1/E2 domain (Pham and Sauer 
2000). 
 
1.3 Chromatin 
 
The fundamental structural unit of eukaryotic chromatin is the nucleosome. It consists of pairs of 
each of the core histones H2A, H2B, H3 and H4, thereby creating the histone octamer and a 
single molecule of the linker histone H1. The whole nucleosome spans about 180 base pairs 
(bp) of DNA. To gain access to the DNA itself, transcription-factors need to pass the organization 
of the DNA into the higher-structures of chromatin. Central mechanisms for regulating chromatin 
include reorganization as well as disassembly of the higher structures of the nucleosome 
(Narlikar et al. 2002).  
 
1.3.1 The structure of chromatin 
 
Eukaryotic genomic DNA is organized into repeating arrays of nucleosomes: 147 bp of DNA are 
wrapped 1.75 times around the histone octamer. The complex of a histone-octamer and the 
surrounding DNA is also termed “nucleosome-core-particle” (Hansen 2002).  
Histone H1 and related "linker" histones bind to the extranucleosomal linker-DNA that separates 
core nucleosomes and H1-H1 interactions participate in the compaction of the 10 nm beads-on-
a-string-structure into the 30 nm fiber (Thoma et al. 1979). Compared to core-histones, linker 
histones are evolutionary less conserved (Baxevanis et al. 1995, Lee and Young 2000, Horn and 
Peterson 2002).  
The 30 nm fiber can coil to form a hollow tube (100 nm fiber), which finally forms the chromatin, 
which is further condensed into the compact chromosomes observed during mitosis (Hansen 
2002, Horn and Peterson 2002). This complex compaction and structuring of DNA serves 
several functions: The overall negative charge of the DNA is neutralized by the positive charge 
of the histones and the large DNA fits into the small nucleus (Figure 8).  
Each core-histone consists of a globular domain, which intermediates histone/histone- and 
histone/DNA-interactions within the nucleosome and a flexible amino terminal region, called the 
NH2-terminal tail (Arents et al. 1991, Luger et al. 1997a, Suto et al. 2000).  
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The current model of the nucleosome which is in part derived from high-resolution structures, 
states that the NH2-terminal tails of all four histones protrude between the gyres of the DNA and 
the histone core binds the DNA backbone at 14 superhelical locations, resulting in more than 
120 direct atomic histone-DNA interactions (Luger et al. 1997a, Khorasanizadeh 2004, Luger 
2003). While the NH2-terminal-tails are unstructured in the context of a single nucleosome, they 
take part in formation of higher-order chromatin organization by mediating interactions with 
nucleosomes or other chromatin proteins (Luger et al. 1997b, Hansen 2002) and the tails 
interact also with linker-DNA (Pruss and Wolffe 1993, Angelov et al. 2001).  
Additionally, the flexible histone tails are targets for numerous covalent modifications (Strahl and 
Allis 2000, see below). 
Histone H3 and H2A variants confer specialized function to nucleosomes. One prominent H3 
variant is the “centromere protein A” (CENP-A) that participates in the assembly of specialized 
centromeric nucleosomes that are essential for centromere structure and function (Ahmad and 
Henikoff 2001). The histone H2A variant H2A.Z is important for silencing for a specific subset of 
genes. The crystal structure of a H2A.Z containing nucleosome core particles revealed only 
subtle changes on the accessible surface area of the nucleosome (Suto et al. 2000). However 
the role of histone variants is unclear and their structure and function remain unknown. 
 
1.3.2 The dynamic nucleosome 
 
Earlier studies led to the proposal that the nucleosome is a monolithic, static assembly of DNA 
and protein. In contrast, newer studies provide evidence that chromatin is not static and describe 
Figure 8. The structure of chromatin and the condensed chromosome. 
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the model of the “dynamic nucleosome”: Nucleosomes were shown to have a dynamic 
equilibrium in vitro between a fully wrapped state and a set of partially unwrapped states, in 
which stretches of DNA transiently detach from the histone surface and then rewrap in a 
spontaneous and rapid fashion (Li et al. 2005). 
Histone modifications and chromatin-remodelers facilitate changes in the structure of chromatin 
and DNA (Chakravarthy et al. 2005).  
Chromatin remodeling ATPases, histone modifying enzymes as well as the underlying DNA 
sequence dynamically change chromatin structure, thus making the chromatin more or less 
accessible (Mellor 2005). Enzymes that act on chromatin themselves show dynamic interactions 
with the chromatin template and allow rapid changes to chromatin states (Karpova et al. 2004, 
Phair et al. 2004). Recent data in vivo suggest that within highly condensed mitotic 
chromosomes, both core histones and chromatin-associated factors are in dynamic equilibrium, 
which varies with the phases of mitosis (Chen et al. 2005). Additionally, replication-independent 
core histone replacement has been demonstrated and extensive nucleosome displacement and 
replacement occurs upon gene activation, particularly at highly active domains of the chromatin 
(Tagami et al. 2004, Schwabish and Struhl 2004, Schwartz and Ahmad 2005, Thiriet and Hayes 
2005). This dissociative equilibrium is shifted in opposite directions, depending on the enzymes 
which modificate the state of the nucleosome. 
 
1.4 Regulation of chromatin activity 
 
Nucleosomes can restrict the binding of proteins to DNA. Among major classes of protein factors 
that regulate the dynamic structure of chromatin and therefore the accessibility of DNA to 
specific DNA binding factors, are chromatin remodeling complexes and enzymes that 
posttranslationally modify histones. 
1.) ATP-dependent chromatin-remodeling complexes can “slide”, relocate or disassemble 
nucleosomes on DNA, in this way expose or occlude DNA sequences and thereby facilitate or 
inhibit the interaction of DNA-binding proteins with DNA (Becker and Horz 2002, Becker 2002). 
2.) Specific enzymes can posttranslationally modify histones by adding or removing chemical 
moieties. Posttranslational histone modifications include acetylation, methylation, ubiquitination 
and phosphorylation, which may modulate the contacts between histones and DNA (Cheung et 
al. 2000a). Especially multiple covalent modifications of histone tails have been well 
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characterized and shown to play a global role in gene expression (Berger 2002, Jenuwein and 
Allis 2001). 
 
1.4.1 ATP-dependent chromatin-remodeling complexes 
 
ATP-dependent chromatin remodeling complexes (CRCs) are multi-protein complexes and use 
ATP-hydrolysis to overcome the considerable energy barrier for remodeling nucleosomes within 
chromatin (Becker and Horz 2002). The remodeling process requires ATP-binding to the 
conserved ATPase-subunit of these complexes, which show homology to each other within the 
yeast Snf2-ATPase (Narlikar et al. 2002).  
Based on the identity of the catalytic ATPase-subunit, four families of CRCs have been identified 
so far, the SWI/SNF, ISWI, CHD (also called Mi-2 family) and INO80 family (Narlikar et al. 2002, 
Khorasanizadeh 2004).  
The characterized chromatin-remodeling complexes have been implicated in at least three types 
of activities. These are DNA looping (Fan et al. 2003, Fazzio and Tsukiyama 2003), octamer 
sliding (Kassabov et al. 2003) and histone substitution (Mizuguchi et al. 2004).  
 
1.4.2 Covalent modifications of histones: the “histone code” 
 
A multitude of posttranslational histone modifications (Figure 9) has been discovered, most of 
them attached to phylogenetically highly conserved amino acids in the histone tails, such as 
acetylation of lysine-residues, methylation of lysine- or arginine-residues and phosphorylation of 
serine- or threonine-residues. Additionally, histones can be ubiquitinated at their COOH-terminus 
(Zhang and Reinberg 2001, Khorasanizadeh 2004).  
Recently, modifications of histones have been discovered within the structured globular domain 
(Zhang et al. 2003, Freitas et al. 2004). Several of these modifications occur near the 
nucleosome lateral surface, close to the DNA wrapped around the histones, indicating that these 
modifications may affect the interaction between the histone octamer and the DNA (Cosgrove et 
al. 2004). However, most of recent research efforts have focused on post-translational histone 
modifications occurring at the histone tails and have revealed that histone modifications play an 
essential role for chromosome function.  
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In context of the dynamic nucleosome, it appears that prior acetylation of histone tails is a 
prerequisite for nucleosome remodeling by CRCs in vivo, thus resulting in disassembly or 
repositioning of nucleosomes (Lomvardas and Thanos 2001, Reinke and Horz 2003, Nourani et 
al. 2004).  
The correlation of specific histone modifications with the execution of specific biological events 
gave rise to the histone code hypothesis, which postulates that specific histone modifications 
determine chromosome function (Strahl and Allis 2000). Specifically modified amino acid 
residues are also referred to as “marks”, bearing information for the specific functional code of a 
histone and the packaged DNA. 
 
 
Figure 9. Posttranslational modifications on the core histones (human). 
a The histone octamer portion of the nucleosome, the aminosequences of the NH2- and COOH-
terminal ends of single histones are shown, sites of modifications are marked. 
b Chemical structure of the covalent modifications of the amino acids as shown in a (Khorasanizadeh
2004). 
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1.4.2.1 Acetylation 
 
The reversible histone acetylation on lysine residues is so far the best characterized of all 
modifications (Grunstein 1997, Jenuwein and Allis 2001, Berger 2002, Kurdistani and Grunstein 
2003). Hyperacetylation of lysine in the histone tails was proposed to be involved in activation of 
transcription over 40 years ago and has subsequently been strongly correlated with 
transcriptionally active genes (Allfrey et al. 1964) and hyperacetylated chromatin regions display 
a higher accessibility of their DNA (Hebbes et al. 1988 and 1994). The discovery that 
transcriptional regulators can have histone acetyltransferase- (HAT-) and histone deacetylase- 
(HDAC-) activity, provided evidence that acetylation is involved in transcription (Struhl 1998, 
Kornberg and Lorch 1999).  
Besides transcription, histone acetylation contributes to other biological processes, for example, 
histone deposition: Histones H3 and H4 are brought to replicating chromatin in an acetylated 
state that becomes erased after replication (Turner and O’Neill 1995). Studies of the acetylation 
levels of bulk histones have shown that up to 13 of the 30 lysine-residues in the tail in a histone 
octamer are acetylated (Roth et al. 2001). Major acetylation sites are lysines 9, 14, 18 and 23 in 
histone H3 in most species (Thorne et al. 1990).  
HATs are present in transcription factors and CRCs (Roth et al. 2001). HAT domains contain a 
central conserved core unit that is important for acetyl-coenzyme-A (acetyl-CoA) binding and a 
cleft, used for substrate recognition, which lies directly over the cofactor-binding pocket 
(Khorasanizadeh 2004). HATs reside within the context of large multisubunit complexes, 
separated into two main classes of histone acetyltransferases: Type A (nuclear) HATs and type 
B (cytoplasmic) HATs (Narlikar et al. 2002). Nuclear regulatory complexes contain mainly type A 
HATs, of which three families have been identified: the GNAT family, containing yeast GCN5 
and human PCAF, the MYST family (containing yeast complex NuA4 with its HAT yESA1) and 
the P300/CBP family.  
The different HAT-complexes have different but distinct histone specificities (Roth et al. 2001) 
even if they contain similar subunits: The HAT GCN5 is part of two complexes in yeast, Ada and 
SAGA, each with distinct biological functions (Marmorstein 2001a). GCN5 acetylates histones 
H3 and H4 in vitro, but in context with Ada or SAGA H3 and H2B in vivo.  
Acetylation is reversed by HDACs, which fall into three main classes (Khochbin et al. 2001, 
Marmorstein 2001b). Those classes reside in different complexes: The class I HDAC family 
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contains for example the remodeling-complex NuRD with its subunit HDAC1 or the 
transcriptional corepressor Sin3 with its subunit HDAC2. Class II HDACs have yet to be purified. 
A prominent member of the class III HDACs is Sir2 that is involved in heterochromatin silencing 
at silent mating loci, telomeres and ribosomal DNA (Moazed 2001). The histone specificities of 
the class I HDAC family complexes are linked to transcriptional repression: the yeast homolog of 
HDAC1, Rpd3, deacetylates all sites except lysine 12 on histone H4, a site that is linked to 
heterochromatic silencing and whose acetylation by the Drosophila HAT dMOF is linked to 
activation of the male X chromosome (Roth et al. 2001, Suka et al. 2001). The fact that the 
NuRD complex includes the chromatin remodeling ATPase Mi-2 protein and HDAC activity is an 
example of functional cooperation between chromatin-remodelers and histone deacetylases 
(Tong et al. 1998, Wade et al. 1998, Zhang et al. 1998). 
This interplay between HAT- and HDAC-complexes maintains the steady-state level of 
acetylation (Reid et al. 2000, Vogelauer et al. 2000). 
 
1.4.2.2 Ubiquitination 
 
The reversible covalent attachment of multiple copies of ubiquitin, a 79 amino acid polypeptide, 
or the ubiquitin-related SUMO (small ubiquitin-related modifier) is often associated with the 
degradation of proteins through the proteasome pathway (Varshavsky 1997). In contrast, 
histones are mono-ubiquitinated and transcriptionally active chromatin has been linked to 
ubiquitination:  
Histone ubiquitination was first described for H2A, H2B and H3 and ubiquitinated H2A and H2B 
were detected in transcriptionally active chromatin (Nickel et al. 1989, Lee and Young 2000, 
Robzyk et al. 2000). Histone ubiquitination occurs at lysine residues at the COOH-tail and 
involves three enzymatic activities: ubiquitin activating- (E1), ubiquitin conjugating- (E2) and 
ubiquitin ligase-activity (E3) (Hershko and Ciechanover 1998). While histone ubiquitination has 
typically been attributed to positive control of transcription (Zhang et al. 2003), sumolation of 
histone H4 is involved in transcriptional repression (Shiio and Eisenmann 2003). Not only core-
histones but also linker histones are the target for ubiquitination, TAF1 mono-ubiquitinates 
histone H1 in Drosophila embryos (Pham and Sauer 2000). 
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1.4.2.3 Methylation 
 
Methylation occurs on lysine and arginine residues in histones and the ε-aminogroup of lysine 
residues can be mono-, di- or tri-methylated, while the addition of methyl-groups is correlated 
with an increase in the basicity of the lysine side chain. While acetylation is generally correlated 
with active transcription, histone methylation has been linked to both transcriptional activation 
and repression (Roth et al. 2001, Zhang and Reinberg 2001). 
Histone methylation was believed to represent a stable modification with important functions in 
epigenetic gene control and for organizing chromatin domains and the enzymes that can add up 
to three methyl-groups to a single residue are called histone methyltransferases (HMTs). The 
domain containing the enzymatic activity responsible for lysine methylation of histone tails is 
called SET-domain, which consists of 130 amino acids folding into three discrete β-sheet regions 
flanked by α-helices (Khorasanizadeh 2004). The cofactor S-adenosyl-L-methionine (SAM) 
binds to a concave surface of the enzyme, providing methyl groups for modification. The histone 
tail inserts as a parallel strand between two strands of the SET-domain (Zhang and Reinberg 
2001, Khorasanizadeh 2004). A HMT, which is untypical since it does not contain a SET-domain, 
is Dot1, which despite the lack of SET, still specifically methylates lysine 79 of histone H3 in the 
core domain. Dot1 methylation of lysine 79 in H3 mediates gene-silencing mechanisms in yeast 
(Min et al. 2003b, Park et al. 2002). 
Methylation was long thought to be irreversible, but newer studies show evidence for a histone 
demethylase (LSD1) that reverts an activating methyl mark and is only compatible with mono- 
and dimethylation (Shi et al. 2004). Recent studies show that LSD1-demethylation works also on 
nucleosomes in combined action with other factors (Lee et al. 2005) and is involved in 
transcriptional events (Metzger et al. 2005). To date, histone arginine demethylases have not 
been identified. 
 
1.4.2.4 Phosphorylation 
 
Reversible histone phosphorylation contributes to transcription, chromosome condensation, DNA 
repair and apoptosis (Cheung et al. 2000a). Phosphorylation of specific amino acid residues 
alters the electrostatic charge of the modified and surrounding amino acids. Histone tails contain 
short stretches of basic amino acids, which are flanked by potential phosphorylation sites. These 
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“basic patches” may engage in histone-DNA interactions or other histones or chromatin-
associated factors. Reversible phosphorylation represents a mechanism to disrupt the 
electrostatic interactions in order to unfold the nucleosomes (Cheung et al. 2000b). Studies of 
modulation of “charge patches” in the linker histone H1 via reversible phosphorylation showed 
that phosphorylation regulates transcription, presumably through altering higher-order chromatin 
structure (Dou and Gorovsky 2000).  
H3 phosphorylation during gene expression was discovered in mammalian cells as an 
immediate early response to mitogenic stimulation, leading to transcription of c-Fos and c-Jun 
(Mahadevan et al. 1991). Kinases that phosphorylate H3 are Aurora-B/IpI1, PKA, Rsk-2 and 
Msk-1, which tend to target serine/threonine sites that are surrounded by basic residues.  
When mammalian cells are exposed to mitogen or stress, the time course of H3 phosphorylation 
corresponds to the transient expression of activated immediate early genes (Thomson et al. 
1999a). The p42/p44 mitogen-activated protein (MAP) kinase pathway (also known as ERK 
pathway) as well as the stress-activated p38 pathway, can each induce histone H3 
phosphorylation. Additionally, the ERK-activated Rsk-2 (ribosomal protein S6 kinase 2) kinase 
has been shown to be directly involved in H3 phosphorylation in vivo in studies with RSK-2-
deficient cells, which were impaired in the transcriptional activation of c-fos gene and EGF-
induced phosphorylation (De Cesare et al. 1998, Sassone-Corsi et al. 1999). Msk-1 (MAP- and 
Stress-activated kinase 1) is activated by ERK and p38 pathways and it is possible that both of 
these pathways can activate this kinase to induce H3 phosphorylation (Thomson et al. 1999b). 
These studies provide a direct link between signal transduction pathways and histone 
phosphorylation.  
Nucleosomes containing phosphorylated and acetylated H3 are associated with EGF-activated 
genes, indicating that both modifications may cooperate in the transcription of these genes and 
several studies point out that H3 phosphorylation and acetylation are tightly coupled in response 
to EGF stimulation (Barratt et al. 1994, Cheung et al. 2000b, Clayton et al. 2000).  
The probably best-studied histone-phosphorylation so far is at serine 10 in the NH2-terminal tail 
of H3 (H3S10), which has been correlated with transcription activation, mitosis and chromosome 
condensation (Nowak and Corces 2004). The kinase IpI1 in yeast, which is expressed in M-
phase, phosphorylates H3S10 in vivo and genetic inactivation of IpI1 results in defects in 
chromosome segregation during mitosis (Francisco et al. 1994, Biggins et al. 1999) and 
complete loss of H3 phosphorylation during mitosis (Hsu et al. 2000). Phosphorylation of H3S10 
is reversed by the protein phosphatase 1 (PP1) family and the yeast PP1 homolog Glc7, which 
acts also on H3S10 (Hsu et al. 2000).  
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Histone phosphorylation has been linked to cellular processes other than transcription, such as 
DNA damage response (Vidanes et al. 2005). Histone H2B becomes phosphorylated at serine 
32 in apoptotic mammalian cells and the phosphorylation event coincides with nucleosomal DNA 
fragmentation (Ajiro 2000). The H2A variant of mammalian cells, H2A.X, is rapidly 
phosphorylated at its C-terminal serine 139 upon exposure to ionizing radiation or apoptosis-
induced signals. In yeast, phosphorylation of the corresponding serine 129 has been found in 
association with DNA damage (Rogakou 1998, 1999 and 2000). Phosphorylation of histone H3 
at serine 14 is uniquely associated with apoptotic chromatin in species ranging from frogs to 
humans (Cheung et al. 2003). Phosphorylation of nucleosome-associated proteins in areas of 
transcriptional active nucleosomes is mediated by the protein-kinase CK2 (casein kinase 2) in 
mammalian cells (Guo et al. 1998, Guo et al. 1999). A recent study suggests that 
phosphorylation of serine 1 of histone H4 in yeast requires CK2 and occurs within 1 kb of DNA 
double-strand breaks (DSBs). Though the mechanism how the phosphorylation might mediate 
DSB-repair is unclear, these are first indicators that there might be a histone-code for DNA-
damage response (Cheung et al. 2005). 
 
1.4.2.5 Functions of histone modifications 
 
Histone modifications have different functions. They might change the charge of a specific area 
within the histone tail, resulting in a different electrostatic conformation. Another function is the 
change of binding sites for proteins that interact with histones. Specific histone modifications can 
increase the binding of specific proteins or inhibit binding to histones. Several histone 
modifications can work in a combinatorial fashion to have an effect, and this crosstalk between 
several possibly different kinds of modifications transfers specific characteristics to the modified 
region. 
 
1.4.2.5.1 Histone modifications change the charge of histone tails 
 
Acetylation and methylation result from addition of acetyl or methyl groups, usually to the basic 
amino acid lysine and these additions prevent positive charges from forming on the amino group. 
Phosphorylation adds a phosphate group, usually to the hydroxyl group of a serine or threonine 
residue, less frequently to a threonine residue. The phosphate group introduces negative 
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charges and has therefore a significant effect upon the electrostatic properties of the whole 
protein. 
 
1.4.2.5.2 Histone modifications can recruit chromatin binding proteins 
 
Histone modifications can function as target binding sites for chromatin binding proteins. 
Acetylation plays an essential role in transcriptional activation by recruitment of transcription 
factors:  
An acetylated lysine residue has no longer a basic side chain, allowing it to be recognized by 
bromodomain modules which are conserved protein motifs of around 100 aminoacids and found 
in many chromatin-associated proteins. The bromodomain contacts the acetyl-carbonyl group of 
acetyl-lysine with a conserved asparagine residue and additional contacts to adjacent residues 
add specificity to the interaction (Owen et al. 2000, Jacobson et al. 2000). The central ATPase-
subunits of various CRCs contain histone modification recognition motifs, which interact with 
acetylated/methylated histone tails (Langst and Becker 2004). Swi/Snf and Gcn5 bromodomains 
are required for the stable association of Swi/Snf with acetylated histone tails (Syntichaki et al. 
2000, Hassan et al. 2002) and the tandem bromodomains of the yeast RSC nucleosome-
remodeling complex recognize acetylated H3 Lysine 14 (Kasten et al. 2004). There is evidence, 
that the HAT Gcn5 sequentially acetylates a subset of lysines in histones H3 and H4, which 
leads to the ordered recruitment of bromodomain-containing transcription complexes (Agalioti et 
al. 2002). Acetylation of lysine 8 in histone H4 for example leads to recruitment of TFIID, whose 
bromodomains anchor it directly to nucleosomes at promoter regions (Khorasanizadeh 2004). 
TAF1 contains a double bromodomain (DBD), which enables TAF1 to bind to the acetylated N-
terminal tail of histone H4. The DBD binds most tightly to H4 acetylated at lysine 5 and 12. This 
is consistent with the crystal structure of the DBD, which shows that the binding pockets for 
acetyllysine span a distance equivalent to seven residues (Jacobson et al. 2000). Therefore, the 
TAF1 bromodomains may target TFIID to chromatin-packaged promoters. Another example is 
the yeast SAGA complex, which interacts with acetylated nucleosomes through its bromodomain 
(Hassan et al. 2002).  
Methylated lysine and arginine marks on histones can act as a recruitment signal or anchor for 
transcription factors:  
The chromodomain conserved module, which is found in chromatin-associated proteins related 
to heterochromatin-protein HP1, binds to histone tails with methylated lysine in an affinity-
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specific manner, being highest for tri-methyllysine and lowest for mono-methyllysine (Jacobs et 
al. 2001, Lachner et al. 2001, Bannister et al. 2001). Chromodomains are, like bromodomains, 
also found in several CRCs that also have HAT, SET or ATPase domains. Two distinct self-
sustaining epigenetic silencing mechanisms are identified that are linked to the methylation of 
lysines 9 and 27 in H3. Methyllysine 9 plays a direct role in chromatin condensation and gene 
silencing. The chromodomain of the Polycomb protein specifically binds to H3 containing 
methyllysine 27 to mediate gene silencing during developmental stages (Fischle et al. 2003b, 
Min et al. 2003a). An example of epigenetic activation by lysine methylation involves the 
Drosophila Ash1 protein that methylates lysines 4 and 9 in histone H3 and lysine 20 in H4, 
creating a distinct signal for the recruitment of the epigenetic activator complex called Brahma to 
chromatin. Brahma binding inhibits HP1 association with a nucleosome and thus, Ash1 
maintains a transcriptionally active state (Beisel et al. 2002). The human HMT Suv39H is a 
dominant modifier of heterochromatin-induced gene silencing. It methylates H3 at lysine 9 and 
contains both chromo- and SET-domains (Rea et al. 2000).  
In the case of heterochromatin assembly, Suv39H methylates lysine-residue 9 of histone H3. 
The methylated lysine residue is then recognized and bound by the chromodomain protein HP1 
(Bannister et al. 2001, Lachner et al. 2001). The Suv39H-HP1 methylation system may also 
mediate heterochromatin propagation. 
In addition, studies show that H3S10 phosphorylation can also promote TBP recruitment through 
distinct promoter-specific mechanisms (Cheung et al. 2000a). 
 
1.4.2.5.3 Crosstalk between different histone modifications 
 
Several observations point out that specific histone modifications together play a role in 
transcription. For example, hyperacetylation of histone tails and H3 Lysine 4 methylation are 
both associated with transcriptionally active euchromatin, whereas hypoacetylation of H3 Lysine 
9 is associated with heterochromatin (Noma et al. 2001). 
Additionally, histone phosphorylation and methylation regulate histone acetylation in a 
combinatorial fashion (Berger 2001, Zhang and Reinberg 2001). For example phosphorylation of 
serine 10 in histone H3 enhances lysine 14 acetylation and these together promote transcription 
(Clements et al. 2003). 
Besides the fact that multifunctional proteins like TAF1 show several modifying activities like 
HAT and ubiquitin-activating/conjugating (UBAC) activities, sequential ubiquitination and 
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deubiquitination can be concerted with lysine methylation and these events are important for 
transcription regulation (Henry et al. 2003, Daniel et al. 2004). For example, H2B ubiquitination 
at lysine 123 is important for the methylation of lysines 4 and 79 in histone H3 in yeast while 
Ubp8, a subunit of the SAGA complex, has been shown to remove the ubiquitin from the H2B 
lysine. A mutation that changes lysine at position 123 to an arginine perturbs silencing at the 
telomere and links ubiquitination to methylation of H3 and transcriptional silencing (Sun and Allis 
2002). 
A connection between methyllysine binding of chromodomains and acetylation has been 
discovered recently in yeast, which further underlines the cooperation between different 
chromatin modifying complexes in the nucleus (Pray-Grant et al. 2005). 
Methylation of specific arginines in histone H3 and H4 correlate with acetylation and 
transcriptional activation (Zhang and Reinberg 2001). For example, the methylation of arginine 3 
on histone H4 facilitates H4 acetylation and enhances transcription activation by nuclear 
hormone receptors (Wang et al. 2001). 
Several transcription-associated HATs preferentially acetylate H3-S10P over the unmodified 
form as substrate (Cheung et al. 2000b, Lo et al. 2000). The genes INO1 and GAL1 are 
transcriptionally regulated in part by linked H3 modifications: Snf1-kinase-mediated 
phosphoserine 10 and GCN5-mediated acetyllysine 14 (Lo et al. 2001, Lo et al. 2005). 
 
1.4.2.6 Histone code mechanisms: “binary switches” and “modification cassettes” 
 
With the discovery of many histone modifications and their interplay in various organisms led to 
hypothetical models how the histone code might from a mechanism for the regulation of 
transcription. Most sites of post-translational modifications are extremely conserved and the high 
density and versatility observed on histones lead to the hypothesis that local clusters of 
modifications may be used in a combinatorial fashion to regulate chromosome structure and 
function. Possible models for the action of these clusters were described as “binary switches” 
and “modification cassettes” (Fischle et al. 2003a). 
According to the binary switch model, modification by either phosphorylation or ubiquitination of 
a site adjacent or nearby to a methylation mark that engages an effector module, e.g. a CRC, 
could regulate binding to that factor.  
It was shown that binding proteins of heterochromatic methylation marks have a fast mutual 
exchange rate with their environment and are not statically bound to their target sites, which 
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supports a kinetically controlled binding mechanism model (Festenstein et al. 2003, Cheutin et 
al. 2003). A binary switch has been proposed for the function of phosphoserines adjacent to 
methyllysines in histone tails in which the phosphorylation may work to neutralize the effect of 
the lysine methylation: especially in histone H3 serines 10 and 28 are phospho-marks flanking 
methyllysines, suggesting a possible link to the binary switch model in gene silencing (Fischle et 
al. 2003a). 
Beyond binary switch mechanisms between two neighboring or nearby marks, linear strings of 
densely clustered histone modifications might act as discrete information units mediating signals. 
Short clusters of dense mark combinations could form defined “modification cassettes” with 
specific biological readouts that depend on their modification state. For example, a “cassette” of 
3 marks could have 23 possible states if each mark can be modified independently. Such 
cassettes with dense assortment of modification marks have been described for histone H3 and 
H4 tails (Fischle et al. 2003a). They were are also found in minor histone variants as well as in 
the basic COOH-terminal region of the tumor suppressor p53, which is known to have similar 
crosstalk between different modification marks than histones: For example, phospho-marks 
facilitating consecutive acetylation and acetyl-marks possibly interfering with ubiquitination 
(Appella and Anderson 2000, Brooks and Gu 2003).  
The NH2-terminus of minor human H2A variants like H2A.1 and H2A.Z show conserved motifs 
which might be putative modification cassettes, where phosphorylation of serine 1 might interact 
with two other modifications, methylation of arginine 3 and acetylation of lysine 5. Interestingly, 
this motif appears also in the NH2-terminal tail of human histone H4, where a second putative 
modification cassette might exist at an acid-labile phosphorylation site around histidine 18 
(Fischle et al. 2003a, Fujitaki et al. 1981). 
 
1.4.2.7 TAF1 modifies histones 
 
TAF1 is a multifunctional enzyme and its many enzymatic activities also recognize histones as 
substrates: 
TAF1 is a histone acetyltransferase and binds to acetylated histones: The HAT domain of TAF1 
can acetylate NH2-terminal-tail lysines in H3 in vitro, preferred there at lysine 14, H4 and H2A 
(Mizzen et al. 1996, Wassarman et al. 2000).  
Additionally to its acetylating function, TAF1 is also an ubiquitin-activating/conjugating (ubac) 
enzyme: TAF1 has been demonstrated to mediate mono-ubiquitination of the linker histone H1 in 
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vitro. Mono-ubiquitination requires the sequential activity of ubiquitin-activating (E1) and 
ubiquitin-conjugating (E2) enzymes (Ciechanover et al. 2000). TAF1 contains both of these 
activities and it does not require an E3 ubiquitin-ligase to mono-ubiquitinate histone H1 in vitro: it 
links ubiquitin covalently via a thioester bond in an ATP-dependent manner (E1 activity) and it 
transfers activated ubiquitin to histone H1 via an isopeptide bond (E2 activity). The E1 and E2 
activities of Drosophila and human TAF1 reside in the central region of the protein (figure 5, 
Pham and Sauer 2000, Wassarman and Sauer 2000). It is unclear how mono-ubiquitination of 
histone H1 by TAF1 mediates transcription, but inactivation of the TAF1 E1/E2 activity in vivo 
reduces the cellular level of mono-ubiquitinated histone H1 and the expression of genes targeted 
by the maternal activator Dorsal (Pham and Sauer 2000). 
The COOH-terminal kinase domain of human TAF1 contains autokinase-activity (Dikstein et al. 
1996). Interestingly, this CTK shows no apparent homology to other known protein kinases, 
including the NTK of TAF1. Drosophila TAF1 has a similar structure like its human counterpart 
and its NTK also autophosphorylates TAF1 and transphosphorylates RAP74. Previous studies 
advancing this work showed that hTAF1 and the CTK of dTAF1 are able to phosphorylate 
histone H2B, a new substrate for TAF1, in vitro (Kwoczynski 2002, Maile et al. 2004). Serine 33 
(H2B-S33) is a conserved serine/threonine-phosphorylation site within H2B of several organisms 
(see Figure 10).  
A target gene for TAF1 in Drosophila is the gene snail, which encodes a highly conserved, zinc-
finger transcription factor that specifies mesodermal cell fate in a variety of organisms. In situ-
hybridisation experiments showed that Snail expression is reduced in mutant TAF1 Drosophila 
Figure 10. Serine/threonine at position 33 in the N-terminal tail of H2B is conserved among various
organisms (Maile et al. 2004). 
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embryos containing a CTK-deletion of TAF1, leading to the hypothesis that the CTK may be 
important for the activation of transcription by TFIID in vivo (Kwoczynski 2002).  
  
1.5 Specific aims of this study 
 
During the last decade, the field of chromatin research proceeded in a fast pace. The discovery 
of the histone code and corresponding histone modifying enzymes added more complexity to the 
mechanisms of transcriptional regulation (Strahl and Allis 2000). 
One of the histone modifying enzymes in the focus of research is TAF1, a subunit of the GTF 
TFIID and a multifunctional enzyme, whose activities contribute to transcription activation in 
multiple ways (Wassarman and Sauer 2001).  
Previous studies revealed that the CTK of dTAF1 phosphorylates H2B-S33 in vitro and that the 
CTK is required for TFIID-dependent transcription activation (Kwoczynski 2002).  
These results imply that CTK-mediated phosphorylation of H2B-S33 is involved in transcriptional 
regulation.  
The main goal of this work was to uncover the role of the CTK-mediated phosphorylation of H2B-
S33 in transcriptional activation. To achieve this goal, several tasks were assessed: 
RNA interference was used to detect the CTK-mediated phosphorylation of H2B-S33 in vivo. 
Another task was to characterize the kinase-activity as an integral part of the CTK of TAF1. 
The identification and localization of the catalytic domain of the CTK and its specific kinase-
motifs needed to be assessed with computational and experimental methods. 
An important task was to correlate the transcriptional activation of target genes of TAF1 with the 
presence of H2B-S33P with in vivo assays. 
The results of this work were intended to identify TAF1CTK as a major kinase of H2B-S33, to 
identify the catalytic motif in the CTK responsible for phosphorylation of H2BS33P and to reveal 
the importance of H2B-S33 phosphorylation by CTK at the promoter of TAF1 target genes for 
transcriptional activation in Drosophila. 
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2. Materials and Methods 
 
2.1 Materials 
 
2.1.1 Laboratory Equipment 
 
ABI 7700 QPCR-Cycler     CIF: Core Instrumental Facility, UCR 
Cell counting chamber     Neubauer 
Centrifuge 5415D     Eppendorf 
Centrifuge 5810R     Eppendorf 
Centrifuge Biofuge pico    Heraeus 
Chromatography columns    Pharmacia Biotech 
Class II A2 Biological Safety Cabinet   ThermoForma 
Computer, Hardware     iMac, 800 MHz 
Computer, Software:     Microsoft Excel 
       Microsoft Word 
       Microsoft Powerpoint 
       Mozilla Firefox Internet Browser 
       Lasergene Navigator, DNAStar 
       Adobe Photoshop 5.0 
       DNA Strider 1.3 
Custom DNA-gel system     ZMBH Heidelberg, Workshop 
Eagle Eye II still video system    Stratagene 
Freezer -20°C      Frigidaire 
Freezer -80°C      ThermoForma  
Fridge 4-10°C      Frigidaire 
Gel Dryer Vacuum system     Fisher Scientific 
Heatblock      Techne Dri-block DB-2A 
Ice machine       Scotsman 
Ice-bath      Neolab 
Innova 4230 refrigerated incubator shaker   New Brunswick Scientific 
Intensification cassettes for autoradiography Suprema, Dr. Goos 
LB-122 β-γ-detector      Berthold 
Low Temperature Incubator     Fisher Scientific 
Magnetic stirrer / heatplate    Fisher Scientific 
Microscope      Nikon 
Microwave oven     Sharp Carousel 
Milli-Q Synthesis water purification system   Millipore 
Mini Trans-Blot transfer cell     BioRad 
Nutator       Clay Adams Brand 
pH-meter (accumet® basic AB15)   Fisher Scientific 
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Pipettes (Pipetman: 2, 10, 20, 200, 1000 µl size) Gilson  
Electronic Pipettes      Brandt 
Power supplies     Power Pac 300, BioRad 
Printer HP Laserjet 4100    Hewlett Packard 
Protean 3 minigel system     BioRad 
PTC-100 Peltier Thermal Cycler    MJ Research 
PTC-200 Peltier Thermal Gradient Cycler   MJ Research 
Quarz Cuvette (1 cm, Z = 8.5)   Sarna Cells 
QuixSep Micro Dialyzer dialysis chamber   Membrane Filtration Products Inc. 
RC-5(B) refrigerated superspeed centrifuge  Sorvall 
Rocker/shaker Roto Shake Genie    Scientific Industries Inc. 
Scale        Fisher Scientific 
Scale (analytical)     Fisher Scientific 
Scanner      Epson 
Scintillation Counter     Beckman 
Shaker (horizontal)     GFL 3005 
SmartSpec™Plus spectrophotometer   BioRad 
Sonifier 450       Branson 
Spinner flasks for cell culture    Wheaton, Bellco 
Thermomixer      Eppendorf 
Vortex Genie 2      Scientific Industries Inc. 
Waterbath SUB 14      Grant 
Zip-drive      Iomega 
 
2.1.2 Consumables and Kits 
10 cm cell culture dishes    Greiner 
100 ml cell culture flask (with filter cap)  Greiner 
15 cm cell culture dishes    Greiner 
15 ml tubes      Fisher 
50 ml tubes      Fisher 
6-well plates for cell culture    Greiner 
ECL-Plus Western Blotting Detection System Amersham 
Filter pipette tips (10, 20, 200, 1000 µl size)  Axygen 
Filterpaper      Whatman 
Parafilm “M”      American National Can 
Perfectprep™ Gel Cleanup Kit   Eppendorf 
Pipet tips (10, 20, 200, 1000 µl)   Axygen 
QiagenMaxi Kit     Qiagen 
QiagenMini Kit     Qiagen 
Quick Ligation Kit     NEB 
QuikChange™ Site-Directed Mutagenesis Kit Stratagene 
RNA Midiprep Kit     Qiagen 
Scintillation fluid     Betamax 
Serological pipettes     Falcon 
Sterile filters (20 µm and 45 µm)   Millipore 
Sterile filtration units     Nalgene 
Streptavidine      BioRad 
TOPO TA cloning kit      Invitrogen 
X-OMAT™ autoradiography film   Kodak 
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2.1.3 Chemicals, Enzymes, Proteins and Molecular Weight Markers 
 
Chemicals not listed were of p. A. quality and were purchased from the companies Sigma (St. 
Louis, MO), Fisher Scientific (Hampton, NH) and VWR (West Chester, PA). 
 
Acrylamide (40% stock)    Fisher 
Agarose (ultra pure)     VWR 
APS (ammoniumpersulfate)    Merck 
Baculovirus DNA     Baculo Gold, Pharmingen 
BCIP (5bromo-4chloro-3indolyl-phosphate)  Boehringer Mannheim 
Bromophenol Blue (Na-salt)    Sigma 
Cellfectin      Invitrogen 
Citric Acid      VWR/EMD 
Coomassie® R250 Brilliant Blue   Serva 
Deep Vent Polymerase    NEB 
DTT       AppliChem GmbH 
EDTA       VWR 
Ethanol 95%      Biochemistry Dpt., UC Riverside 
Ethidiumbromide     ICN Biomedicals Inc. 
GeneRuler 1kb DNA-Ladder    MBI Fermentas 
Glucose      MP Biomedicals 
Glycerine (Glycerol)     VWR/EMD  
Glycogen      J.T. Baker 
Guanidine hydrochloride    VWR/EMD 
Hepes (N-Cyclohexyl-2-aminoethanesulfonic acid) Fisher 
Histone-octameres     F. Sauer 
Hotmaster Taq Polymerase     Eppendorf 
Isopropanol (2-propanol)    VWR 
L-Arginine free base      VWR/EMD 
L-Glutamin/Penicillin/Streptomycin-Mix  Gemini Bioproducts 
LB Broth, Miller     VWR 
LB-Agar      VWR 
Lysozyme      Roche 
Methanol      VWR 
NBT (nitro blue tetrazolium chloride)  Boehringer Mannheim 
NONIDET® P40     Calbiochem 
Nucleosomes      F. Sauer 
Pipes (Piperazine-1,4-bis[2-ethanesulfonic acid]) Fisher 
Pluronic® F-68     Gibco 
PMSF       Roche 
Ponceau-S protein staining solution   Serva 
Potassiumtetrathionate    Pfaltz & Bauer Inc. 
Protein marker, broad range    NEB 
Protein marker, prestained     NEB 
Proteinase K      Roche 
Quick Ligase      NEB 
Restriction enzymes and buffers   NEB 
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RNasin, ribonuclease inhibitor   Promega 
RNaseA      Roche 
ROX reference QPCR dye    Stratagene 
Salmon testis DNA     Sigma 
SDS (sodiumdodecylsulfate)    VWR 
Shrimp alkaline phosphatase    Boehringer Mannheim 
Sodiumchloride     VWR 
sodiumdesoxycholate    Fisher 
Skim milk powder     SACO Foods Inc. 
SF900II serum-free insect cell media  Gibco 
Sodiumhydroxide     VWR/EMD 
Superscript RT     Invitrogen 
SYBR-Green QPCR dye    Molecular Probes 
TaKaRa ExTaq Polymerase    TaKaRa 
TEMED      Fisher 
Tryptone      VWR/EMD 
Tween®20      Fisher 
Yeast extract      Gibco 
 
2.1.4 Antibodies and Affinity Matrixes 
 
Optitran reinforced NC membrane   Schleicher & Schüll 
Westran PVDF-Membrane    Schleicher & Schüll 
Immobilon-P (PVDF) Membrane   Millipore 
Nitrocellulose membrane    Millipore 
Anti-FLAG M2 affinity agarose   Sigma 
Protein-A-Sepharose (PAS)    Amersham 
Anti-H2B, rabbit     F. Sauer 
Anti-phospho(H2BS33), rabbit   S. Kwoczynski / T. Maile 
Anti-dTAF1M      D. Wassarman 
Anti-dTAF1C      D. Wassarman 
Anti-acetyl(H3K14), rabbit    Upstate 
Anti-acetyl(H4), rabbit    Upstate 
Anti-dimethyl(H3K9), rabbit    Upstate 
Anti-phospho(H3S10/28P), rabbit   Upstate 
Anti-rabbit-IgG-AP-conjugate   Sigma 
Anti-rabbit-biotinylated    Amersham 
 
2.1.5 Radioactive Nucleotides 
 
Redivue adenosine-5’-[γ-32P]-triphosphate, 
triethylammoniumsalt 10 mCi / ml (AA0018) Amersham 
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2.1.6 Bacteria Stocks 
 
XL-1 blue (Bullock et al. 1987); Stratagene 
 
recA1 end A1 gyrA46 thi-1 hsdR17 supE44 relA1 lac- F’ [proAB+ lacIq lacZ∆M15 Tn10 
(Tetr)] 
 
 
2.1.7 Insect Cells 
 
Sf9 insect cells; Orbigen Inc. 
 
Cell line derived from pupal ovarian tissue of Spodoptera frugiperda (fall armyworm). Sf9 
cells were used to isolate and propagate recombinant baculoviral stocks and to produce 
recombinant proteins. 
 
Schneider S2 cells; Invitrogen 
 
Cell line derived from Drosophila melanogaster (fruit fly; wildtype-strain “Oregon R”) 
dissociated, near hatching embryos. S2 cells were used to produce recombinant proteins 
and for XChIP experiments (Schneider 1972). 
 
2.1.8 Oligonucleotides 
 
Oligonucleotides (oligos) were produced by Sigma-Genosys in desalted purity grade. All 
sequences are shown in 5’-3’ orientation. 
 
 
2.1.8.1 Oligonucleotides for inserting point-mutations with PCR 
 
Mutated codons are shown in bold letters. 
 
5’-CTK-D1541A GAGATGTTCCTCGAGGCTCTCAAGCAGATTGTGG 
3’-CTK-D1541A CCACAATCTGCTTGAGAGCCTCGAGGAACATCTC 
5’-CTK-D1725A GCACCAGAGTTTGCTGAAGCCTGGGGC 
3’-CTK-D1725A GCCCCAGGCTTCAGCAAACTCTGGTGC 
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2.1.8.2 Oligonucleotides for cloning 
 
The positions of restriction sites are underlined and the specific enzyme is shown in brackets. 
Tags are shown in bold letters. 
 
5’-TAFII250-1500 (NdeI) GGGCGCATATGCCATTCCTGTTCCCGGTAAG 
3’-TAFII250-Ende (XbaI) CATGTCTAGACTAAAAAGTCCAGGCATAATCATTG 
3’-CTK∆ATP-A (SalI) ACGCGTCGACGTCGATGTAGTCATCTCCGG 
5’-CTK∆ATP-B1 (SalI) ACGCGTCGACCGCGGAAGGGGTAGGC 
5’-CTK∆ATP-B2 (SalI) GCGTCGACGAATCCATGGATGTGG 
5’-Bdf1-FLAG (NcoI, 
NdeI) 
CTAGCCATGGCTGACTACAAGGACGACGATGACAAGCATATGACC 
GATATCACACCCGTACAGAACGATGTGGAT 
3’-Bdf1-Stop (EcoRI, 
SmaI)  
GCGTCCTCGAGGAATTCCCCGGGTCACTCTTCTTCATTTCG 
CTGCTAAC 
5’-Bdf2-Start (NdeI) GGAATTCCATATGTCTCGTACTAACATGGATACAAGAC 
3’-Bdf2-Stop (XbaI) CATGTCTAGATTAATCACTGTCACTGTCGCTACTATCAC 
 
 
2.1.8.3 Oligonucleotides for RT-PCR-reactions 
 
Name of oligo 5’-oligo (5’-3’) 3’-oligo (5’-3’) 
actin5C CGTTCTGGACTCCGGCGATGG GTACTTGCGCTCTGGCGGGGC 
cdc25-2 (string, stg) GTGGATCTCGTCGTGCTCGCC TGCTGGCGGTTCCGGGCGCTT 
 
 
2.1.8.4 Oligonucleotides for XChIP-reactions (all in 5’-3’ direction) 
 
cdc25pro-5’ (stg-promoter) ATCATATGACTGCGGCCACTACC 
cdc25pro-3’ (stg-promoter) CAGGATCATATGGACTCAGTTTTGGA 
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cdc25code-5’ (stg-coding) ATTTCTTCGGCTTCAGACTCGCCAGC 
cdc25code-3’ (stg-coding) GCTTTTGGGTCACACGTCACGCAAG 
 
2.1.8.5 Oligonucleotides for QPCR-reactions (5’-3’) 
 
cdc25-SYBR-5’ TACGCGTCGCGGTATAAAAGCTCG 
cdc25-SYBR-3’ ACCAATGTCCCGAGAAACGAGGAG 
gtpro-SYBR-5’ TCCGGATTTTCGGTATAAATGCAG 
gtpro-SYBR-3’ GACTGGTGATCTAGCTCTGATGTTGC 
 
2.1.8.6 Oligonucleotides for sequencing (5’-3’) 
 
pVL-fwd (vector forward) ATAGTTGCTGATATCATGGAG 
GST-Thr-fwd (tag fwd) TCCAAAATCGGATCTGGTTC 
T7 (vector forward) TAATACGACTCACTATAGGG 
T3 (vector revers) AATTAACCCTCACTAAAGGG 
dTAF1fwd487 GAGGCCAAGTTGACTAAGGAC 
dTAF1fwd1024 GAGAACAGCGATCAGAAGC 
dTAF1fwd1466 AGCAAAATGCTCAAGCAAAG 
dTAF1fwd2001 CCTAAAGAAGTACTCCCACGG 
dTAF1fwd2464 CGGTCGGTGAATTCAATATAC 
dTAF1fwd2908 AAGCTTGACGACGAAGTAAAG 
dTAF1fwd3446 GCAAGAATCTTGAGAACATGC 
dTAF1fwd3898 CAGAACCAGAAGCTTCAGCC 
dTAF1fwd4434 GTCCTCTATCCTGGAGATTATCC 
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dTAF1fwd4647 (250-CT-*) CTGATCTACAATGGACCGC 
dTAF1fwd5057 (250-1) GAAGATACTTGAGTATGCCC 
dTAF1fwd5585 (250-CT1-2) CGAAGACGAGAACAATGCG 
dTAF1fwd5884 (250-2) TCGGCGAGCCCAGCAGC 
Bdf1fwd305 AGAAGGAAGAAGGAGGACAAG 
Bdf1fwd831 TGTAATTAGACGAGCCCAAAC 
Bdf1fwd1277 ACTACGATTCCGATGAAGATTC 
Bdf1fwd1723 TTAGATAATCACACCATCTTAACATTG 
Bdf2fwd243 CGGTATCACTAACCTGAATTCTTC 
Bdf2fwd713 CAATGCCACCAAGAGTTTTAC 
Bdf2fwd1214 GCAATGAAGTCCATTCAATG 
Bdf2fwd1643 CCGCAGATGAAATACTAACTTC 
 
 
2.1.8.7 Linker-Oligonucleotides 
 
Linker-oligonucleotides are pairs of long complementary nucleotides that were used for cloning 
new vectors with different multiple cloning sites (MCSs) or to introduce a variation in the NH2-
terminal tags of existing vectors used for proteinexpression. 
 
 
LinkerA-5’: 
  
NotI, NcoI, 
FLAG-tag, 
NdeI, SpeI, 
XbaI. 
 
AAGGAAAAAAGCGGCCGCCATGGCTGACTACAAGGACGACGATGACAAGC 
ATATGAGATCCACTAGTTCTAGACTAG 
 
 
LinkerA-3’ 
(complementary 
strand to 
LinkerA-5’): 
 
CTAGTCTAGAACTAGTGGATCTCATATGCTTGTCATCGTCGTCCTTGTAGTCAGC
CATGGCGGCCGCTTTTTTCCTT 
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LinkerB-5’: 
NcoI, 10x HIS-
tag, FLAG-tag, 
NdeI. 
 
CATGCCATGGCTCATCATCATCATCATCATCATCATCATCACATGGCTGACTACA
AGGACGACGATGACAAGCATATGGAATTCC 
 
 
LinkerB-3’: 
 
 
GGAATTCCATATGCTTGTCATCGTCGTCCTTGTAGTCAGCCATGTGATGATGATG
ATGATGATGATGATGATGAGCCATGGCATG 
 
 
2.1.9 Plasmids 
 
2.1.9.1 Cloning- and expressionvectors: 
 
pBluescript II KS+ (pBS, Stratagene) 
Standard vector for cloning purposes (www.stratagene.com). 
 
pTβSTOP (Jantzen et al. 1992) 
Derivate of pT7βSal (Norman et al. 1988) that carries a multiple-cloning-site- (MCS)-
insertion followed by three STOP-codons in three separate coding-frames. 
 
pVL-FLAG (Näär and Tijan 1995) 
Baculovirus-expressionvector and derivate of pAcSG2 (Pharmingen) containing an 
insertion for the sequence of the FLAG-epitope. This vector allows the production of 
recombinant baculoviruses to express NH2-terminal-FLAG-tagged fusionproteins in SF9-
cells. 
 
pVL-GST-FLAG (Kwoczynski S., 2002) 
Baculovirus-expressionvector, pVL-FLAG-derivate (Lichtsteiner and Tjian 1995) with an 
insertion of a 0.3 kbp GST-cDNA-fragment upstream of the sequence for the FLAG-
epitope. 
 
pBluescript-NotI/NotI-dTAFII250 (Kwoczynski 2002) 
pBluescript KS+ plasmid which contains the full length dTAFII250-cDNA. The cDNA 
consists of three additional sequence-sections, which are not listed in the sequence of 
the NCBI (ID NM_057608.2). These sections are coded by an exon in the NTK and the 
additional exons 12a and 13a in the CTK. 
 
pTβSTOP-dTAFII250-CT1500 (Kwoczynski 2002) 
pTβSTOP-derivate, contains an insert of the C-terminal part of dTAF1 (CTK), starting at 
aminoacid 1496.  
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2.1.9.2 Constructed vectors for cloning and expression: 
 
pBluescript-FLAG 
Derivate of pBluescript II KS+ with an insertion of the FLAG-tag sequence upstream of 
the MCS. This vector was constructed by inserting the annealed LinkerA-oligos (2.1.8.7) 
into pBluescript using the NotI/XbaI restriction sites. 
 
pBluescript-His-FLAG 
pBluescript KS+ derivate with an insertion of the (10xHis)-FLAG-tag sequence upstream 
of the MCS. This vector was constructed by inserting the annealed LinkerB-oligos 
(2.1.8.7) into pBluescript-FLAG using the NotI/NdeI restriction sites. 
 
2.1.9.3 Cloned constructs 
 
pTβSTOP-dTAF1CTK(D1541A) 
pTβSTOP-clone with insertion of the 1.9 kb CTK(D1541A)-PCR-fragment using 
NdeI/BamHI restriction sites. The PCR-fragment was amplified with the CTK-D1541A-
primers (2.1.8.1.) following the protocol for inserting pointmutations into DNA (2.2.1.14.). 
Template-DNA was the vector pTβSTOP-dTAFII250-CT1500. 
 
pTβSTOP-dTAF1CTK(M1537I-D1541A) 
pTβSTOP-clone with insertion of the 1.9 kb CTK(M1537I-D1541A)-PCR-fragment using 
NdeI/BamHI restriction sites. This PCR-fragment was amplified with the CTK-D1541A-
primers following the protocol for inserting pointmutations into DNA. Template-DNA was 
the vector pTβSTOP-dTAFII250-CT1500, but in this PCR, a second pointmutation (amino 
acid 1537 M -> I, codon ATG to ATA) was accidentally inserted, resulting in a double-
pointmutation. 
 
pTβSTOP-dTAF1CTK(D1725A) 
pTβSTOP-clone with insertion of the 1.9 kb CTK(D1725A)-PCR-fragment using 
NdeI/BamHI restriction sites. The PCR-fragment was amplified with the CTK-D1725A-
primers following the protocol for inserting pointmutations into DNA. Template-DNA was 
the vector pTβSTOP-dTAFII250-CT1500. 
 
pTβSTOP-dTAF1CTK∆ATP 
This pTβSTOP-construct carried the dTAF1CTK-insert lacking the putative ATP-binding 
domain. It was cloned in two steps: Fragment A was amplified in PCR with the primers 5’-
TAFII250-1500 / 3’-CTK∆ATP-A and inserted into pTβSTOP using NdeI/SalI. Fragment B 
was PCR-amplified with the primers 5’-CTK∆ATP-B1 / 3’-TAFII250-Ende and then 
inserted into the previously cloned pTβSTOP-dTAF1CTKA by using the restriction sites 
SalI/XbaI. This resulted in a CTK∆ATP construct which encodes amino acids 1496-1747 
and 1780-2132 respectively, replacing the ATP-domain with a single aspartatic-acid 
residue (D). 
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pVL-GST-FLAG-dTAF1CTK(D1541A) 
Expressionvector with the dTAF1CTK(D1541A)-insert cut out of pTβSTOP-
dTAF1CTK(D1541A) via NdeI/SmaI and ligated into pVL-GST-FLAG. 
 
pVL-GST-FLAG-dTAF1CTK(M1537I-D1541A) 
Expressionvector with the dTAF1CTK(M1537I-D1541A)-insert cut out of pTβSTOP-
dTAF1CTK(M1537I-D1541A) via NdeI/SmaI and ligated into pVL-GST-FLAG. 
 
pVL-GST-FLAG-dTAF1CTK(D1725A)  
Expressionvector with the dTAF1CTK(D1725A)-insert cut out of pTβSTOP-
dTAF1CTK(D1725A) via NdeI/SmaI and ligated into pVL-GST-FLAG. 
 
pVL-GST-FLAG-dTAF1CTK∆ATP 
Expressionvector with the 1.8 kb dTAF1CTK∆ATP-insert cut out of pTβSTOP-
dTAF1CTK∆ATP via NdeI/XbaI and ligated into pVL-GST-FLAG. 
 
pBluescript-FLAG-Bdf1 
Derivate of pBluescript with a 2.1 kb Bdf1-PCR-fragment, amplified using the primers 5’-
Bdf1-FLAG and 3’-Bdf1-Stop (2.1.8.1.) by following the protocol for PCR (2.2.1.2.1). The 
fragment was then cut with NcoI and EcoRI and ligated into a similar restriction-digested 
pBluescript-FLAG vector. 
 
pBluescript-His-FLAG-Bdf1 
Derivate of pBluescript-His-FLAG: This vector was constructed stepwise by insertion of 
fragments obtained from restriction-digests of pBluescript-FLAG-Bdf1:  
Fragment Bdf1-A was created by restriction-digest of pBluescript-FLAG-Bdf1 with NdeI 
and BamHI. Fragment Bdf1-B was created by restriction-digest of pBluescript-FLAG-Bdf1 
with BamHI and EcoRI. The Bdf1-A fragment was ligated into a similar restriction-
digested pBluescript-His-FLAG plasmid, creating the plasmid pBluescript-His-FLAG-
Bdf1-A. Fragment Bdf1-B was ligated into pBluescript-His-FLAG-Bdf1-A, which was cut 
with BamHI and EcoRI, creating pBluescript-His-FLAG-Bdf1.  
 
pBluescript-His-FLAG-Bdf2 
Derivate of pBluescript-His-FLAG: A 2.0 kb PCR-fragment of Bdf2 was amplified using 
the primers 5’-Bdf2-Start and 3’-Bdf2-Stop, cut with the restriction enzymes NdeI and 
XbaI and ligated into a similar cut pBluescript-His-FLAG. 
 
pVL-His-FLAG-Bdf1 
Derivate of pVL-FLAG: pBluescript-His-FLAG-Bdf1 was cut with the restriction enzymes 
NcoI and SmaI and the resulting His-FLAG-Bdf1-fragment was ligated into a similar cut 
pVL-FLAG vector. 
 
pVL-His-FLAG-Bdf2 
Derivate of pVL-FLAG: pBluescript-His-FLAG-Bdf2 was cut with the restriction enzymes 
NcoI and XbaI and the resulting His-FLAG-Bdf2-fragment was ligated into a similar cut 
pVL-FLAG vector. 
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2.1.10 Baculoviruses for expression in Sf9-cellculture 
 
Baculoviruses, which were created during this work to express proteins, are not additionally 
listed. The corresponding fusionproteins can be found in chapter three and are described by the 
constructed baculo-expressionvectors in chapter 2.1.9.3. 
 
GST-FLAG-dTAFII250CT1500 (S. Kwoczynski) 
Baculovirus for expression of the N-terminal GST-FLAG-tagged dTAF1CTK-
fusionprotein.  
 
2.1.11 Proteins 
 
2.1.11.1 Histones and histone-peptides 
 
Histone H2B: Purified Drosophila histone H2B, expressed in E. coli (F. Sauer). 
 
Histones H2A, H2B, H3 and H4 from Xenopus laevis: Recombinant purified histones, expressed 
in E. coli (F. Sauer). 
 
Histone-N-terminal-tail H2B-phosphoserine33-peptide (H2BT-S33P; Biosynthesis) for coupling 
to SulfoLink-columns, sequence: CKRKE(S-phospho)YAIY. 
 
Unphosphorylated Histone-N-terminal-tail H2B-serine-33-peptide (H2BT; Biosynthesis) for 
coupling to SulfoLink-columns, sequence: CKRKESYAIY 
 
Histone-N-terminal-tail H2B-peptide, sequence: 
MPPKTSGKAAKKAGKAQKNITKTDKKKKRKRKES. 
  
Histone-N-terminal-tail H3-peptide (H3T; S. Kwoczynski), sequence: 
MARTKQTARKSTGGKAPRKQLATKAARKS. 
 
Histone-N-terminal-tail H3-phosphoserine10/28-peptide (H3T-S10/28P; F. Sauer), sequence: 
MARTKQTARK(S-phospho)TGGKAPRKQLATKAARK(S-phospho). 
 
2.1.11.2 Fusionproteins  
 
His- and GST-FLAG-tagged fusionproteins, cloned and expressed by S. Kwoczynski and F. 
Sauer. These proteins were used for transkinase-assays and the UV-crosslinking experiments 
(Maile et al. 2004, Kwoczynski 2002). 
 
His-TAFII250-CT1500 (dTAF1CTK) 
Renatured poly-His-tagged dTAF1CTK fusionprotein starting at amino acid 1496 of 
Drosophila melanogaster TAF1, S. Kwoczynski. 
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GST-FLAG-TAFII250-CT1600 (dTAF1CTK∆1600) 
GST-FLAG-tagged dTAF1CTK fusionprotein starting at amino acid 1593 of Drosophila 
melanogaster TAF1, S. Kwoczynski. 
  
GST-FLAG -TAFII250-CT1800 (dTAF1CTK∆1800) 
GST-FLAG-tagged dTAF1CTK fusionprotein starting at amino acid 1797 of Drosophila 
melanogaster TAF1, S. Kwoczynski. 
  
GST-FLAG -TAFII250-CT1900 (dTAF1CTK∆1900) 
GST-FLAG-tagged dTAF1CTK fusionprotein starting at amino acid 1958 of Drosophila 
melanogaster TAF1, S. Kwoczynski. 
  
GST-FLAG -TAFII250-CT17-18 (dTAF1CTK17-18) 
GST-FLAG-tagged dTAF1CTK fusionprotein, ranging from amino acid 1594 to 1802 of 
Drosophila melanogaster TAF1, S. Kwoczynski. 
  
GST-FLAG -TAFII250-CT18-19 (dTAF1CTK18-19) 
GST-FLAG-tagged dTAF1CTK fusionprotein, ranging from amino acid 1797 to 1963 of 
Drosophila melanogaster TAF1, S. Kwoczynski. 
 
GST-FLAG-dTAF1∆CTK (dTAF1∆CTK) 
GST-FLAG-tagged dTAF1 full-length fusionprotein, but lacking the CTK due to site 
directed-mutagenesis using a primer pair, that introduces a stop codon behind amino 
acid 1728, F. Sauer. 
 
2.1.11.3 Other proteins 
 
TFIID (F. Sauer) 
 Purified Drosophila TFIID-complex (Maile et al. 2004). 
 
Nucleosomes (F. Sauer)  
Purified nucleosomes from 0-6 h old Drosophila embryos (Maile et al. 2004). 
 
Octamers (F. Sauer) 
 Purified octamers from Schneider S2 cells (Maile et al. 2004). 
 
2.1.12 Media, Buffers and Stock Solutions 
 
All solutions were prepared in Milli-Q-filtered dH2O unless otherwise mentioned below. Solutions 
which needed to be sterile were autoclaved or sterile-filtered depending on solution type. The pH 
of the solutions was adjusted with HCl and NaOH unless otherwise mentioned below. 
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2.1.12.1 Media 
 
LB-media    1 %  peptone 
     0,5 %  yeast extract 
     0,5 %  NaCl 
 
LB-agar-media   1.5 %   agar-agar in LB-media 
 
SOB-media:    20 g  tryptone 
     5 g  yeast extract 
     0.5 g  NaCl 
     2.5 mM  KCl 
     pH 7.0 
     add dH2O to a final volume of 1 l 
     autoclave 
     add 5 ml sterile 2 M MgCl2 just before use 
 
serum-free Sf9-media:  1 l  SF900II serum-free media 
     1%  Pluronic® F-68 
     1%  L-Glutamin/Penicillin/Streptomycin-Mix 
 
2.1.12.2 Buffers 
 
AP-buffer:    100 mM Tris-HCl, pH 8.0 
     100 mM NaCl 
     50 mM  MgCl2 
 
10x PAGE-buffer:   2 M  Glycine 
     250 mM Tris-HCl pH 8.3 
 
SDS-PAGE-runningbuffer  4.5 l  dH2O 
     500 ml  10x PAGE-buffer 
     25 ml  20 % SDS 
 
Transferbuffer I:   3.5 l   dH2O 
(proteins <150 kDa)   1 l  Methanol 
     500 ml  10x PAGE-buffer 
     2.5 ml  20 % SDS    
      
Transferbuffer II:   50 mM  Tris-HCl pH 8.3 
(proteins >150 kDa)   380 mM Glycine 
     0.1 %  SDS (w/v) 
     20 %  Methanol 
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4x SDS-loadingbuffer:  125 mM Tris-HCl pH 6.8 
     10 %  β-Mercaptoethanol 
     6 %  SDS 
     20 %  Glycerol 
     1 grain/10ml Bromophenolblue 
 
TBjap-buffer:    10 mM  Pipes 
(Transformationbuffer japanese) 15 mM  CaCl2 
     250 mM KCl 
     set pH to 6.7 (KOH) 
     55 mM  MnCl2 
     filter-sterilization 
 
5x TBE-buffer :   54 g  Tris-HCl pH 8.0 
     27.5 g  Boric acid 
     20 ml  0.5 M EDTA 
     add dH2O (Milli-Q) to a total volume of 1 l 
 
TBST-buffer:    100 mM Tris-HCl pH 8.0 
     150 mM NaCl 
     0.1 %  Tween®20 
 
TE-buffer:    10 mM  Tris-HCl, pH 8.0 
     1 mM   EDTA 
 
Plasmidprep-lysisbuffer:  7.8 ml  3.2 M LiCl 
(LiCl-method)    1.3 ml  0.5 M EDTA pH 8.0 
     0.4 ml  10% Triton X 100 
     0.25 ml 2 M Tris pH 7.5 
     0.25 ml dH2O 
     250 µl   Lysozyme stock solution 
 
DNA-loadingbuffer 10x:  50%  Glycerol 
     0.1%  Orange-G  
     49.9%  1x TBE-buffer 
 
5x HEMG-buffer:   125 mM Hepes pH 7.6 
     62.5 mM MgCl2 
     0.5 mM EDTA 
     50 %  Glycerol 
 
0.5 – 1 M KCl-HEMG-buffer:  0.5 - 1 M KCl 
     0.2 M   PMSF 
     1 %  NONIDET® P40 
     20%  5x HEMG-buffer 
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His-lysisbuffer:   25 mM  Hepes pH 7.9 
     1 M  NaCl 
     10 %  Saccharose 
     5 mM  Imidazol 
     0.2 mM PMSF 
 
Buffer A:    25 mM  Hepes pH 7.9 
     200 mM NaCl 
     10 %  Saccharose 
     5 mM  Imidazol 
     0.2 mM PMSF 
 
Buffer B:    25 mM  Hepes pH 7.9 
     200 mM NaCl 
     10%  Saccharose 
     500 mM Imidazol 
     0.2 mM PMSF 
 
Guanidinium-lysisbuffer:  6 M  Guanidinium 
     25 mM  Hepes pH 8.0 
     250 mM NaCl 
 
Buffer C1:    8 M  Urea 
     25 mM  Hepes pH 8.0 
     250 mM NaCl 
 
Buffer C2:    as C1 but with 50 mM imidazol instead 
 
Buffer D:    8 M  Urea 
     25 mM  Hepes pH 8.0 
     250 mM NaCl 
     1 M  Imidazol 
 
Renaturationbuffer:   100 mM Tris-HCl pH 7.5 
     7.5 mM EDTA 
     100 mM NaCl 
     1 M  Arginin 
     10 mM  DTT 
     0.2 mM PMSF 
 
Kinasebuffer:    25 mM  Hepes pH 8.0 
     12.5 mM MgCl2 
     100 mM KCl 
     0.1 mM EDTA 
     0.1 %  NONIDET® P40 
     0.2 mM PMSF 
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Membrane-renaturationbuffer: 140 mM NaCl 
     10 mM  Tris-HCl pH 7.5 
     2 mM  EDTA 
     0.1 %  NONIDET® P40 
     2 mM  DTT 
 
Guanidine-denaturationbuffer: 7 M  Guanidine-HCl 
     50 mM  Tris-HCl pH 8.3 
     2 mM  EDTA 
     50 mM  DTT (added fresh) 
 
TBS (Tris buffered saline):  10 mM  Tris-HCl pH 7.5 
     140 mM NaCl 
 
10x PBS:    1.4 M   NaCl 
     27 mM  KCl 
     100 mM  Na2HPO4 
     18 mM  KH2PO4 
     pH 7.3 
 
XChIP-lysisbuffer:   25 mM  Tris, pH 7.5 
     140 mM NaCl 
     1 mM   EDTA 
     1 %   Triton-X-100 
     0.1 %   SDS 
     filter-sterilization 
 
IP1:     similar as XChIP-lysisbuffer but with 500 mM NaCl instead  
 
IP2:     10 mM  Tris, pH 8.0 
     250 mM  LiCl 
     0.5 %   NONIDET® P40 
     0.5 %   Sodiumdesoxycholate 
     1 mM   EDTA 
     filter-sterilization 
 
2.1.12.3 General stock solutions 
 
Ethidiumbromide solution:  10 mg/ml Ethidiumbromide in dH2O 
 
Ampicillin stock solution:  100 mg/ml  Ampicillin (Na-salt) 
 
PMSF-stock solution:   100 mM  PMSF in dH2O 
 
Lysozyme stock solution:  10 mg/ml Lysozyme in dH2O 
 
Proteinase-K solution:  20 mg/ml Proteinase K in dH2O 
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NBT-solution:    0.5 g  Nitro-blue-tetrazolium-chloride 
     10 ml  70 % dimethylformamide (dH2O) 
 
BCIP-solution:   0.5 g  5bromo-4chloro-3indolylphosphate 
       (disodium salt) 
     10 ml  100 % dimethylformamide 
 
2.1.12.4 Proteingel solutions 
 
Coomassie-destaining-solution: 10 %  Acetic acid 
     45 %  Methanol 
     45 %  dH2O 
 
Coomassie-staining-solution: 0.25 %  Coomassie® R250 Brilliant Blue 
     9.75 %  Acetic acid 
     45 %   Methanol 
     45 %  dH2O 
 
SDS-PAGE-resolving-gel:  25 %  4x resolving-gel buffer: 
(in dH2O)    6 – 18 % Acrylamide (depending on gel concentration) 
     0.1 %  TEMED 
     0.6 %  APS 
      
SDS-PAGE-stacking-gel:  25 %   4x stacking-gel buffer 
(in dH2O)    4 %  Acrylamide 
     0.1 %  TEMED 
     0.6 %  APS 
 
4x resolving-gel buffer:  1.5 M  Tris-HCl pH 8.8 
(lower tris buffer)   0.4 %  SDS 
 
      
4x stacking-gel buffer:  0.5 M  Tris-HCl pH 6.8 
(upper tris buffer)   0.4 %  SDS 
 
2.1.12.5 Silverstaining-solutions 
 
Fixative 1:    400 ml  Ethanol 
     100 ml  Acetic acid 
     add dH2O (Milli-Q) to a total volume of 1 l 
 
Fixative 2:    300 ml  Ethanol 
     2.5 g  Potassium tetrathionate 
     41 g   Sodium acetate, anhydrous 
     add dH2O (Milli-Q) to a total volume of 1 l 
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Silvernitrate-solution:   2 g  AgNO3 
     add dH2O (Milli-Q) to a total volume of 1 l 
     add 250 µl 37 % formaldehyde just before use 
 
Developer-solution:   15 g  Potassium carbonate 
     7.5 mg  Sodium thiosulfate 
     add dH2O (Milli-Q) to a total volume of 1 l 
     add 150 µl 37 % formaldehyde just before use 
 
Stop-solution:    50 g  Tris base 
     20 ml  Acetic acid 
     add dH2O (Milli-Q) to a total volume of 1 l 
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2.2 Methods 
 
2.2.1 Analysis and Manipulation of Nucleic Acids 
2.2.1.1 Photometric determination of DNA/RNA concentrations 
Nucleic acids absorb light in the ultraviolet range. The absorption-maximum of DNA is at 260 
nm, RNA and proteins (aromatic residues) at 280 nm respectively. To determine the 
concentration of DNA, the sample was tested for absorption at 260 nm in a spectrophotometer 
(2.1.1). To determine the degree of impurities due to RNA and proteins the absorption (optical 
density or OD) at 280 nm was also measured. The quotient of OD260/OD280 is an indicator for the 
purity of DNA and lies within 1.8 to 2.0 for pure (column purification) solutions. For calculation of 
the DNA-concentration, following conventional unit was used: an OD260 of 1 resembles a 
concentration of 50 µg double-stranded DNA per ml. 
 
2.2.1.2 Polymerase chain reaction (PCR) 
2.2.1.2.1 PCR for cloning of cDNA-fragments 
To amplify cDNAs out of template DNA-pools (Plasmidpreps, Libraries), primers containing 
specific restrictionenzyme cutting sites were created (2.1.8.2). The PCR reaction used 50-100 
ng DNA template, 1-2 U DeepVent proofreading polymerase (NEB), 2 µl of 10x ThermoPol 
reaction buffer (NEB), 1 µl of 2.5 mM dNTP-Mix (TaKaRa) and 1 µM endconcentration of the 
corresponding 5’- and 3’-Primer. The reaction was set to a total volume of 20 µl (ad dH2O). After 
initial denaturation of 95°C for 1.5 min. around 25 to 30 amplification cycles followed: melting 
temperature was set to 95°C (30 sec.), annealing around 5°C below the average melting 
temperature of the specific primerpair (45 sec.) and elongation was set to 75°C (1 min. per 1kb 
fragment length). The PCR ended with a final elongation at 75°C for 20 min. The amplified DNA 
was analyzed and purified afterwards via gelelectrophoresis on an agarose gel (2.2.1.6). 
 
2.2.1.2.2 PCR for standard detection of specific DNA-sequences 
To detect primer specific DNA-sequences in a sample by amplification, a PCR-reaction was set 
up as described above, but with ExTaq-Polymerase (TaKaRa) using same amounts of ExTaq-
buffer. Denaturation temperature was set to 94°C, elongation to 72°C.  
 
2.2.1.2.3 PCR for real-time quantitative detection of specific DNA-sequences (QPCR) 
Detection of amplified cDNA in real-time was performed using an ABI 7700 light cycler. The 
reaction (20 µl total volume) used 8 µl of HotMasterMix (Eppendorf), 2 µl of template DNA, 1 µM 
primers, SYBR-Green (Molecular Probes) as corresponding dye (final concentration 1:10000) 
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and ROX (Stratagene) as reference dye (final concentration 1:300). 40 cycles were performed 
and temperature steps were set as described in 2.2.1.2.2.  
The comparative threshold cycle (CT) method was used to compare the various amplification 
results obtained: The threshold cycle (CT) represents the fractional cycle number at which two or 
more different PCR reactions amplify DNA at the exact same ratio.  
 
2.2.1.2.4 Reverse-Transcriptase-PCR (RT-PCR) 
RNA, isolated with the midiprep kit from Qiagen, was measured on a spectrophotometer (Biorad) 
and used in a concentration of 10 µg per reaction. The RNA has been incubated at 65°C for 5 
min and subsequently cooled down on ice. For the reverse transcriptase (RT) reaction 20 µl of 
5x RT-buffer (Invitrogen), 10 µl 0.1 M DTT, 10 µl random hexamer primers (Boehringer 
Mannheim [200 ng/µl]), 10 µl of 10 mM dNTPs, 2.5 µl RNasin and 2 µl Superscript RT were 
added and the sample was set to a total volume of 100 µl (dH2O). After incubation at 37°C for 1 
h the sample was heated up to 95°C for 5 min and then cooled down on ice. The cDNA 
produced with this reaction could be stored at -20°C or immediately analyzed via PCR 
(2.2.1.2.2). 
 
2.2.1.3 Annealing of single-strand DNA (ssDNA) 
To create double-strand DNA (dsDNA) out of ssDNA strands like linker-oligonucleotides, 20 µg 
of each complementary oligonucleotide was added to a volume of 40 µl Milli-Q dH2O containing 
4 µl NEB-buffer 3 and mixed by inversion. The sample was heated up to 95°C for 5 min and then 
cooled down at room temperature. The annealed dsDNA was then frozen at -20°C or 
immediately digested with restrictionenzymes (2.2.1.4). 
 
2.2.1.4 Digestion of DNA with restrictionendonucleases 
The digestion of DNA with restrictionendonucleases was performed in a standard volume of 20 
µl with sticky-end or blunt-end cutting restriction enzymes of bacterial origin. Single and double 
digest temperature, usage of BSA as a stabilizing agent and buffer settings were chosen 
following the recommendations of the manufacturer (NEB). 2-5 U (units) of enzyme were used 
for 2 h digest assays, overnight digests were performed using 5 U of enzyme. Digested DNA 
was either dephosphorylated (2.2.1.5) or directly analyzed and purified via gelelectrophoresis 
(2.2.1.6). 
 
2.2.1.5 Dephosphorylation of linearised plasmids 
To prevent intramolecular religation with the 3’-hydroxy-ends of digested linearised vector-DNA 
in following ligation reactions, the free 5’-phosphate-groups of the vectors were removed using 
shrimp alkaline phosphatase (SAP, Boehringer Mannheim) directly after digestion. 2.3 µl of 10x 
dephosphorylation buffer and 1 U of shrimp alkaline phosphatase were added to 20 µl digestion 
sample and incubated at 37°C for 1 h. The sample was then purified from contaminants using 
gelelectrophoresis (2.2.1.6). 
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2.2.1.6 Agarosegelelectrophoresis 
Depending on the size of the expected DNA-fragments, gels were used within concentrations of 
0.7 - 2% agarose. The specific amount of agarose was solubilised in 1x TBE by melting in a 
microwave and poured into a gel tray (custom DNA-gel system, 2.1.1) after addition of 
ethidiumbromide-solution (0.1 µl/ml of gel). 10x DNA-loadingbuffer has been added to the DNA 
samples in 1/10 concentration and the samples have been separated by electrophoresis. 0.1–1 
µg DNA in 20-25 µl sample volume was separated, “Gene-Ruler™ 1 kb DNA ladder” (MBI) was 
used as DNA marker (0.1-1 µg). The gel was then analyzed and documented using the “Eagle 
Eye” UV-system (Stratagene). 
 
2.2.1.7 Isolation of DNA-fragments out of agarose gels 
DNA was extracted of agarose gels using the Perfectprep Gel Cleanup Kit from Eppendorf 
(2.1.2). The fragment of interest was cut out of the gel, melted in a binding buffer and then 
bound to the column matrix by means of centrifugation. Following a washing step, the purified 
DNA can be eluted using water or buffer. 
 
2.2.1.8 Ligation of DNA-fragments 
Ligation of DNA-fragments was done using the Quick Ligation Kit from NEB. Dephosphorylated 
vector-DNA and insert-DNA were combined in a volume of 10 µl, containing at least five molar 
excess of insert. 10 µl of 2x ligation buffer (NEB) was added and the sample was vortexed 
shortly. 1 µl of Quick T4 DNA ligase has been added, the sample was incubated for 5 min. at 
25°C and then cooled down on ice. The ligated DNA could be stored at -20°C or directly 
transformed into E.coli cells. 
 
2.2.1.9 Growing transformation-competent E.coli cells 
The establishment of transformation-competent cells followed a modified method of Stratagene’s 
Epicurian competent XL-1 blue (Inoue et al. 1990):  
E. coli XL-1 blue cells (2.1.6) were grown over night in 5 ml SOB media. The culture was 
transferred afterwards into 250 ml SOB media and grown at 18°C for approximately 31 h until it 
reached an OD600 of 0.6. It was then incubated on ice for 10 min and centrifuged in a precooled 
Sorvall GS3 rotor for 10 min with 2500 g at 4°C. Meanwhile 2 ml of 100% DMSO was added to 
100 ml of TBjap (2.1.12.2). After centrifugation, the supernatant has been discarded and the cell 
pellet has been resuspended in 80 ml TBjap buffer with DMSO. The suspension was incubated 
on ice for 10 min and centrifuged again. The supernatant has been discarded and the pellet was 
resuspended in 18.6 ml of precooled TBjap (without DMSO). After adding 1.4 ml of DMSO to the 
suspension (final concentration of 7%), it was incubated again on ice for 10 min. After incubation 
the cell suspension was dispensed into 200 µl aliquots in cryotubes which have been frozen 
immediately in liquid nitrogen and were stored at -80°C. 
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2.2.1.10 Transformation of competent E.coli cells 
Frozen competent XL-1 blue cells were slowly thawed on ice. Pre-chilled DNA sample (25 ng 
ligation-mixture-DNA or 100 ng plasmid-DNA) was added to 100 µl of cells, the sample was 
mixed gently and incubated on ice for 30 min. After the following heat shock of 37°C for 1.5 - 2 
min, the sample was chilled on ice again for 5 min. 900 µl of SOB or LB media was added and 
the solution was incubated at 37°C for 1 h. 100µl were spread on a 1:10 dilution LB-agar-plate 
containing 0.1 mg/ml ampicillin. The remaining 900 µl were centrifuged, the cell pellet was 
resuspended in 100 µl media and spread on a 1:1 plate. The plates were incubated at 37°C over 
night and checked for colonies the next day. Single colonies were picked with a pipet tip, 
transferred into a bacteria-culture vial with 5 ml LB-media containing 0.1 mg/ml ampicillin and 
were grown over night in an incubator-shaker. 
 
2.2.1.11 Isolation of plasmid-DNA out of E.coli cells 
2.2.1.11.1  Plasmid isolation with LiCl 
1.5 ml out of the 5 ml overnight culture (2.2.1.9) were centrifuged (5 min, 1000g, Eppendorf 
centrifuge) and the resulting cell pellet was resuspended in 200 µl plasmidprep-lysisbuffer 
(2.1.12.2). After incubation for 5 min at room temperature, the sample was boiled at 100°C for 
90 sec and immediately cooled on ice. Chromosomal DNA and denatured proteins were 
separated from the plasmid-DNA by centrifugation at 16000g for 8 min and the formed pellet 
was removed from the plasmid containing supernatant using a pipet tip. The plasmid-DNA was 
precipitated then by adding 0.7 volumes of isopropanol, incubated at room temperature for 10 
min and centrifuged at 16000g for 15 min. The supernatant was discarded, the DNA-pellet 
washed with 70% ethanol and centrifuged again at 16000 g for 5 min. The supernatant was 
pipetted off carefully and the pellet was dried in the speedvac concentrator. After the sample 
was dry, the DNA got resuspended in 20 µl dH2O. 
 
2.2.1.11.2  Plasmid isolation with the QIAGEN Miniprep kit 
To isolate plasmid-DNA with additional purification through a mini size column, the Qiagen 
miniprep kit was used. The isolation was performed following the protocol of the manufacturer. 
For each column DNA of 3 ml of the 5 ml overnight culture was used. The DNA has always been 
eluated from the column using 30 µl eluation buffer of the manufacturer. 
 
2.2.1.11.3  Plasmid isolation with the QIAGEN Maxiprep kit 
To isolate plasmid-DNA with additional purification through a maxi size column, Qiagens 
maxiprep kit was used. The 5 ml overnight culture was inoculated into a 250 ml LB-culture and 
again grown over night. The isolation was performed according to the protocol of the 
manufacturer, the plasmid-DNA was eluated in 100-500 µl TE-buffer. 
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2.2.1.12 Isolation of RNA out of S2 cells 
For isolation of RNA out of Schneider S2 cells, the RNA midiprep kit from Qiagen was used. The 
experiment was done following the manufacturers protocol and the total amount of cells used 
per preparation was within the recommended range of 3–4x107 cells. 
 
2.2.1.13 Phenole-chloroform extraction of DNA 
To purify DNA-samples from hydrophobic impurities like lipids or proteins the samples were 
treated with phenole and ethanole-precipitated: 
The total volume of the DNA-sample was set to 100 µl with TE-buffer (pH 8.0), 200 µl phenole 
was added and the sample was mixed (Vortex) and centrifuged at max speed for 1 min 
(Eppendorf microfuge). The upper aqueous phase was pipetted off into a new microcentrifuge 
tube and 100 µl TE were added to the remaining lower phenole phase to extract additional DNA. 
The two forming phases were mixed and centrifuged again and the aqueous phase was 
removed as before and combined with the first 100 µl of DNA-fraction. After adding 200 µl 
chloroform to the sample, it was mixed and centrifuged as before and the upper phase was 
pipetted into a new centrifuge tube.  
To precipitate the DNA, 400 µl ice cold ethanol and 1 µl glycogen [20 mg/ml] was added to the 
sample which was then incubated for 30 min at -80°C. After incubation, the sample was 
centrifuged at max speed for 20 min, and the ethanol was discarded. The DNA-glycogen pellet 
was washed with 1 ml of 70% ethanol and the sample was centrifuged for another 20 min at 
max. speed. The ethanol was carefully pipetted off and the DNA was air-dried at room 
temperature. After the DNA was dry, the pellet was resuspended in 30 µl of dH2O. 
 
2.2.1.14 Insertion of point mutations in DNA 
Point mutations were inserted into DNA using the QuikChange™Site-Directed Mutagenesis Kit 
protocol from Stratagene: 
Site specific complementary primers, which both bind to the sequence to be mutated and 
carrying the desired pointmutations were used to amplify DNA from a template plasmid. The 
enzyme DpnI was then used to digest the methylated non-mutant template DNA but not the 
unmethylated nicked circular strands that were amplified from it by the polymerase. The 
undigested DNA was then transformed into competent XL-1 blue cells, which repaired the nicks, 
forming mutated plasmid-DNA, to be analyzed by sequencing. The DNA of those clones which 
carried the specific pointmutated plasmid was then restriction-digested and re-cloned into a new 
plasmid to avoid complications due to unwanted mutations within the old vector during PCR. 
The procedure was done following the settings in the protocol of the manufacturer, except that 
ExTaq-Polymerase (TaKaRa, 5 U/µl) was used as polymerase and 5 µl of the amplified sample 
was added to 100 µl XL-1 blue bacteria suspension for transformation. 
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2.2.2 Analysis and Manipulation of Proteins 
 
2.2.2.1 SDS-polyacrylamide-gelelectrophoresis (SDS-PAGE) 
The separation of proteins according to their molecular weight was done via discontinual SDS-
polyacrylamide-gelelectrophoresis following the method of Laemmli (Laemmli 1970): 
Depending on the molecular weight of the separated proteins, matrixes of concentrations 
between 6 – 18% polymerised acrylamide were created:  
Two glassplates of specific size were assembled, which were divided from each other by two 
vertical spacers of specific width (0.75 – 1.5 mm) on the sides and sealed on the bottom by 
another spacer (custom maxigel system) or a rubber mat (BioRad Protean minigel system). The 
resolving-gel (2.1.12.4) was then pipetted between the glassplates to polymerise at room 
temperature. Isopropanole was filled above the liquid resolving-gel solution before 
polymerisation to create a flat resolving-gel surface. After the gel was polymerised, the 
isopropanole was discarded, the gel surface was washed with MilliQ-dH2O and the lower 
concentrated stacking-gel (2.1.12.4) was poured on top of the resolving-gel. Before the stacking-
gel could polymerise, a comb of sample-specific length and width was stuck into the stacking-
gel, creating slots for loading the proteins into the gel. Protein samples were boiled in SDS-
loadingbuffer at 100°C for 5 min before they were loaded on the gel to disrupt the spacial 
structure (secondary, tertiary and quartiary structures) of the proteins within the β-
mercaptoethanole-containing buffer and to anneal the SDS to create an overall negative charge 
according to the size of the protein for the electrophoretic separation in the gel. 
The electrophoresis was started at 80 V (minigels) to 100 V (maxigels) to stack the proteins 
within the stacking-gel and set to 150 V (minigels) to 200 V (maxigels) once the proteins entered 
the resolving-gel. 
 
2.2.2.2 Coomassie-staining of SDS-PAGE gels 
To visualize electrophoretically separated proteins in a SDS-gel, the gels were incubated for 30 
min to overnight in Coomassie-stainingsolution (2.1.12.4). Afterwards the gels were incubated 
with several washes of destaining-solution (2.1.12.4) until bands became visible. The gel was 
washed with dH2O, documented and dried onto Whatman-paper with a vacuum-geldryer (2.1.1) 
at 80°C for 1-2 h. 
 
2.2.2.3 Silverstaining of SDS-PAGE gels 
Silverstaining allows a detection of proteins which is 10-100 x more sensitive than Coomassie 
staining: 
The gels were incubated in fixative 1 (for all solutions used, see 2.1.12.5) for 1 h and then again 
1 h in fixative 2. After fixation of the protein bands, the gels were washed in Milli-Q dH2O 4x for 
15 min. The gel was sensitized for 1 min in 0.1mM sodium thiosulfate solution and rinsed 3x for 
20 sec in Milli-Q dH2O. To stain the gel, it was incubated in silvernitrate-solution for at least 30 
min and afterwards washed again in Milli-Q dH2O for 1 min. The gel was placed into developer-
solution for up to 30 min to visualize faint protein bands. When the gel was stained at the desired 
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intensity, the reaction was stopped placing the gel into stop-solution for 10 min. The gels were 
documented afterwards and stored in 1% acetic acid (Milli-Q dH2O) at 4°C or dried onto 
Whatman-paper as in 2.2.2.2. 
 
2.2.2.4 Immunodetection of SDS-PAGE proteins (western-blot) 
The power of the technique lies in the simultaneous detection of a specific protein by means of 
its antigenicity, and its molecular mass: proteins are first separated by mass in the SDS-PAGE, 
then specifically detected in the immunoassay step: 
SDS-PAGE separated proteins can be transferred out of the gel onto a membrane in an 
electrical field without changing the separation pattern of the bands. Once on the membrane, 
protein bands can be immunologically assigned to specific proteins using specific antibodies in 
various immunodetection methods. 
 
2.2.2.4.1 Western-blot and primary antibody 
Transfer-membranes used for the western-blot analysis were either nitrocellulose- or PVDF-
membranes. PVDF-membranes needed to be activated by a short incubation in methanol before 
the blotting procedure and were then, like the nitrocellulose membranes, equilibrated in 
transferbuffer. Two different transferbuffers (blottingbuffers) were used, transferbuffer II (Harlow 
1999) for proteins above 150 kDa and transferbuffer I for smaller sized proteins. 
Proteins were blotted using BioRad’s Mini Trans-Blot transfer cell, at 300 mA (around 5 mA/cm2 
gel-surface). The blotting setup (“blotting sandwich”, in blotting direction left to right) consisted of 
one fiber pad, three Whatman-filterpapers, SDS-PAGE gel, membrane, another three Whatman-
filterpapers and the second fiber pad. If necessary, the blot was checked by staining the proteins 
on the membrane with Ponceau S and marking their position by piercing the membrane with a 
sterile needle. The membrane was incubated in blocking-solution (5% skim milk powder in 
TBST-buffer, 2.1.12.2) for 1 h at room temperature. The blocking-solution was discarded, the 
membrane was washed 3x for 10 min in TBST and incubated in the primary-antibody-TBST-
dilution (set according to the antibody manufacturers protocol) for 1 h at room temperature or at 
4°C over night. To remove remaining primary antibody, the membrane was washed again in 
TBST as before. The membrane was now ready to be incubated with the secondary antibody. 
 
2.2.2.4.2 Immunodetection with alkaline phosphatase 
In this type of immunodetection, the secondary antibody was coupled to the enzyme alkaline 
phosphatase (AP) and was diluted in TBST according to the manufacturers protocol. After 
incubation with the secondary-antibody-TBST-dilution at room temperature for 1 h, the 
membrane was washed again 3x for 10 min with TBST and then incubated in AP-buffer 
(2.1.12.2) with 4.5 µl/ml NBT and 3.5 µl/ml BCIP until the bands became visible and the reaction 
was stopped then by adding dH2O. 
 
2.2.2.4.3 Immunodetection with chemiluminescence (ECL-Plus-Kit) 
The ECL-Plus-Kit (Amersham) uses biotinylated antibodies to detect proteins via 
chemiluminescence through the enzyme horse-raddish-peroxidase (HRP). After incubation with 
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the secondary-antibody-TBST-dilution and washing in TBST 3x for 10 min, the membrane was 
incubated in streptavidin-HRP solution (1:3000 in TBST) for 1 h at room temperature. The 
membrane was washed again in TBST as before and put in between two plastic foils with 1 ml of 
the ECL-solution (according to the manufacturers protocol). The fluorescence signals were 
detected using a Kodak X-Omat film in the darkroom within 5 min to 1 h.  
 
2.2.3 Expression and Purification of recombinant Proteins out of Sf9-cells 
 
For expression of the different tag-fusionproteins in Spodoptera frugiperda (Sf9) cells, the 
baculovirus-system was used: 
pVL-baculovectors were cloned (2.1.9) and the specific viruses were created. For other proteins, 
certain baculoviruses already existed (F. Sauer). 
 
2.2.3.1 Growing Sf9-cells in cell culture 
Frozen Sf9-cells (-80°C) were quickly thawed at 37°C and transferred into a 100 ml cell-culture 
flask containing 20 ml serum-free Sf9-media (2.1.12.1). The cells were grown at 27°C, changing 
the media every two days until a stable adherent layer of young cells had been formed. The cells 
were then transferred into a spinner-flask and kept as suspensionculture, checking the amount 
of cells with a cell counting chamber (Neubauer) every two days. Cell numbers were kept at 1-
2x106 cells per ml by repeated dilution of the culture with fresh media. To create backup-
samples for growing new cell cultures, 1x106 cells per ml were slowly frozen to -80°C in fetal-
bovine-serum containing 10% DMSO. 
 
2.2.3.2 Baculovirus-transfection 
2.2.3.2.1 Primary transfection 
To create recombinant baculoviruses in the primary transfection, 106 Sf9-cells were pipetted in 
each cavity of a 6-well-plate and incubated at room temperature for 15-30 min to settle down 
and adhere to the plate. Mix A (175 ng Baculo Gold-DNA, 1.3-1.5 µg plasmid-DNA and 33µl 
serum-free Sf9-media) and Mix B (10µl Cellfectin reagent and 23 µl serum-free Sf9-media) were 
prepared seperately, then combined, mixed and incubated for 15 min at room temperature. After 
incubation, the Sf9-cells were washed 3x with 1 ml serum-free Sf9-media to remove old media 
and cell debris. 440 µl serum-free Sf9-media was added to mixture AB and the complete 
transfection-solution was added to the cells. The plate was sealed with parafilm to prevent 
dehydration and incubated on a rocker at low speed for 15 h at room temperature. The 
transfection-solution was pipetted off and the transfected cells were washed once with serum-
free Sf9-media. 2 ml media was added to the cells which were sealed again and incubated at 
27°C for 5 days. The cells were resuspended and the solution was centrifuged at 1000 rpm for 5 
min at 4°C (Eppendorf microfuge). The supernatant was taken off and stored at -80°C or directly 
used for the amplification step. 
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2.2.3.2.2 Amplification and proteinexpression-test 
The virus-concentration after primary transfection is usually low and there is no detectable 
proteinexpression at this stage. Therefore, the virus needs to be amplified in order to determine 
if the protein is expressed or not. 
7.5x106 Sf9-cells were spread on a 10 cm cell culture dish and settled down for 15 min. The old 
culture media was replaced with 2.5 ml fresh Sf9-media and 1 ml of the primary transfection 
supernatant was added. The plate was incubated on a rocker for 1 h at room temperature and 
then 10 ml Sf9-media were added to the cells. The plate was incubated afterwards at 27°C for 5 
days and the cells were resuspended and centrifuged as before in sterile 15ml tubes (Eppendorf 
centrifuge 5810R, rotor A-4-62). The supernatant was stored or used for a proteinexpressiontest. 
To test if the transfection was successful and protein is expressed, 7.5x106 cells were spread on 
a 10 cm cell culture dish, settled down and washed as before. 0.5-1 ml of the amplification-
supernatant was added and the solution was incubated for 1 h, slowly rocking. 10 ml media were 
added to the plate and the cells were incubated at 27°C for 2 days. After incubation, the media 
was removed, the cells were harvested and the protein purified for analysis with SDS-PAGE. 
 
2.2.3.2.3 Reamplification and proteinexpression 
After the transfected cells proved to express the protein, the virus was amplified again in order to 
be concentrated highly enough for a larger scale proteinexpression. 
12x106 Sf9-cells were spread on a 15 cm cell culture dish and settled down for 15 min. The 
media was discarded and 5 ml fresh Sf9-media and 50 µl of the amplification supernatant was 
added. The plate was incubated on a rocker for 1 h at room temperature and 15 ml Sf9-media 
has been added to the cells. The cells were incubated afterwards at 27°C for 5 days and then 
resuspended and centrifuged as before in sterile 50 ml tubes. The supernatant was stored or 
used for proteinexpression. 
To express the protein in a larger scale, amounts between 200 – 500ml of 106 cells/ml were 
added into a 4 l erlenmeyer flask. Between 1/50 – 1/100 volumes virus-reamplification-
supernatant was added and the expression-culture incubated for 2-3 days at 27°C in a 
incubator-shaker (2.1.1) before the cells were harvested and protein was purified. 
 
2.2.3.3 Purification of Sf9-expressed, FLAG-tagged proteins 
2.2.3.3.1 Cell extracts of FLAG-protein-expressions 
The protein expressing cells were harvested by decanting (shaker cultures) or resuspending with 
a pipet (culture plates) into appropriate centrifuge tubes. They were centrifuged at 4°C and 2000 
rpm (Eppendorf centrifuge 5810R, rotor A-4-62) for 10 min, after this centrifugation step all other 
steps were done at 4°C. The cell pellet was resuspended in 1ml/plate or 40ml/erlenmeyer 0.5 M 
KCl-HEMG-buffer (2.1.12.2) and twice freezed in liquid nitrogen and thawed again to open the 
cells. The sample was sonified 2x for 15 sec and the cell debris was removed by centrifugation 
for 20 min (4°C) at 13000 rpm (Sorvall RC-5 superspeed centrifuge, SS34 rotor). The 
supernatant was subsequently passed through a 0.45 µm and a 0.20 µm filter. The filtrate was 
used directly for binding to FLAG-beads or was frozen in liquid nitrogen and stored in a low 
temperature freezer at -80°C. 
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2.2.3.3.2 Purification with FLAG-beads 
Anti-FLAG M2 affinity beads (FLAG-beads) were washed once with 0.8 M KCl-HEMG-buffer and 
incubated with the cell extract filtrate (2.2.3.3.1.) over night on a nutator at 4°C. The sample was 
centrifuged for 5 min at 1000 rpm (4°C) and 3x washed with 1 M KCl-HEMG-buffer, carefully 
centrifuging the beads as before. The third wash with 1 M KCl-HEMG contained also 0.1% 
CHAPS as an additional cleaning step to remove other impurities bound to the FLAG-beads. 
After one additional washing step with 0.5 M KCl-HEMG-buffer, the sample was eluted off the 
beads by adding FLAG-peptide-solution [10mg/ml] in a relation of 1:1 to the beads-volume and 
incubating at 4°C on a nutator for at least 4 h. The sample was centrifuged as before and the 
eluate was pipetted into a new sterile tube and frozen in liquid nitrogen. The beads were stored 
at 4°C and used as eluation-control. 
 
2.2.3.4 Purification of Sf9-expressed, HIS-tagged proteins under native conditions 
Cells were harvested as described (2.2.3.3.1.), centrifuged at 2000 rpm for 10 min at 4°C 
(Eppendorf centrifuge 5810R, rotor A-4-62) and resuspended in 30 ml His-lysisbuffer (for all 
buffers see chapter 2.1.12.2) per 500 ml expression culture. The suspension was freezed in 
liquid nitrogen and thawed twice before sonification on ice 3x for 15 sec. After centrifugation at 
20000rpm for 30 min at 4°C (SS34), the supernatant was passed through a 0.45 µm filter. The 
filtrate was incubated over night (4°C) with Ni2+-beads (2.1.4) which have been equilibrated 
before in buffer A. The sample was loaded on a column and after the beads had settled down, 
the column was washed with buffer A until no proteins could be detected in the wash-
flowthrough with the spectrophotometer. After washing, the bound proteins were eluted using a 
gradient of buffer B up to 100% over 10 ml. Proteins were collected in fractions of 0.5 ml, frozen 
in liquid nitrogen for storage at -80°C and analyzed on SDS-PAGE. 
 
2.2.3.5 Denaturating/renaturating purification of Sf9-expressed, HIS-tagged proteins 
2.2.3.5.1 Denaturation 
Cells were harvested as described (2.2.3.3.1.), centrifuged at 2000 rpm for 10 min at 4°C 
(Eppendorf centrifuge 5810R, rotor A-4-62) and resuspended in 30 ml guanidinium-lysisbuffer 
(all buffers 2.1.12.2.) per 500 ml expression culture. The sample was incubated on a rocker for 1 
h at room temperature, sonified on ice 3x for 15 sec, centrifuged at 20000 rpm for 30 min at 4°C 
(SS34) and the supernatant was passed through a 0.45 µm filter. To purify the His-epitope 
tagged proteins, the filtrate was incubated over night (4°C) with Ni2+-beads which were 
equilibrated before in buffer C1. The sample was loaded on a column and after the beads had 
settled down, the column was washed with 15-20 column-volumes buffer C2 until no proteins 
could be detected in the washing-flowthrough with the spectrophotometer. After washing, the 
bound proteins were eluted using a gradient of buffer D up to 100% over 10 ml. Proteins were 
collected in fractions of 0.5 ml, frozen in liquid nitrogen for storage at -80°C and analyzed for 
purity on SDS-PAGE. 
Pure fractions were afterwards renaturated with dialysis. 
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2.2.3.5.2 Renaturation 
1 ml of protein-fraction from the denaturation was transferred into a dialysis chamber (2.1.1.) 
which was sealed with a dialysismembrane (Wheaton, MWCO 30 kDa) which was incubated 
stirring in 1 l renaturationbuffer for 16 h at 4°C. After the first incubation, the dialysate was 
incubated again under the same conditions in kinasebuffer. The concentration of the renatured 
proteins was analyzed via SDS-PAGE and the aliquots were frozen in liquid nitrogen and stored 
at -80°C. 
 
2.2.4 In vitro Kinase Assays 
2.2.4.1 Transkinase-assay 
The transkinase-assay used in this work originates from an assay used for characterisation of 
the transkinase-activity of human TAF1 (hTAFII250, Dikstein et al. 1996). In this assay was 
analyzed, if a protein is able to act as a kinase in transferring radioactive labeled phosphate to a 
specific substrate. 32P-γ-ATP (2.1.5.) was used as donor for the phosphate group and substrates 
used were single histones and histone-peptides (2.1.11.1.). 
Kinase-proteins, which were purified according to chapter 2.2.3.3, were incubated with the 
specific substrate and 0.25-1 µCi 32P-γ-ATP for 25-60 min. at 30°C in kinasebuffer (2.1.12.2.) 
depending on the amount of kinase-proteins (100 - 400ng) used. The reactions were stopped by 
adding SDS-loadingbuffer (2.1.12.2.) and boiling of the samples at 100°C for 5 min. The 
samples were analyzed on a SDS-PAGE gel with coomassie staining (2.2.2.1. and 2.2.2.2.), the 
gel was dried and the phosphorylation was detected via autoradiography. The X-ray films 
(Kodak X-OMAT™) were exposed for 5 min or with weak signals over night in an intensification 
cassette (Suprema, Dr. Goos) at -80°C. Besides measuring the kinase activity on x-ray films, 
bands were also excised from the dried gel, put into scintillation vials containing scintillation fluid 
(2.1.2.) and incubated on a shaker for 1 h. After incubation, the radioactivity in each vial was 
measured on a scintillation counter (2.1.1.). 
 
2.2.4.2 Transmembrane-autokinase-assay 
This kinase-assay was used to detect autokinase activity of proteinkinases under repeatedly 
strong denaturing conditions involving western-blotting (Shackelford 1998). Purified kinase-
proteins were first denatured in SDS-loadingbuffer containing 2 M urea and 2% SDS for 40 min 
before loading on a SDS-PAGE gel. The gel was blotted on an Immobilon-P-membrane (2.1.4.) 
and the bands were made visible on the membrane by staining with Ponceau-S. The membrane 
was rinsed afterwards with double-filtered (Milli-Q) water and was denatured again in guanidine-
denaturationbuffer for 1 h at room temperature (for all buffers see chapter 2.1.12.2.). After this 
secondary denaturation-step, the membrane was rinsed 3x with TBS and incubated at 4°C over 
night in membrane-renaturationbuffer on a rocker at low speed. The membrane was then 
incubated for 1 h in 30 mM Tris-HCl pH 7.5 and incubated for 30 min in kinasebuffer containing 
50 µCi of 32P-γ-ATP. After that, the membrane was washed twice in standard 30 mM Tris-HCl 
(pH 7.5), then once in 30mM Tris-HCl with 0.1 % NONIDET® P40 and then again in standard 30 
mM Tris-HCl. All washes were done for 10 min. After the Tris-HCl washing steps, the membrane 
was incubated for 10 min in 1 M KOH to remove ATP-background, rinsed with Milli-Q water, then 
with 10% acetic acid and again with Milli-Q water. An X-ray film (Kodak) was put on the 
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membrane for at least 3 days to detect the autophosphorylation-activity of the membrane-bound 
proteins in an intensification cassette at -80°C. 
 
2.2.5 Crosslinked Chromatin Immunoprecipitation (XChIP) 
 
Protein-A-Sepharose (PAS) was blocked with XChIP-lysisbuffer, BSA [1mg/ml, Roth] and 
salmon testis DNA [1mg/ml] for 2-3 h and then washed 3x with XChIP-lysisbuffer. 
Schneider S2 cells were added into an erlenmeyer flask at a concentration of around 400x106 
cells. Formaldehyde (crosslinker) was added to a final concentration of 1.8% and incubated 15 
min on a shaker at room temperature. Glycine was added to a final concentration of 125 mM and 
incubated 5 min at room temperature. The cells were centrifuged at 1000 rpm (Eppendorf 
centrifuge) and the pellet was washed in precooled 1x PBS. The sample was then centrifuged 
again at 1000rpm and the pellet was resuspended in XChIP-lysisbuffer (3 ml per 200 ml of cell 
pellet). The suspension was frozen and thawed twice in liquid nitrogen, sonified (6x for 30 sec) 
to an average fragment length of 700 basepairs, afterwards centrifuged at 15000 rpm for 15 min 
and the supernatant (x-linked-chromatin) has been taken off with a filterpipet-tip. 25 µl blocked 
PAS was added to each 1000 µl of the supernatant, incubated for 1.5 h at 4°C and then 
centrifuged at 1000 rpm for 1 min. These pre-cleaned supernatants were pooled again and, at 
same amounts of chromatin, incubated with the specific antibodies (around 4 µg or 1:100 
dilution, depending on antibody, except control sample) at 4°C over night. 
25µl of blocked PAS was added to the samples and incubated at 4°C for 3 h. The samples were 
centrifuged at 4000 rpm for 1 min. and washed 4x in XChIP-lysisbuffer, 4x in IP1, 4x in IP2 and 
4x in TE (pH 8.0). The PAS-complexes were resuspended in 100 µl TE, RNaseA was added 
(final conc. 50 µg/ml) and incubated at 37°C for 30 min. SDS was added to a concentration of 
0.5% and Proteinase-K was added to a concentration of 0.5mg/ml. The samples were then 
incubated over night at 37°C. 
In a second incubation step to reverse the cross-links, the samples were heated to 65°C for 6 h. 
The DNA was cleaned up with phenol-chloroform-extraction (2.2.1.13) and analyzed with PCR. 
 
2.2.6 UV-crosslinking experiments 
 
Crosslinking experiments using ultraviolet (UV)-light were used to determine the exact position 
of the ATP-binding domain in the kinase-proteins. Proteins were combined with [0.5 µCi] 32P-γ-
ATP in 1x Kinase-buffer (2.1.12.2.). The samples were immediately exposed to 9600 joules of 
UV-radiation in a crosslinking-chamber (2.1.1) for 10 min at room temperature. A secondary 
sample for each tested protein was incubated in normal daylight conditions as a negative 
control. The samples were then subject to SDS-PAGE (2.2.2.1.) with subsequent drying of the 
gel followed by analysis on X-ray film as described before. 
 
2.2.7 Purification of polyclonal H2B-phosphoserine-33-antibodies 
 
To purifiy the α-H2BS33P-antibody out of serum from immunized rabbits (S. Kwoczynski), two 
purification steps were performed. The first step implied the removal of antibodies unspecific to 
phosphoserine-33-H2B, the second implied the concentration of phosphoserine-33-H2B specific 
antibodies.  
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To separate H2B-specific from H2B-phospho-S33-specific antibodies, two affinity-columns were 
generated: 1 mg H2B-phosphoserine-33-peptide (2.1.11.1.) was coupled to 1 ml “SulfoLink”-
Matrix (Pierce) via its reactive SH-group of the N-terminal cysteine, which was added to the 
peptide sequence. The second column was created in the same way but using 
unphosphorylated H2B-peptide (2.1.11.1.) instead. The coupling of both peptides was done 
following the protocol of the manufacturer, but all buffers used contained protease and 
phosphatase inhibitors at manufacturer-recommended concentrations (Roche). The rabbit-
serum was run three times over the H2B-peptide column to remove the phosphoserine-
unspecific antibodies from the flowthrough-serum. The flowthrough was then run again three 
times on the phosphoserine-H2B-peptide-column to concentrate the remaining α-H2BS33P-
antibody which was eluted from the matrix by adding 100 mM glycine-buffer at pH 2.7. Fractions 
of 1 ml were collected, immediately neutralized with 100 µl 1M Tris-HCl at pH 7.5 and analyzed 
for the antibody on a SDS-PAGE gel. 
 
2.2.8 RNAi  
 
Plasmids used to produce TAF1-dsRNA were generated by PCR amplifying basepairs 3873-
4879 from a TAF1-cDNA and cloning the product in both orientations into the pCRII-TOPO 
cloning vector using the TOPO TA cloning kit (Invitrogen). 
RNAi was carried out as described in Pile et al. 2002: Briefly, 2 x 106 cells were plated into a 60-
mm-diameter dish. After 1 h, FBS-containing medium was removed and replaced with 2 ml of 
serum-free medium. Approximately 40 µg of dsRNA was added per dish and mixed by swirling. 
After 30 min, 4 ml of medium containing 10% FBS, 100 U of penicillin per ml, and 100 µg of 
streptomycin per ml was added. Cells were assayed at a specified day following addition of 
dsRNA. To determine the growth curves of RNAi cells, cells were mixed and counted each day 
following the addition of dsRNA for a total of 4 days. 
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3. Results 
 
This chapter addresses the question whether the phosphorylation of H2B at serine 33 (H2BS33) 
is truly intrinsic to dTAF1CTK and if this kinase-activity can be correlated with transcriptional 
activation of specific target genes. 
Histone H2B has been reported in previous studies to be phosphorylated in apoptotic 
mammalian cells (Ajiro 2000). Interestingly, the dTAF1 protein used in this work and in initial 
preceding studies has been discovered in apoptotic cells and bears three additional exons. The 
first one resides in the NTK, adding three more amino acids at position 113. The other two 
exons, named 12a and 13a are located in the CTK, ranging from position 1809 to 1841 (for exon 
12a) and from 1907 to 1937 (exon 13a). Exon 12a adds an additional AT-hook motif to the CTK 
of dTAF1, which bears the first one at amino acids 1792-1801 (Kwoczynski 2002). 
The protein kinase-activity of TAF1 appears to be highly substrate specific, as it is unable to 
phosphorylate a variety of common phosphoacceptor proteins. Moreover, none of the other eight 
subunits of TFIID that are in contact with TAF1 appear to be targeted for phosphorylation by 
TAF1. Interestingly, in addition to RAP74, TAF1 is able to weakly phosphorylate the large 
subunits of TFIIA and TFIIE but not other components of the basal machinery. These findings 
are consistent with the notion that the phosphorylation of RAP74, and possibly TFIIA and TFIIE, 
by TAF1 might represent highly specific and potentially important steps during transcriptional 
regulation (Dikstein et al. 1996a). A big question regarding the specificity of the kinase-activity 
was, if there are other physiologically relevant substrates for the TAF1 kinase.  
It has been argued that the TAF1-mediated activation of transcription is connected to enzymatic 
modifications of histones, which leads to the hypothesis that TAF1-kinase-dependent gene-
expression gets activated due to TAF1-mediated phosphorylation of specific components of the 
chromatin, e.g. histones (Mizzen et al. 1996, Imhof et al. 1997, Wassarman et al. 2000). That 
implies that TAF1 has the ability to specifically modify not only GTMs but also histones 
posttranslational. 
Earlier studies have characterized TAF1 as a bipartite kinase containing a NTK- and a CTK-
activity (Dikstein et al. 1996a). The NTK phosphorylates RAP74, a part of the TFIIF complex but 
a substrate for the CTK has not been discovered.   
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In studies preceding this work, using similar kinase-assays in vitro, histone H2BS33 was found 
to be a substrate of the CTK of TAF1, underlining the hypothesis that TAF1 might activate 
transcription via histone-modification (Kwoczynski 2002).  
The discovery of H2B as CTK-activity substrate, which is phosphorylated at serine 33 posed 
new questions whether the observed kinase-activity is truly intrinsic to the CTK and if so, which 
kinase-motifs responsible for the phosphorylation were located.  
In summary, this work examines and characterizes the c-terminal kinase-activity of TAF1 closer 
and investigates the functional properties of TAF1 kinase-activity in transcription with several in 
vitro and in vivo experiments: 
Experiments underlining the observed kinase-activity of dTAF1CTK as an intrinsic part of CTK 
were conducted. The positions and true natures of the unknown kinase-motifs were investigated 
in silico by computational analysis of the CTK-sequence. Putative kinase-motifs were modified 
via insertion of point mutations and/or deletions and subsequent investigation of the mutant-
proteins in vitro by using similar kinase-assays as done in the previous studies (Dikstein et al. 
1996, Kwoczynski 2002). An important part of this work was to investigate whether H2BS33 is 
phosphorylated in vivo and if this specific histone modification can be linked to transcriptional 
activation. To address this issue, various immunodetection-experiments have been conducted, 
using a specific antibody targeted against phosphorylated H2BS33. 
 
3.1 Kinase-activity is intrinsic to the CTK of dTAF1 
 
The first step in characterizing the kinase activity of the CTK was to rule out the possibility that 
the observed kinase-activity may be due to a CTK-associated proteinkinase, which might have 
been co-purified with the expressed CTK protein. To investigate whether the kinase-activity of 
the CTK of TAF1 is the result of intrinsic kinase activity rather than an associated kinase activity, 
a transmembrane-kinase assay (2.2.4.2.) was conducted with CTK and bovine-serum-albumin 
(BSA) as a negative control. During this assay, the proteins are denatured via SDS-
polyacrylamid gelelectrophoresis (SDS-PAGE) and blotted on a membrane. The membrane-
bound proteins are subsequently denatured again, then renatured and finally tested for 
autokinase activity. The repeated denaturing steps in this experiment and the correlated 
unfolding of the CTK should result in the removal of associated proteins such as co-purified 
kinases: 
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His-tagged Drosophila TAF1CTK (2.1.11.2.) and BSA were denatured with SDS/urea-buffer for 
40 min. The denatured proteins were separated by SDS-PAGE, electrophoretically transferred 
onto PVDF membrane and the position and amount of transferred dTAF1CTK and BSA on the 
membrane was determined by staining with Ponceau-S. The membrane-bound proteins were 
subsequently denatured, washed, renatured, incubated with radiolabeled ATP and exposed to 
an X-ray film (Kodak).  
A clear signal of radiolabeled dTAF1CTK was detected in the assay. In contrast, radiolabeled 
BSA was not detected and this although 10 fold more BSA was used in the assay than CTK 
(Figure 11). Due to the repeated denaturing and washing steps used in this experiment, it is 
highly unlikely that another kinase, initially co-purified with dTAF1CTK, is still bound to 
dTAF1CTK and therefore responsible for the observed phosphorylation of dTAF1CTK. This 
result indicates that dTAF1CTK has an intrinsic kinase-activity in Drosophila and auto- 
phosphorylation is not mediated by another dTAF1CTK-associated kinase. 
 
Figure 11. dTAF1-Membrane-autokinaseassay, the size of the protein 
marker bands are indicated on the left.  
Left box: Coomassie-stained gels showing dTAF1CTK (CTK) and bovine-
serum-albumin (BSA) with the loaded amounts in µg.  
Right box: Autokinaseassay on denatured / renatured membrane-bound 
BSA (white arrowhead) and dTAF1CTK (black arrowhead). M = prestained
protein marker (NEB). 
Results    65 
     
 
 
 
3.2 Identification of the essential kinasedomains of dTAF1 
 
Proteinkinases are divided in two classes of kinases depending on their amino acid substrate: 
the protein-serine/threonine kinases and the protein-tyrosine kinases (Hanks and Hunter 1995). 
These enzymes use the y-phosphate of ATP (or GTP) to generate phosphate monoesters using 
protein alcohol groups (on serine and threonine residues) and/or protein phenolic groups (on 
tyrosine residues) as phosphate acceptors. The kinase-activity of protein kinases lies within their 
conserved catalytic domain. Eukaryotic protein kinases share a conserved catalytic core 
common to both serine/threonine and tyrosine protein kinases.  
Protein kinases contain a number of conserved subdomains, also referred to as motifs, in their 
catalytic domain of which two are essential for kinase function: the ATP-binding motif and the 
amino acid specific (serine/threonine or tyrosine) catalytic motif (Hanks et al. 1988). The ATP-
binding motif is usually located NH2-terminal to the amino acid specific motif (Figure 12). 
This chapter addresses the search for putative kinase motifs in the CTK by computational 
means in silico and by experimental means in vitro. 
 
3.2.1 Computational identification and characterization of the kinase motifs 
 
To identify putative ATP-binding and amino acid specific motifs, the amino acid sequence of 
dTAF1CTK was examined in silico for homologies to sequences of known kinase motifs: 
 ATP S/T
  Y
catalytic domain
ATP-binding-motif
Substrate-specific-motif
COOH   NH
 
Figure 12. Typical structure of a proteinkinase. The catalytic motif of 250-300 aminoacids 
is located COOH-terminal with the ATP-binding motif (red) at the NH2-terminal part of the 
catalytic domain followed by the substrate specific motif for serine/threonine (S/T) or
tyrosine (Y, black). 
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These two types of motifs are defined by three signature patterns shown in Figure 13 (PROSITE 
database: documentation PDOC 00100, http://ca.expasy.org/prosite/PDOC00100), which can be 
used for computational screening of protein sequences to detect the presence of putative 
kinase-motifs.  
In the majority of protein kinases the ATP-binding motif is located in the NH2-terminal extremity 
of the catalytic domain. The motif consists of a glycine-rich stretch of residues (basic sequence-
pattern GxGxx[SGA]) in the vicinity of a conserved lysine-residue (K) that has been shown to be 
involved in ATP-binding. The amino acid specific kinase-motif (either serine/threonine- or 
tyrosine-specific), which is located in the central part of the catalytic domain, contains a 
conserved aspartic-acid-residue, which is essential for the catalytic activity of the kinases and a 
conserved lysine- and asparagine-residue (Knighton et al. 1991).  
To identify motifs in dTAF1CTK, two signature patterns were used to detect the amino acid 
specific kinase-specific motifs: one pattern specific for serine/threonine-kinases (Ser/Thr) and 
Figure 13. Overview of the patterns used for identification of kinase-specific and ATP-binding 
motifs: each aminoacid (AA) is separated by a hyphon (-), several possible allowed AAs at one 
location are shown in square parentheses, forbidden AAs are shown in curly parentheses. The number 
of repetitions of AAs is shown in standard parentheses. An x stands for any AA that is possible at that
location. 
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the other for tyrosine-kinases (Tyr). If an analyzed protein includes both of the two protein-kinase 
signatures covering the sequence of the same motif, the probability of it being a protein-kinase is 
close to 100% (http://ca.expasy.org/prosite/PDOC00100). 
In the study preceding this work, the sequence of dTAF1CTK was examined for the kinase 
motifs described above (Kwoczynski 2002). As shown in Figure 14, a tandem ATP-motif (amino 
acids 1747 to 1780) was detected within the CTK of dTAF1 by computational search with the 
PROSITE patterns using the protein-pattern search program of the internet-application “Network 
protein sequence analysis” NPS@ (NPSA) at the Pôle Bioinformatique Lyonnais (“PBIL” in Lyon, 
France: http://pbil.univ-lyon1.fr).  
 
Figure 14. Identification of proteinkinase-motifs within the CTK of dTAF1. a Left: several protein-
kinase specific motifs compared to the identified dTAF1 motif (Maile et al. 2004). Right: The pattern 
used for identification of serine/threonine active motifs, the catalytic aspartic acid and the conserved
lysine and asparagine are shown in bold letters. b Overview of the location of the active site motifs 
(S/T1 and S/T2) and the ATP-binding motif (ATP). c Pattern used for identification of the ATP-
binding domain, the conserved pattern GxGxx[SGA] is shown in bold letters, the lysine residue which
binds ATP is shown bold-underlined. 
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However, although the tandem ATP-motif showed high homology to the prosite-pattern used 
(84-90% respectively), the program at PBIL was unable to detect any amino acid specific motifs 
since it can not detect kinase motifs that show less homology to the patterns than 50%.  
A manual approach to detect putative amino acid specific motifs resulted in the discovery of two 
putative serine/threonine-specific motifs. Interestingly, one of the putative serine/threonine-
specific motifs (S/T-1, amino acids 1537 to 1549) resides within the first bromodomain (B1) of 
the DBD, whereas the second amino acid specific motif (S/T-2, amino acids 1721 to 1733) was 
found closely NH2-terminal to the ATP-binding motif (Kwoczynski 2002).  
A second computational approach detecting the amino acid specific motifs was done in this work 
using both available patterns for the amino acid specific motifs: While the pattern for 
serine/threonine-specific kinase motifs repeatedly did not show any motifs (homology >50% for 
Ser/Thr), the pattern for tyrosine-specific (Tyr) kinase motifs recognized sequences overlapping 
the previously manually detected sequences. With a low pattern-homology of 50% the sequence 
for S/T-1 was detected. S/T-2 was detected also, but with a higher homology of 65% to the 
tyrosine specific pattern. 
However, only the motif S/T-1 contained the conserved aspartatic-acid residue and the lysine 
residue both of which are essential for S/T-specific kinase activity (Figure 14a). 
Additionally, the detected overlapping tandem ATP-binding motif is located COOH-terminal of 
the detected amino acid specific motifs, which is contrary to the NH2-terminal location of this 
motif as it is observed in other discovered protein-kinases. 
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3.2.2 Functional characterization of kinase-motifs in dTAF1CTK 
 
To investigate whether the in silico identified specific kinase-motifs are responsible for the CTK-
activity of dTAF1, mutant dTAF1CTK-derivates containing mutations or deletions of kinase 
motifs were generated. 
To address the role of the S/T-motifs, proteins containing point mutations which exchange single 
amino acid converting the essential aspartatic-acid- to a catalytic inactive alanine-residue at the 
putative catalytic-active amino acid position 1541 (dTAF1CTK[D1541A]) of the first 
serine/threonine-specific motif S/T-1. For the second amino acid specific motif S/T-2, a protein 
 
Figure 15. Pointmutation- and deletion-proteins of dTAF1CTK. 
Pointmutations are shown in large bold letters, aminoacid
exchanges are indicated with arrows, deleted regions are indicated
with brackets. 
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was created that contained a similar point-mutation at amino acid 1725 (dTAF1CTK[D1725A]). 
Another protein was created that carried a double-pointmutation in positions 1537 and 1541 of 
the motif S/T-1. This protein contained an additional amino acid exchange of the methionine 
residue at position 1537 to an isoleucine residue (dTAF1CTK[M1537I/D1541A]).  
To address the role of the detected ATP-binding motif, a deletion-mutant (dTAF1CTK∆ATP) was 
created that lacks the entire ATP-binding motif (Figure 15).  
Mutant dTAF1CTK-proteins were expressed in Sf9-cells as His-FLAG-fusionproteins and 
immunoaffinity-purified using FLAG-beads (2.2.3.3, Figure 16):  
The purified recombinant mutant proteins were subjected to in vitro kinase-assays to detect 
phosphorylation activity. Additionally to the created point mutation- and deletion-containing 
dTAF1CTK-proteins several other proteins were also investigated in the assays: 
Besides unmodified wildtype dTAF1CTK, purified TFIID and unmodified full-length wildtype 
 
Figure 16. Coomassie-stained gels of expressed and FLAG-
purified GST-FLAG-fusionproteins. M = prestained protein 
marker, S/T-dbl = dTAF1CTK(M1537I/D1541A), S/T-1 = 
dTAF1CTK(D1541A), S/T-2 = dTAF1CTK(D1725A), ∆ATP = 
dTAF1CTK∆ATP. B = 10 µl of washed, FLAG-bead-bound 
protein. E = 15 µl of protein, eluted with FLAG-peptide. Black 
arrow = fusionproteins, white arrowhead = heavy FLAG-antibody 
chain, black arrowhead = light FLAG-antibody chain. The size of 
the marker bands is indicated on the left. 
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dTAF1-protein (dTAF1) an additional full-length protein bearing a point mutation resulting in a 
stop codon at position 1728, thus lacking the CTK-domain (dTAF1∆CTK), was subjected to 
kinase-assays. Additionally to this COOH-terminal-deleted dTAF1 protein an NH2-terminal-
deleted dTAF1CTK protein was used in the assay (dTAF1CTK∆1600), which started at amino 
acid 1593 and thus lacked the B1 region and S/T-1 motif. 
Kinase reactions were programmed with 1 µg recombinant histone H2B and contained 400 ng 
endogenous TFIID or 250 ng recombinant TAF1 derivatives and 0.25 µCi γ-32P-ATP. The 
reactions were performed in 20 µl kinase buffer (see 2.1.12.2.) for 25 min at 25°C and the 
proteins were analyzed by SDS-PAGE using 15% SDS-polyacrylamide-gels. To compare the 
protein amount present in the reactions, the intensity of protein bands was detected by 
coomassie-blue staining. After staining, gels were dried on filter-paper (Whatman) and the 
kinase activity was analysed after exposure of an X-ray film (Kodak, 2.2.4.1.) to the dried gels.  
The observed signal of both auto- and transphosphorylation of H2B was strongest for the TFIID 
complex, followed by wildtype dTAF1 and dTAF1CTK. Compared to the TFIID complex and the 
two wild type proteins, all mutant proteins showed reduced auto- and transkinase-activity (Figure 
17).  
 
Figure 17. Autoradiogram (top) of in vitro
kinase assays with recombinant H2B and TFIID,
dTAF1 and dTAF1 derivatives. 
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dTAF1∆CTK showed no transkinase-activity compared to TFIID and the unmodified wild type 
proteins. The auto- and transkinase-activities of dTAF1CTK(D1541A) and the double-mutant 
dTAF1CTK(M1537I/D1541A) were significantly reduced, indicating that the serine/threonine-
specific motif S/T-1 is responsible for the serine-specific kinase-activity of dTAF1CTK (see 
Figures 17 and 18).  
This result is underlined by the observed reduced kinase signal of dTAF1CTK∆1600, showing 
that without the complete S/T-1 motif, there is still a small amount of autokinase activity, but no 
detectable transkinase activity (Figure 17). 
The mutation of S/T-2 in dTAF1CTK(D1725A) resulted in a partial reduction of CTK-activity, 
suggesting that S/T-1 dominates over S/T-2.  
Deleting the ATP-binding motif in dTAF1CTK∆ATP leads to a significant decrease in kinase-
activity comparable to dTAF1CTK(D1541A), indicating that the computational detected ATP-
binding motif is important for kinase function of dTAF1CTK (figures 17 and 18). 
 
 
Figure 18. Transkinase-activity of Drosophila TAF1-pointmutation- and 
deletion-proteins.  
Left: 15% coomassie-stained SDS-polyacrylamide-gel.  
Right: autoradiogram, 24 h exposure of film to gel on left side. M = Marker,
white arrowhead = Histone H2B.  
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3.2.3 UV-crosslinking experiments 
 
To determine the position of the ATP-binding motif independently of transkinase-assays, 
crosslinking experiments, using ultraviolet- light (UV-light) as crosslinking agent, were 
performed. By exposing several deletion-constructs to UV-radiation, which was intended to 
crosslink γ32P-ATP with the ATP-binding motif, an identification of an ATP-binding domain in 
dTAF1 by binding of the radiolabeled ATP was expected. 
Various NH2- and COOH-terminal truncated dTAF1CTK-proteins, consisting of different regions 
within the CTK (Figure 19a), had been generated (Kwoczynski 2002, see chapter 2.1.11.2.).  
Three proteins used in the UV-crosslinking experiments were truncated at the NH2-terminal end: 
Besides dTAF1CTK∆1600 (see above), these proteins were dTAF1CTK∆1800, starting at amino 
acid 1797 thus lacking any motifs except the two exons 12a and 13a and dTAF1CTK∆1900, 
starting at amino acid 1958 which lacked any identified motifs. 
Two proteins were truncated at the NH2- and COOH-terminal ends: dTAF1CTK17-18 consisted 
of the amino acid specific motif S/T-2 and the ATP-binding motif, ranging from amino acid 1594 
to 1802. Ranging from amino acid 1797 to 1963, dTAF1CTK18-19 contained only exons 12a 
and 13a. 
Proteins were combined with radioactive γ-labeled ATP in kinase buffer and treated with UV-light 
in a crosslinking chamber (2.2.6). A second set of corresponding samples was assembled in the 
same way but exposed to standard daylight conditions as control. After exposure to UV-light, the 
proteins were separated by SDS-PAGE. The positions of the truncated proteins were detected 
by coomassie-blue staining, the stained gels were dried and radiolabeled ATP, if bound by the 
specific protein, was detected by autoradiography. 
As shown in Figure 19b, dTAF1CTK∆1900, which lacks any identified motifs, did not bind ATP 
indicating that no ATP-binding motifs are located in this fragment.  
An unexpected result of this experiment was the observation that the untreated control samples 
showed as much radioactive signal as their corresponding UV-treated samples. This indicates 
that the binding of ATP to the specific motifs is strong enough to withstand the denaturing effects 
of SDS-PAGE and/or that the truncated proteins still have auto-phosphorylating kinase activity. 
Interestingly, signals were detected on the proteins containing only the exons and no other 
identified motifs. The intensity of the signals detected at dTAF1CTK∆1800 and dTAF1CTK18-19 
is comparable to each other, indicating that one or both exons also bind ATP.  
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However, dTAF1CTK∆1600 that also contains the two exons plus the ATP-binding motif, the 
S/T2 motif and the second bromodomain shows a comparably stronger background, indicating 
CTK-activity. Additionally, dTAF1CTK17-18, containing the S/T-2 and the ATP-binding motif, 
which are only 20 amino acids apart from each other, shows the strongest signal compared to 
the other samples.  
In conclusion, these results show that even without the first kinase-domain, the motifs within 
dTAF1 still contain some ability to bind ATP strongly enough without the need of a UV-light as a 
crosslinking agent. Both proteins that contain the detected ATP-binding motif, dTAF1CTK∆1600 
and dTAF1CTK17-18, show the strongest detected signals compared to the other truncated 
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proteins. This also indicates that the S/T-2 motif and the ATP-binding motif together have kinase 
activity, thus forming a basic catalytic domain of a proteinkinase.  An intriguing observation is 
that dTAF1CTK∆1600, which contains the additional NH2-terminal regions missing in 
dTAF1CTK17-18, shows a weaker signal compared to the smaller dTAF1CTK17-18. This 
indicates that the additional regions, including B2, might have an inhibitory effect on the kinase 
activity of the ATP-binding motif and S/T-2.  
The ATP-binding motif might also be longer than previously expected and might encompass the 
region of the additional two exons. The fact that the motif-lacking dTAF1CTK1900 shows no 
detectable signal underlines this theory. 
Interestingly, a region ranging from amino acids 1791 to 1821 with weak homology to the ATP-
binding motif pattern (71%) was detected in an earlier study (Kwoczynski 2002). This region also 
contains two AT-hooks, which are characteristic motifs for DNA-binding proteins. AT-hooks can 
bind to AT-rich DNA-sequences via adenosine-binding. This ability might be responsible for the 
observation that the proteins dTAF1CTK∆1800 and dTAF1CTK18-19, containing only this 
identified motif, can still bind ATP and that the binding is strong enough to result in a signal even 
after exposure of the proteins to SDS-PAGE (Figure 20). 
 
 
 
 
Figure 20. AT-Hooks in dTAF1. The start of exon 12a is indicated at
position 1806. Both AT-Hook regions (KRGRGRPRK) are marked
overlined. 
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3.2.4 Determination of the turnover-rate of dTAF1CTK-kinase activity 
 
An interesting question was whether the kinase activity of the CTK of dTAF1 shows any 
differences in regard to the full-length dTAF1-protein or in the case of association with other 
proteins as TFIID complex. To determine the potency of the dTAF1CTK-kinase, we determined 
the turnover-rate of the kinase activity of TFIID, dTAF1 and dTAF1CTK correlated to 
recombinant Drosophila H2B and nucleosomes as substrates. 
All enzymes and substrates were subjected to kinase assays and the turnover values for 
phosphorylation of H2B-S33 were determined by measuring the incorporation of radiolabeled 
phosphate groups into H2B in the presence of 3 µg TAF1, TFIID, or CTK-derivatives and 3 µg 
H2B or 12 µg nucleosomes. The reaction products of in vitro kinase assays were separated by 
SDS-PAGE, stained with coomassie-blue dye and the gels were afterwards dried on filter paper. 
The bands of radioactive H2B, nucleosomes and controls were excised from the dried gel and 
incorporation of radioactivity was determined by scintillation counting (2.2.4.1.).  
All samples measured, reached a kinetic plateau in kinase activity within 5 to 15 minutes. The 
time point when the measured values reached this plateau was used to calculate the turnover 
values specific for each enzyme/complex with the specific substrate as shown in Figure 21. The 
calculated turnover values are:  
TFIID (nucleosomes: 3.3/sec; H2B: 2.6/sec); dTAF1: (nucleosomes: 2.5/sec; H2B: 10.5/sec); 
CTK: (nucleosomes: 4.4/sec; H2B: 2.6/sec). 
The full-length dTAF1-protein showed the highest kinase activity on H2B as substrate in 
comparison to the TFIID complex or dTAF1CTK, while TFIID showed slightly higher kinase 
activity than dTAF1CTK. This indicates that within the TFIID complex, the kinase activity of 
dTAF1 might be inhibited due to other TAFs binding to dTAF1 and that the NH2-terminal dTAF1 
regions, which are missing in dTAF1CTK, are also contributing to the overall kinase-activity of 
the CTK.  
In contrast, when nucleosomes were used as substrate, dTAF1CTK showed about double as 
much kinase activity compared to dTAF1 and TFIID, which kinase activities were measured at 
about the same intensities. This result indicates that the smaller size of dTAF1CTK, which lacks 
the 1495 NH2-terminal amino acids of dTAF1, might be of sterical advantage for dTAF1CTK to 
access H2B as substrate within the nucleosome structure. 
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Figure 21. Kinase-activity of the TFIID-complex (A), dTAF1 
(B) and dTAF1CTK (C) over time with recombinant H2B and 
nucleosomes as substrate. The x-axis shows the amount of 
incorporated radiolabeled phospho-groups measured with 
scintillator-counts and the y-axis shows the time in minutes. 
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3.3 Immunodetection of phosphorylated H2B in vivo 
 
The results shown in the previous chapters show that dTAF1CTK has intrinsic kinase activity. To 
prove in vivo kinase activity of dTAF1CTK, it is essential to show that dTAF1 phosphorylates 
histone H2B in vivo. This chapter addresses the issue by various immunodetection experiments, 
which were conducted on nucleosomes, octamers and specific H2B derivates. 
For these experiments, an antibody was needed that specifically recognizes the phosphorylated 
NH2-terminal tail of H2B, differing in only one additional phosphate group at serine-residue 33 
from the unmodified histone. A study preceding this work showed that dTAF1CTK 
phosphorylates H2BS33 and established an antibody recognizing phosphorylated H2BS33. 
However, this study did not detect phosphorylated histone H2B in vivo (Kwoczynski 2002). 
 
3.3.1 Purification of the H2BS33P-antibody 
 
To confirm the specificity of the antibody against serine 33 phosphorylated H2B (anti-H2BS33P), 
antibody was purified over sulfolink columns as described in chapter 2.2.7. 
The two NH2-terminal peptides of H2B, which were used to purify the antibody, were separated 
on two similar SDS-PAGE gels. One peptide contained phosphorylated S33 whereas the serine-
residue of other peptide was unmodified (2.1.11.1). One SDS-PAGE gel was silver-stained to 
visualize the peptide-bands. The peptides on the other SDS-PAGE gel were blotted on a PVDF 
membrane, probed with anti-H2BS33P and the signals on the western-blot were detected with 
alkaline phosphatase (2.2.2.4.2). Purified antibody in a 1:100 dilution was able to detect as little 
as 10 ng of the phosphorylated H2B-peptide (not detectable on silver-stained gels), but did not 
detect the unphosphorylated H2B peptide (Figure 22). Besides the peptide signals, no other 
signals were detected on the membrane.  
The NH2-terminal tails of histones H2B and H3 have slight structural similarities. For example, 
the H3 tail can be phosphorylated at serine-residues 10 and 28. To detect if anti-H2BS33P 
shows a possible cross-reaction with histone H3 in a phosphorylated or unmodified state, 
several NH2-terminal tail peptides of H3 were probed with anti-H2BS33P.  
Nucleosomes, histone H2B and NH2-terminal tail peptides of H2B (H2BT), phosphorylated H2B 
(H2BT-S33P), unmodified H3 (H3T) and double-phosphorylated H3 at serine-residues 10 and 28 
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(H3T-S10/28P, amino acids 1 to 32) were separated on two SDS-PAGE gels. One gel was 
stained with coomassie-blue while the proteins on the other gel were blotted on a PVDF 
membrane and probed with anti-H2BS33P (Figure 23). The antibody-signals on the western-blot 
were detected by chemiluminescence using the ECL-Plus-Kit of Amersham (2.2.2.4.3). 
Anti-H2BS33P did not recognize an unmodified H3-tail peptide (H3T) or the double-
phosphorylated H3 peptide (H3T-S10/28P), containing phosphorylated serine 10 and serine 28 
(2.1.11.1.).  
These results indicate that anti-H2BS33P specifically recognizes H2BS33P. 
Figure 22. Purification of the H2BS33P-antibody over sulfolink columns. 
Left: Eluated fractions containing antibody after purification over both sulfolink-columns. Top: 
Coomassie-stained SDS-PAGE gel (15%) of purified antibody fractions 1-8. Black arrowhead = heavy 
antibody chain at around 62 kDa; white arrowhead = light antibody chain at 27 kDa; M = prestained
protein marker (NEB). Bottom: Concentration of corresponding fractions estimated with UV-
spectrophotometer in ng/µl. 
Right: The column-purified H2BS33P-antibody is specific for serine 33 phosphorylated H2B N-
terminal tail peptide. Top: Silver-stained SDS-PAGE gel (18%) of  phosphorylated peptide and 
standard H2B tail peptide. Amounts of phosphorylated and unmodified peptide are given in µg.
Bottom: Western-blot on similar gel as on top, purified H2BS33P-antibody (fraction 2) used in 1:100 
dilution with secondary antibody coupled to AP (1:3000 dilution). M = prestained protein marker
(NEB). H2BS33P = serine 33 phosphorylated N-terminal-tail H2B peptide, H2B = N-terminal-tail 
unmodified peptide. 
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3.3.2 Drosophila H2B serine 33 is phosphorylated in vivo 
 
To determine if H2BS33 is phosphorylated in Drosophila, purified Drosophila nucleosomes and 
recombinant H2B were probed on western blots with anti-H2BS33P.  
The antibody recognized a protein in nucleosomes with a molecular weight similar to that of 
H2B, providing evidence that H2BS33 is a target for phosphorylation in vivo (Figure 23). 
Since phosphorylated H2BS33 was now detected in Drosophila, the next step was to investigate 
if the kinase activity of dTAF1 can be linked to this specific histone modification.  
To examine whether dTAF1 phosphorylates H2BS33 in vivo, RNA interference (RNAi) 
experiments were conducted, targeting the expression of dTAF1. In short, RNAi involves post-
Figure 23. H2B serine 33 is phosphorylated in 
Drosophila:  
Top: Coomassie-stained SDS-PAGE gel of 
purified nucleosomes, H2B-tail peptide 
(H2BT), serine 33 phosphorylated H2B-tail 
peptide (H2BT-S33P), H3-tail peptide (H3T), 
serine 10/28 doublephosphorylated H3-tail 
peptide (H3T-S10/28P) and recombinant 
histone H2B. Bottom: Corresponding western-
blot with H2BS33P-antibody (1:1000 dilution, 
ECL-detection). 
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transcriptional gene silencing initiated by the introduction of double-stranded RNA (dsRNA) as a 
tool to knock out expression of specific genes in a variety of organisms. The dsRNAs direct the 
creation of small interfering RNAs (siRNAs), which target RNA-degrading enzymes to destroy 
transcripts complementary to the siRNAs (Gura 2000). 
Schneider-S2 cells were treated with a 1006 bp long dTAF1-dsRNA fragment (2.2.8), thus 
reducing the levels of expressed dTAF1 in these cells (dTAF1-RNAi). Endogenous histone 
octamers were purified from the dTAF1-RNAi treated and untreated (mock) cells (source: F. 
Sauer) and equal amounts were separated by SDS-PAGE and examined by western-blot 
analysis using anti-H2BS33P (Figure 24). Phosphorylation of H2BS33 was reduced in octamers 
originating from TAF1-RNAi cells compared to mock-RNAi cells.  These results indicate that 
TAF1 is a major kinase for H2BS33 in vivo. 
 
Figure 24: Coomassie blue–stained gel (left) and corresponding Western blots 
(middle and right) of histone octamers purified from mock- (+) or TAF1- (–) RNAi 
treated S2 cells.  
The same Western blot was first probed with the H2B-S33P antibody (right), then 
stripped off the first antibody and subsequently reprobed with an antibody against
unmodified H2B to present a loading control. Positions of the histones are indicated
on the left, the position of H2B on the corresponding westerns is indicated on the
right side. 
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3.4 Role of TAF1 phosphorylation of H2BS33 in transcriptional 
activation 
 
Flow cytometry analysis of dTAF1-RNAi treated cells revealed that loss of dTAF1 results in cell 
cycle arrest in G2/M-phase (figure 25), which suggests that dTAF1 regulates the expression of 
genes involved in G2/M-phase cell cycle progression (Maile et al. 2004). 
This leads to the question what genes might be affected in their expression due to the loss of 
TAF1 mediated transcription. 
One of the key cell cycle regulators of is cdc2, which regulates G2/M-phase (Figure 26). The 
gene encodes a protein (CDK1 in humans) that is a member of a family called cyclin dependent 
kinases (CDKs). The activation of CDK is dependent on reversible phosphorylation. Cyclins are 
cell cycle proteins formed and degraded periodically during the cell cycle. The cyclins bind to the 
activated CDK molecules, thereby regulating CDK activity and selecting the proteins to be 
phosphorylated. For example, to proceed from G2 to M phase, a complex of cdc2 and cdc13 
(cyclinB) is essential. The kinase Wee phosphorylates cdc2, thus inactivating it, whereas its 
 
Figure 25. Knockdown of TAF1 causes G2/M phase cell cycle arrest in Drosophila cells. RNAi-
untreated (mock, left) and TAF1-RNAi treated (right) S2 cells were analyzed by flow cytometry.
Phases of the cell cycle (G1, S, and G2/M) are indicated. On average, for asynchronously growing
mock-RNAi cells 40% of the cells were in G2/M while for TAF1-RNAi cells 83% of the cells were in 
G2/M. 
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counterpart, the phosphatase cdc25 (Drosophila string, stg) activates cdc2 by dephosphorylation 
(Figure 27).  
The intriguing question, if dTAF1 can be correlated to the transcription activation of specific 
genes, was investigated in this chapter. By use of reverse transcriptase PCR (RT-PCR), the 
transcription level of genes of interest in dTAF1-RNAi and RNAi-untreated (mock-RNAi) cells 
was monitored. To examine the modification status of histones associated to the promoters of 
genes that showed reduced transcription levels in cells, cross-linked chromatin immuno-
precipitation (XChIP) experiments were conducted. 
Figure 26. The eukaryotic cell cycle. 
Figure 27. TAF1 might mediate cell cycle progression by 
mediating the transcription of essential cell cycle proteins like 
cdc25 (Drosophila string). 
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3.4.1 Transcription of genes in S2 cells 
 
To investigate whether TAF1 regulates the transcription of G2/M-phase specific genes, the 
transcriptional status of specific genes was compared in mock-RNAi and dTAF1-RNAi treated 
Schneider S2 cells by using RT-PCR (2.2.1.2.4). 
RNA was isolated from mock-RNAi and dTAF1-RNAi treated cells, reverse transcribed and 
specific primers were used to detect the presence of cell cycle specific gene transcripts in the 
cDNA pools. The cDNA pools were standardized by monitoring the transcription of actin5C in 
mock and RNAi-treated cells. 
Interestingly, the transcription of the cell-cycle gene string (stg), the homolog of yeast cdc25 in 
Drosophila, was significantly reduced in dTAF1-RNAi cells compared to mock-RNAi cells (Figure 
28). In contrast, transcription of actin5C was not reduced, indicating that the observed 
differences reflect changes in the transcription levels rather than in the cDNA amount. 
In summary, this indicates that dTAF1 regulates cdc25 transcription. 
 
Figure 28. Ethidium-bromide
stained agarose gels showing RT-
PCR products for stg (left) and
actin5C (right) transcripts in mock
(+) and TAF1 (-) RNAi treated S2
cells. 
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3.4.2 H2BS33P is correlated to transcription at the stg promoter 
 
To assess whether TAF1-mediated phosphorylation is involved in activation of stg transcription, 
XChIP-experiments were chosen as a means to examine the phosphorylation status of the stg-
promoter in mock- and dTAF1-RNAi cells.  
XChIP-assays were performed as described in chapter 2.2.5: In vivo cross-linked chromatin was 
isolated from mock- or RNAi-treated cells. The in vivo cross-linked chromatin was sheared to an 
average fragment length of 700 bp and was immunoprecipitated with the following antibodies: 
H2B-S33P, dimethyl-H3K9 and an additional non-antibody sample as control. Chromatin-
antibody complexes were purified by Protein-A sepharose affinity-chromatography, incubated 
with RNase and Proteinase K to remove RNA and proteins respectively, and incubated at 65°C 
for 6 h to reverse the cross-link. The precipitated DNA was purified (2.2.1.13) and used as a 
template for PCR. Specific PCR-primer pairs (2.1.8.4) were used to detect the string promoter 
region from position [-333] to [+157] (relative to the start of transcription at position +1) in DNA 
pools. 
PCR products were analyzed by gel electrophoresis using ethidium bromide containing agarose 
gels and detected by UV-illumination. Phosphorylation of H2B serine 33 was detected at the stg 
promoter in mock-treated cells.  In contrast, H2BS33 phosphorylation was strongly reduced in 
dTAF1RNAi cells (Figure 29).  
TAF1 contains a histone acetyltransferase (HAT) domain that acetylates histone H3 lysine 14 
(H3-K14) and unidentified lysine-residues in histone H4 in vitro (Mizzen et al. 1996). To assess 
the role of dTAF1 mediated histone actylation towards transcription of stg, XChIP assays with 
antibodies to acetylated H3-K4 and H4 (2.1.4) were performed. Interestingly, acetylated H3-K14 
and H4 were detected at the transcriptionally active stg promoter in mock-RNAi cells but not at 
the inactive stg promoter in TAF1-RNAi cells (Figure 30a). 
In conclusion, these results indicate that there is a correlation between TAF1-mediated 
phosphorylation of H2B-S33 and acetylation of H3 and H4 to potentiate transcriptional activation 
in Drosophila cells. 
To distinguish whether the loss of H2B-S33 phosphorylation at the stg promoter is due directly to 
the loss of dTAF1 due to RNAi or indirectly due to G2/M-phase arrest, XChIP assays were 
performed on S2 cells, which were arrested in G2/M-phase by RNAi of the SIN3 transcriptional 
corepressor. Although stg transcription is repressed in SIN3-RNAi cells (Pile et al. 2002), yet the 
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stg promoter remains associated with H2B-S33P and dTAF1, indicating that loss of H2B-S33 
phosphorylation in dTAF1 RNAi cells is because of elimination of dTAF1 rather than G2/M-
phase cell cycle arrest (Figure 30b). 
To confirm these results, Realtime-PCR was performed. The stg promoter was detected in DNA-
pools, using Realtime-PCR-primer pairs (2.1.8.5) for generating a short amplicon of 100 bp in 
the presence of SYBR-green. The comparative threshold cycle (CT) method was used to 
compare the presence of the stg promoter in immunoprecipitated DNA pools derived from 
dTAF1- or mock-RNAi cells. The data shown in Figure 30c represents the relative amount of 
precipitated stg promoter of mock-RNAi treated cells compared to dTAF1-RNAi or SIN3-RNAi 
treated cells, supporting the results which were obtained from the XChIP experiments. 
In summary, these results indicate that the loss of phosphorylation of H2BS33 is not due to 
indirect effects of cell cycle arrest in G2/M-phase and that the transcription of stg is not only 
correlated with dTAF1-mediated phosphorylation of H2BS33 but also with acetylation of H3 and 
H4.  
Figure 29. Photographs of ethidiumbromide-stained 
agarose-gels showing XChIP-experiments with antibodies 
against H2B-phosphoserine 33 and H3-lysine 9 in TAF1-
iRNA (iRNA) and mock treated S2-cells. 
a. XChIP-PCRs using a primerpair for the cdc25/string-
promoterregion (string). 
b. XChIP-PCR using primerpairs for the string promoter 
region. S33 = H2BS33P-antibody, K9 = H3K9-dimethyl-
antibody, K = antibody-negative IP control, minus (-) = 
PCR-negative control, plus (+) = PCR-positive control 
(genomic-DNA template). 
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3.4.3 H2BS33 is phosphorylated at the gt promoter 
 
Both maternal as well as zygotic genes control the process of segmentation in Drosophila. 
Members of the gap class of segmentation genes play a key role in this process by interpreting 
maternal information and controlling the expression of pair-rule and homeotic genes. The 
Drosophila gap gene giant (gt) expresses a short-range transcriptional repressor, which refines 
the expression pattern of other gap and pair-rule genes in the Drosophila blastoderm-embryo 
(Rivera-Pomar and Jäckle 1996). Gt is transcribed in two domains along the anterior-posterior 
axis of blastoderm-stage embryos: Transcription of the posterior gt-transcription-domain (pgt) is 
activated by the maternal activator Caudal (Cad), whereas transcription of the anterior gt-
transcription-domain (agt) is Cad-independent (Rivera-Pomar et al. 1996). 
To investigate the role of TAF1-mediated phosphorylation of H2BS33 during fly development, a 
recessive lethal dTAF1-allele, TAF1CTK, was used which contains a nonsense mutation at amino 
acid 1728 that truncates the CTK downstream of the DBD (Maile et al. 2004). The corresponding 
protein (dTAF1∆CTK) is expressed in Drosophila but presumably does not have CTK activity, 
Figure 30. XChIP-experiment and corresponding Realtime-PCR. 
a Photographs of ethidium bromide-stained agarose gels showing PCR products for the stg promoter 
(P) or coding region (CR) in mock (+) and TAF1 (-) RNAi S2 cells. In vivo cross-linked chromatin 
was immunoprecipitated with the indicated antibodies or rabbit preimmune serum (control). Input
represents the amount of stg promoter present in 0.1% of the chromatin used for XChIP. 
b Phosphorylation of H2B-S33 at the stg-promoter in SIN3-RNAi cells. Photograph of an 
ethidiumbromide-stained agarose gel. PCR products are representing a 500bp fragment containing the 
stg-promoter in mock (+) and SIN3 (-) RNAi treated S2 cells. control = rabbit preimmune serum. 
c Schematic representation of Realtime-PCR experiments with the XChIP-precipitated DNA from a 
and b detecting the string promoter.  
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since it does not phosphorylate H2B in vitro (see Figure 17). In situ hybridization was used to 
monitor the transcription of gt in embryos, which were homozygous mutant for TAF1CTK and 
heterozygous mutant for cad (Rivera-Pomar and Jäckle 1996, Maile et al. 2004). The 
hybridization experiments indicated that in this genetic background, the transcription of giant was 
reduced. Relative to controls (cad/+ or TAF1CTK), pgt but not agt transcription was reduced in 
cad/+;TAF1CTK embryos (Figure 31a).  
To examine whether dTAF1-mediated phosphorylation of H2B-S33 contributes to pgt 
transcription, the histone modification status at the gt-promoter was investigated by XChIP-
analysis.  
Figure 31.  
A Gt-transcription in heterozygous mutant cad (top, cad/+), homozygous mutant TAF1∆CTK (middle, 
TAF1CTK), or heterozygous mutant cad and homozygous mutant TAF1∆CTK (bottom, cad/+;TAF1CTK) 
blastoderm-stage Drosophila embryos. Gt-transcription was detected by in situ hybridization with gt 
anti-sense RNA. Anterior is to the left and dorsal is up. The positions of the posterior gt-transcription-
domains are indicated by arrows.  
B Photographs of ethidiumbromide-stained agarose-gels showing PCR products for the gt promoter 
(P) or coding region (CR) in embryos described in A. In vivo cross-linked chromatin was isolated from 
the posterior halves of embryos and immunoprecipitated with the indicated antibodies or rabbit
preimmune serum (control). Input represents the amount of gt promoter present in 2% of the chromatin 
used for XChIP.  
C Schematic representation of the relative amounts of precipitated gt promoter in DNA pools 
generated by XChIP using the indicated antibodies. Chromatin was prepared from embryos laid by
cad/+ females expressing wild type TAF1 or TAF1∆CTK or homozygous mutant TAF1CTK embryos. 
D Schematic representation of TAF1 and the epitopes recognized by TAF1 antibodies TAF1-M and 
TAF1-C. The position of the premature stop-codon mutation in TAF1∆CTK is indicated. 
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Cross-linked chromatin was isolated from the posterior halves of cad/+;TAF1CTK- and control-
embryos and immunoprecipitated with antibodies against H2B-S33P, acetylated histones, or 
dTAF1. PCR detected H2BS33P at the transcriptionally active gt promoter in control embryos 
(cad/+ or TAF1CTK), but not at the transcriptionally silent promoter in cad/+;TAF1CTK-embryos 
(Figure 31b). To monitor the binding of dTAF1 to the promoter, two different antibodies (TAF1-M 
and TAF1-C) were used, which recognize the middle domain (TAF1-M) or the CTK of TAF1 
(TAF1-C), respectively (Figure 31d). The gt-promoter was precipitated by both antibodies from 
control embryos indicating that dTAF1CTK and maternally contributed wild-type TAF1 are 
present at the gt-promoter in the pgt (Figure 31b).  
Interestingly, although the TAF1-M antibody precipitated the gt promoter from cad/+;TAF1CTK-
embryos, TAF1-C did not. This result suggests that TAF1∆CTK is preferentially recruited to the 
gt-promoter in the pgt (Figure 31b), suggesting that TAF1∆CTK, which is recognized by TAF-M, 
is present at a higher concentration in cad/+;TAF1CTK-embryos than maternal contributed 
dTAF1. 
This result is supported by the presence of TAF1-mediated histone acetylation at the 
transcriptionally silent gt-promoter, since TAF1∆CTK still contains HAT activity and a functional 
DBD (Figure 31d). Thus, TAF1-mediated phosphorylation of H2B-S33 contributes to 
transcriptional activation during Drosophila embryogenesis.  
To confirm these results, Realtime-PCR was used to detect the gt promoter in the same 
immunoprecipitated DNA pools that were used to generate the results shown in Figure 31b.  
Realtime-PCR assays were programmed with primers (2.1.8.5) detecting the gt promoter in the 
presence of SYBR-green to generate a short amplicon of about 100 nucleotides to compare the 
presence of the gt promoter in immunoprecipitated DNA pools derived from precipitation with 
H2B-S33P, TAF1-M, or TAF1-C antibodies. Figure 31c shows the relative amounts of 
precipitated gt promoter in the DNA pools generated by XChIP using the indicated antibodies. 
As shown with the XChIP assays before, the gt promoter could not be detected by Realtime-
PCR in the DNA pools of cad/+;TAF1CTK-embryos. 
Summarizing these results, H2BS33 is phosphorylated at the gt promoter and this modification 
status can be correlated with transcription activation of gt in Drosophila. The finding that loss of 
H2B-S33P from the gt  promoter results in reduced transcription, despite the presence of TAF1-
mediated histone acetylation indicates that dTAF1 CTK- and HAT-activities can cooperate in 
transcriptional activation of some genes. Thus, TAF1-mediated phosphorylation of H2B-S33 
contributes to transcriptional activation during Drosophila embryogenesis. 
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3.5 TAF1CTK homologs in yeast 
 
The sequence of yeast TAF1 does not contain a CTK, which instead is formed by the two 
proteins Bdf1 and Bdf2 (Matangkasombut et al. 2000). Both proteins contain a DBD and the 
acidic COOH-terminal regions, similarly to dTAFCTK (see Figure 6). In intriguing question was if 
these proteins also contain kinase motifs and if kinase activity towards histones as substrates 
can be detected. In this chapter, Bdf1 and Bdf2 were screened for the presence of kinase motifs 
and kinase assays were used to detect specific kinase activity towards the core histones H2A, 
H2B, H3 and H4. 
 
3.5.1 Saccharomyces cerevisiae Bdf1 and Bdf2 contain putative kinase 
motifs 
 
Using the PROSITE patterns shown in Figure 13, the amino acid sequences of Bdf1 and Bdf2 
were screened for the presence of ATP-binding and amino acid specific motifs with the internet 
application PATTINPROT.   
This computational analysis of Bdf1 and Bdf2 revealed that these proteins share a putative 
conserved serine/threonine-specific motif in the second bromodomain (B2) of the DBD, which 
shows homology to the specific PROSITE pattern used to identify S/T-motifs in dTAF1. This 
motif ranges from amino acids 353-365 in Bdf1 and 357-369 in Bdf2. The calculated homology 
of the detected motifs towards the PROSITE patterns was 52% for Ser/Thr and 69% for Tyr in 
Bdf1 and Bdf2. However, this S/T-motif does not contain the conserved lysine at position seven 
within the 13 amino acid motif sequence (Figure 32).  
Additionally, Bdf2 contains an NH2-terminal ATP-binding motif (amino acids 44-77) showing 83% 
homology to the pattern, which is missing in Bdf1. Although Bdf1 has glycine-rich areas in the 
NH2-terminal part of the protein sequence, the conserved sequence GxGxx[SGA] missed at 
least one of the conserved amino acids and thus, a conserved ATP-binding motif could not be 
detected. 
Results    91 
     
 
 
Instead, Bdf1 contains a second S/T-motif besides the motif in B2, ranging from amino acids 
528-540. Interestingly, a conserved lysine at position seven is present in this motif but the 
conserved asparagine-residue at position 10 could not be found in any of the detected S/T-
motifs. The Bdf1 S/T-motif shows weak homology compared to the pattern from the PROSITE 
database (Ser/Thr 53%, Tyr 50%), which is comparable to the homology of S/T-1 in dTAF1CTK.  
The presence of an NH2-terminal ATP-binding-motif followed by an S/T-motif in Bdf2 might form 
a functional catalytic domain as found in other typical proteinkinases. 
Thus, Bdf2 appears like a mirror image of dTAF1CTK that contains the kinase-motif in the first 
bromodomain and a C-terminal ATP-binding motif (Figures 12 and 32). 
 
Figure 32. Kinase motifs found in yeast Bdf1 and Bdf2 by computational search.  
Grey areas = regions of the bromodomains 1 and 2 (B1, B2). Kinase-specific motifs are shown in 
black and ATP-motifs in red boxes. Conserved and catalytic active residues in the amino-acid 
sequence are shown highlighted (graphical motif-size shown in scale to overall length of protein). 
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3.5.2 Bdf1 and Bdf2 phosphorylate H3 in vitro 
 
To investigate, whether Bdf1 and Bdf2 have kinase activity, FLAG-epitope tagged fusionproteins 
of Bdf1 and -2 were expressed and purified from Sf9 cells (Figure 33). The recombinant Bdf1 
and -2 proteins were subjected to in vitro kinase assays to detect kinase activity. 
Kinase-assays were programmed with 1 µg of recombinant X. laevis H2A, H2B, H3 or H4 
respectively and 400 ng of Bdf1 or Bdf2. Bdf1 and Bdf2 have autokinase-activity and 
phosphorylate H3 (Figure 34). This shows that both Bdf-proteins are histone kinases. 
Bdf2 seems to have a stronger transkinase-activity towards H3 when compared to the 
transkinase-signal obtained with Bdf1. Additionally, the autokinase-activity seems to decrease in 
the presence of H3, indicating that H3 as substrate competes with the autokinase-activity of Bdf1 
and Bdf2. 
 
Figure 33. Sf9-expressed Bdf1&2 fusionproteins. B = 
beads, E = eluate, black arrows show the bands of the 
fusionproteins, white arrowhead = heavy antibody 
chain. M = prestained protein marker (NEB), molecular 
weights (in kDa) are indicated on the right. 
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This result indicates that Bdf1 and Bdf2 have histonekinase-activity. The higher activity of Bdf2 
might be correlated to the more conserved ATP-binding motif. However, since Bdf1 shows 
kinase activity too, a not very high conserved ATP-binding motif might be located within the 
glycine-rich areas in the NH2-terminal part of the protein. 
 
 
Figure 34. Kinase-assay with Bdf1&2 and recombinant histones (X. 
laevis) H2A (2A), H2B (2B), H3 and H4. Top: Coomassie stained 
15% SDS-PAGE gel, the positions of the histones are indicated on
the right, Bdf1 and Bdf2 are indicated with white arrowheads.
Bottom: Autoradiogram of the gel shown above, autokinase-signals 
of Bdf1 and Bdf2 are indicated with white arrowheads, the 
transkinase-signal of H3 is indicated with a black arrowhead. M =
prestained protein marker (NEB). 
Discussion    94 
     
 
 
 
4. Discussion 
 
The coactivator TAF1 plays an essential role in the regulation of essential biological processes 
by activating for example the transcription of cell cycle, cell-growth- and developmental factors 
(Wang et al. 1997, Walker et al. 1997, O’Brien and Tjian 2000, Pham and Sauer 2000). TAF1 
activates transcription of target genes by initiating the assembly and activity of the PIC at the 
promoter and through enzymatic modifications of components of the general transcription 
machinery (GTM) and histones, resulting in the transfer of activation-signals to the GTM 
(Dikstein et al. 1996a, O’Brien and Tjian 1998, Solow et al. 1999; 2001).  
The HAT-activity of TAF1 can acetylate histones H3 and H4 while the E1/E2-activities mono-
ubiquitinate histone H1. In contrast, the kinase activity of the NTK targets components of the 
GTM (Dikstein et al. 1996a, O’Brien and Tjian 1998, Wassarman et al. 2000). 
A previous study discovered that the CTK of dTAF1 phosphorylates H2BS33 and is essential for 
TAF1 activity in vivo (Kwoczynski 2002). However, the kinase motifs of the CTK remained 
unknown. Furthermore, it remained mysterious whether phosphorylated H2BS33 existed in vivo 
and if this modification is involved in transcriptional activation of specific TAF1-target genes. 
This work functionally characterizes the CTK of dTAF1 as an atypical serine-kinase and 
uncovered the characteristic kinase motifs, the serine/threonine-specific motif and the ATP-
binding motif in the CTK. The results provided evidence that TAF1 is a major kinase of H2BS33 
in vivo. Genetic and RNAi assays revealed that TAF1 plays an essential role in the transcription 
of cell cycle and developmental genes. Therefore, the kinase activity can be linked to TAF1-
mediated transcriptional activation. 
 
4.1 dTAF1 is an atypical histone-kinase 
 
The most important difference of TAF1 compared to other kinases is the fact that TAF1 contains 
with NTK and CTK two distinct kinase-domains.  
However, the kinase activity of human TAF1 (hTAF1) is under dispute. Recently, Sawa et al. 
described that the phosphorylation of the CTK of hTAF1 is not mediated by CTK autokinase 
activity but rather by the TAF1-associated protein kinase CK2, responsible for phosphorylation of 
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the yeast TAF1CTK-homolog Bdf1 (Dikstein et al. 1996a, O’Brien and Tjian 1998, Sawa et al. 
2004). This result is supported by the fact that E. coli-expressed TAF1 shows no 
autophosphorylation activity, probably due to the fact that highly structured molecules of the size 
of TAF1 get differently folded or lack eukaryotic posttranslational modifications. To verify that 
dTAF1 has intrinsic autokinase activity, His-tagged dTAF1CTK, which has been denatured and 
subsequently renatured, was subjected in this study to an additional denaturing/renaturing step 
by a transmembrane-autokinase-assay. The results revealed that, contrary to the findings by 
Sawa et al., dTAF1CTK contained autokinase activity, suggesting that there is no additional 
kinase involved in the autophosphorylation of dTAF1CTK (Figure 11). This data demonstrates 
that dTAF1CTK has intrinsic kinase activity.  
 
4.1.1 dTAF1CTK differs in kinase motif alignment from other proteinkinases 
 
While dTAF1 shares common structural characteristics with typical protein kinases in its NTK, 
the CTK differs from the typical alignment in several points. 
A characteristic attribute of serine/threonine- and tyrosine-specific kinases is a COOH-terminal 
localised catalytic domain consisting of around 250-300 amino acids, which can be separated 
into eleven motifs, also called subdomains (subdomains I-XI) with partially highly conserved 
sequences (Hanks et al. 1988, Hunter and Hanks 1995). These sequences have been identified 
by analyzing protein sequences of a selection of 65 different serine/threonine- and tyrosine-
specific kinases, whose biological function was unknown (Hunter and Hanks 1995). Further 
studies showed that only a few motifs were relevant for the catalytic activity of these kinases and 
that they could be summarized into two essential types of kinase motifs as shown in the 
PROSITE documentation PDOC00100: the ATP-binding motif and the substrate-specific-binding 
motif (Figures 12 and 13). Both of these kinase-motifs were detected by computational 
sequence comparison in dTAF1CTK, but except for the ATP-binding motif, homologies of the 
TAF1 S/T-motifs to other serine/threonine-specific motifs of protein kinases were very low, 
indicating that dTAF1 might belong to a novel class of protein kinases. Supporting this 
hypothesis is the fact that a number of protein kinases have been described whose catalytic 
domains do not share the same attributes as eukaryotic protein kinases (Hunter and Hanks 
1995). However, the majority of known serine/threonine- and tyrosine-kinases contain the 
conserved ATP-binding motif (Ryazanov et al. 1997). As detected by the experiments in this and 
previous studies, both NTK and CTK contain the conserved ATP-binding motif.  
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Interestingly, while the NTK of dTAF1 shows a typical alignment of kinase motifs forming the 
catalytic domain, the CTK shows an untypical catalytic domain: The NTK contains a common 
serine/threonine-kinase-specific alignment, involving a NH2-terminal localised ATP-binding motif 
followed by a conserved serine-threonine-specific motif within the catalytic domain (Kwoczynski 
2002). In contrast, the motifs identified in the CTK show a vice-versa assembly (Figure 14), thus 
mirroring the standard pattern of subdomains as found in the NTK. 
Except for the double-bromodomain of hTAF1, no crystal structure of TAF1 exists to date 
(Jacobson et al. 2000). It requires further examination of the three-dimensional structure to 
determine whether a mirrored assembly of two terminal kinases has advantages in terms of 
substrate-recognition, ATP-binding or general stability of the kinase-structure. The TFIID-
complex was documented to have a horseshoe-like three-dimensional structure (Andel et al. 
1999). Since TAF1 builds the main structural scaffold of the TFIID-complex, it is imaginable that 
TAF1 also might form a horseshoe-like substructure, maybe with two parallel-aligned kinase-
domains at the ends of the complex (Figure 35).  
So far, both kinases have been shown to have autokinase activity and specifically recognize and 
phosphorylate different substrates: NTK binds and phosphorylates RAP74 (Ruppert and Tjian 
1995, Dikstein et al. 1996a) whereas CTK phosphorylates H2BS33 (Maile et al. 2004). However, 
the efficient transphosphorylation of RAP74 seems to require the combined action of both 
Figure 35. The 3D-structure of the TFIID-complex. The blue 
mesh corresponds to the holo-TFIID, with the A, B, and C 
lobes indicated. The yellow mesh shows the density 
difference between the holo-TFIID and TFIID that is bound 
to the TBP antibody (Andel et al. 1999). 
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functional kinase domains (Dikstein et al. 1996a), in which, hypothetically, a specific parallel 
assembly of the two kinase domains at the terminal ends of TAF1 might be of functional 
significance, bringing both kinase domains into a close spatial alignment. 
 
4.1.2 Bromodomain 1 of dTAF1CTK contains the amino acid specific motif 
 
The performed kinase experiments identified the substrate-specific motif of the CTK catalytic 
domain. The amino acid specific motif of a total length of 13 amino acids is characterized by 
three highly conserved amino acids: a catalytic aspartic-acid-residue at position five, a 
conserved asparagine-residue at position ten and a substrate specific amino acid at position 
seven which is, in case of typical Ser/Thr-kinases, a lysine-residue (see also Figure 13).  
dTAF1CTK contains such a motif with the two conserved amino acids apartatic-acid and lysine 
in its first bromodomain B1. The aspartic-acid of the amino acid specific motif is presumed to act 
as a base to remove a proton from the protein substrate hydroxyl group (Figure 36), although the 
catalytic mechanism is not definitively established.  
Figure 36: An example of the roles of conserved
kinase motif amino acid residues important for
binding of ATP shown for the Ser/Thr-kinase
cAPK:
The correct alignment of the ATP with respect to
the catalytic residues appears crucial for catalysis.
The adenine is located in a hydrophobic pocket,
and the ribose is stabilized by hydrogen bonds.
The phosphates of ATP are aligned for catalysis by
interactions with the main chain nitrogens of a
NH2-terminal glycine-rich loop, by interactions
with Lys-72 (which is localized by a salt bridge to
Glu-91), and by interactions with Mg2+ ions. An
activatory Mg2+ binds to the β- and γ- phosphates
of ATP and to Asp-184. The catalytic aspartate,
Asp-166, which is invariant in all kinases, is
located in the COOH-terminal lobe in a loop,
termed the catalytic loop. The aspartate is
presumed to act as a base to remove a proton from
the protein substrate hydroxyl group, although the
catalytic mechanism is not definitively established.
The resulting alcoholate or phenolate ion is
positioned to attack the γ-phosphate of ATP
(Johnson et al. 1996).
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The resulting alcoholate or phenolate ion is positioned to attack the γ-phosphate of ATP. All 
amino acid specific motifs detected in dTAF1CTK contain these catalytic residues. 
The results in this work show that the discovered motif S/T-1, which is mainly responsible for 
transkinase-activity of the CTK is located in the DBD. Although no kinase-specific motif has been 
identified in the DBD of hTAF1CTK by the computational approach, the DBDs of human and 
Drosophila TAF1 are highly conserved, indicating that their three-dimensional structure might be 
similar. A comparison of the homologous dTAF1 and hTAF1 DBD-sequences with the crystal 
structure of the DBD of human TAF1 (Jacobson et al. 2000) suggests that the position of the 
Drosophila kinase-specific motif might lie on the lateral surface of the DBD within one of the four 
helices in the helix-bundles of bromodomain 1 and does not overlap with the acetylated lysine-
binding surface which consists of two deep pockets at the bottom surface of the two helix-
bundles of the DBD.  
These findings underline the theory that the kinase-specific motif might be an independent 
functional unit of the DBD. 
 
4.1.3 dTAF1CTK contains a secondary amino acid specific motif 
 
A secondary S/T-specific kinase motif was detected in dTAF1CTK, termed S/T-2. Point 
mutations that exchange the catalytic active aspartic-acid residue to an alanine in S/T-1 revealed 
that this motif dominates over S/T-2. However, point mutations in S/T-2 resulted in reduction of 
kinase activity, indicating that this motif is also involved in kinase activity. 
Interestingly, UV-crosslink experiments intended to locate the ATP-binding motif involving 
proteins lacking S/T-1 revealed that the proteins dTAF1CTK∆1600 and especially dTAF1CTK17-
18 show stronger ATP-binding than all other tested proteins. Both proteins contain the highly 
conserved ATP-binding domain found together with the amino acid specific motif S/T-2.  
The protein dTAF1CTK17-18 showed the strongest ATP-binding compared to all other tested 
deletion-proteins. This might indicate that this protein could have a higher affinity to ATP by 
combining the ATP-binding capabilities of the conserved lysine in the ATP-motif and the 
aspartic-acid plus the asparagine residue of the S/T2-motif. More likely however is the fact that 
the protein, consisting mainly of both kinase motifs, folds into a functional catalytic domain that 
confers auto-kinase activity to the protein. 
Comparably, dTAF1CTK∆1600, which still contains the secondary bromodomain and thus folds 
structurally different from dTAF1CTK17-18 might form a more inhibitory structure, thus resulting 
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in less autokinase activity than dTAF1CTK17-18 but more activity than all other proteins used in 
the crosslinking experiment.  
These results are intriguing in two ways since they suggest that S/T-2 and the ATP-binding motif 
actually form a catalytic core domain capable of autophosphorylation without additional NH2- and 
COOH-terminal located motifs and indicate that additional sequences have a regulatory function 
on this catalytic domain as shown by the protein dTAF1CTK∆1600. Thus, the observation that 
the motif S/T-1 dominates over S/T-2 may be the result of inhibitory effects by additional 
sequences located NH2-terminal to S/T-2 like, for example, the structure of the DBD.  
This result assists the hypothesis that multifunctional proteins indeed show different preferential 
activities depending to their folding in tertiary structure, which results in specific conformations. 
Depending on the conformation, specific domains like the catalytic domain might be spatially 
more or less available to binding partners such as substrates like histone proteins and 
phosphodonors like ATP-molecules. 
 
4.1.4 dTAF1CTK contains a conserved ATP-binding motif 
 
An ATP-binding motif in dTAF1CTK shows high homology (90%) to the PROSITE-pattern used 
in the computational search (Figure 13), containing the catalytic ATP-binding lysine and each 
conserved residue within the G-{P}-G-{P}-x-[SGA] pattern. This motif is well conserved and 
existent in even the most atypical kinases like for example C. elegans’ eEF-2K, which does not 
even show the conserved lysine in the ATP-binding motif and instead contains two cysteines 
that take over the catalytic activity of the missing lysine (Ryazanov et al. 1997, Maru and Witte 
1991).  
Transkinase-assays with CTK proteins lacking the ATP-binding-motif (Figure 15) indicate that 
the motif is essential for kinase activity (Figures 17 and 18).  
UV-crosslinking experiments were conducted to confirm that the identified ATP-binding motif 
binds ATP since additional possible ATP-binding domains were found in the computational 
search (Figure 20). Several deletion-proteins were used to find the exact location of the ATP-
motif responsible for binding the ATP-molecule and subsequently, radiolabeled ATP was 
crosslinked via UV-light to the specific constructs (Figure 19).  
Interestingly, all of the proteins that showed ATP-binding on autoradiography by treatment with 
UV-radiation also showed ATP-binding in similar strength when incubated under standard 
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conditions without being exposed to UV-radiation. This result suggests that these proteins still 
have autokinase activity. 
An intriguing observation is that the proteins containing exon 12a (dTAF1CTK∆1800 and 
dTAF1CTK18-19), which contain AT-hooks, bind ATP while the protein containing only the acidic 
COOH-terminus (dTAF1CTK∆1900), which contains no ATP-binding motifs, did not. AT-hooks 
are part of HMG proteins and bind to adenine-thymine rich DNA-sequences (Reeves and Nissen 
1990, Geierstanger et al. 1994). Interestingly, the AT-hook of exon 12a is part of the secondary 
ATP-binding motif discovered as part of the tandem ATP-domain in an earlier study (Kwoczynski 
2002). This secondary domain (Figure 20) contains two AT-hooks and the UV-crosslinking 
results suggest that the AT-hooks might contribute to the capability of this region to bind ATP. It 
might also be possible that the ATP-binding motif of dTAF1CTK consists of two closely 
overlapping functional ATP-binding motifs that form a functional ATP-binding surface. This 
double-motif might be necessary to secure kinase activity of TAF1 when binding partners of 
dTAF1 such as other TAFs sterically block parts of the complete ATP-binding motif. This theory 
is supported by the function of dTAF1 as flexible scaffold protein of TFIID, which inclines that 
dTAF1 might exist in different conformations depending on the conformation of TFIID, but still 
needs to maintain specific functions like ATP-binding active regardless of its changing 
conformational state. 
 
4.2 Other bromodomain kinase proteins 
 
Three-dimensional structural analysis of several protein kinases revealed, that the catalytic 
domain is composed of two loops, a short NH2-terminal loop that forms a twisted β-sheet 
structure and represents the ATP-binding motif and a bigger loop located COOH-terminal to the 
ATP-binding motif, which mostly consists of α-helices that bind the substrate (Johnson et al. 
1996, Ryazanov et al. 1997). This alignment of the motifs, with the conserved GxGxx[SGA] 
sequence of the ATP-binding motif localized at the very NH2-terminal end of the catalytic 
domain, followed by the amino acid specific motif, is typical for the majority of the discovered 
protein kinases so far (Hardie and Hanks 1995, Taylor et al. 1992, Hanks and Hunter 1995). The 
short loop contains the conserved GxGxx[SGA]-sequence of the ATP-binding motif and interacts 
directly with the phosphates of the ATP-molecule (Hardie and Hanks 1995, Taylor et al. 1992, 
Johnson et al. 1996) whereas the conserved lysine, localised up to 20 amino acids COOH-
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terminal of the GxGxx[SGA]-sequence, takes part at the binding of the β- and γ-phosphates of 
the ATP-molecule (Hanks and Hunter 1995, Johnson et al. 1996).  
Bromodomains consist of a bundle of α-helices (Jacobson et al. 2000) and it might be possible 
that one or both bromodomains in dTAF1 could form a similar structure like the substrate 
recognizing, α-helices-containing loop of protein kinases.  
 
4.2.1 The BET family 
 
Members of the fsh/RING3 (BET) family of DBD proteins have kinase activity, suggesting that 
TAF1 might be a member of a kinase family whose catalytic motif resides within the DBD (Zheng 
and Zhou 2002, Florence and Faller 2001). By a computational approach involving kinase-
specific search patterns in various bromodomains, several bromodomain-kinase proteins of the 
BET-family of proteins have been identified that contain kinase-motifs with higher homology to 
the motifs found in dTAF1.  
The BET proteins are a novel class of transcriptional regulators whose members can be found in 
animals, plants and fungi. Founding members are Drosophila Fs(1)h, human RING3 and yeast 
Bdf1. BET proteins are distinguished by an N-terminal single bromodomain or DBD and an ET 
domain. As predicted by the presence of the (double-) bromodomain, these proteins have been 
found to be associated with chromatin. Additionally, the poorly characterized ET domain 
functions as a protein-protein interaction motif and may be part of a serine-kinase activity 
(Florence and Faller 2001), which underlines the possibility of the dTAF1-bromodomain being an 
essential part of a chromatin-associated kinase activity and points towards a possible interplay 
between the acetylation of histones, possibly the binding to those residues by a bromodomain 
and subsequent kinase-activity. 
In an additional computational approach conducted in this work, kinase-motifs were detected in 
both bromodomains of drosophila fs(1)h. The motif in the first bromodomain shows high 
homology to the typical kinase pattern (58%-59%), indicating that fs(1) seems to be a member of 
the typical serine/threonine-kinases. However, the kinase-motif found in the second 
bromodomain shows very high homology to the one found in ring3, which does not contain a 
highly homologous kinase-motif in bromodomain 1 like the one found in fs(1)h (see Figure 37). 
Interestingly, several transcripts of fs(1)h exist, of which isoform B with a length of 2038 amino 
acids (compared to 1110 amino acids of isoform A) has additional sequences between both 
bromodomains, which encode for transmembrane-regions. These genes have generally been 
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shown to code for membrane proteins (Haynes et al. 1989), thus pointing towards different 
specifities of the two kinase-motifs in the two distinct bromodomains, maybe depending on 
separated spatial compartments within the cell.  
All putative kinase-motifs found in bromodomain 2 (B2) are very homologous in fs(1)h, ring3, 
Bdf1 and 2 (Figures 32 and 37). They all lack the conserved lysine (at position seven) as well as 
the conserved asparagine (at position ten) within their 13 amino acid pattern and thus show 
homology to the kinase-domain described in human TAF1 by Tjian and O’Brien, although this 
kinase-motif is not located within a bromodomain (Tjian and O’Brien 1998). It might be that this 
group of kinase-motifs defines a novel class of proteinkinases, specific for phosphorylating 
substrates within the nucleus such as nucleosomes or other chromatin-binding proteins like 
transcription factors. 
The human homolog to Drosophila fsh, ring3 (Brd2), has been shown to be highly 
phosphorylated in response to mitogens (Denis and Green 1996). Like hTAF1, this protein has 
been proposed to have autokinase-activity despite limited sequence similarity to known kinases. 
 
Figure 37. Motifs found in the bromodomain-kinases fs(1)h 
(isoform A) in Drosophila (a) and its human homolog ring3 
(b). grey = bromodomains 1 and 2. Kinase-specific motifs are 
shown as black, ATP-motifs as red boxes. Conserved and 
catalytic active residues in the amino-acid sequence are shown 
highlighted (all graphical motif-sizes are shown in scale to 
overall length of the proteins). 
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Another mammalian BET family member, Brd4, has been implicated in cell cycle regulation of 
chromosome structure (Dey et al. 2003), which suggests a connection between signal 
transduction and cell cycle pathways to chromatin and gene expression.  
Therefore, bromodomains with different specificity and maybe additional functions besides 
acetyllysine-binding add to the complexity of the histone code. 
 
4.2.2 Yeast Bdf1 and Bdf2 
 
Bdf1 and Bdf2 share the conserved S/T-kinase-motif in bromodomain 2 (Figure 32), but only 
Bdf2 carries a typical ATP-binding motif. Bdf1 instead contains an additional amino acid specific 
kinase motif which shows similarity to S/T-1 in dTAF1CTK, but is located COOH-terminal to the 
DBD. 
The kinase assays performed in this work documented that both Bdf-proteins contain histone-
specific kinase activity, suggesting that the BET family contains specific histone-protein kinases 
related to dTAF1CTK. 
Genetic analyses show that while each gene alone is not essential, disruption of both bdf1 and 
bdf2 is lethal in yeast (Matangkasombut et al. 2000). This implies that besides the essential 
nature of the bromodomain to bind to acetylated lysines, there might be other essential functions 
located in bromodomain 2, such as histone kinase activity. 
An intriguing question is whether there are known interactions of Bdf-proteins with other histone 
modifications. Yeast Bdf1 is known to associate with TFIID and binds histone H4 with preference 
for multiply acetylated forms, whereas, in contrast, Bdf2 shows no preference for acetylated 
forms. Additionally, point mutations within the bromodomain, that block Bdf1-binding to histones, 
disrupt transcription and reduce Bdf1 association with chromatin in vivo (Matangkasombut and 
Buratowski 2003). The same study shows that deletion of Bdf1 but not Bdf2 is lethal when 
combined with a mutant allele of ESA1, a histone H4 acetyltransferase, or with nonacetylatable 
histone H4 variants.  
Interestingly, the study shows also that there may be some interactions between Bdf1 and 
histone H3. While a deletion of the H4 tail is lethal in combination with a deletion of Bdf1, a 
deletion of the H3 tail is not lethal, but this double mutant shows a synthetic slow growth 
phenotype. This suggests that both histone tails may play a role in the function of the Bdfs in 
vivo, with H4 being particularly important. 
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This difference between Bdf1 and Bdf2 in the preference of binding to acetylated H4 and a 
possible role of H3 correlates with the observation in this study that Bdf1 and Bdf2 
phosphorylate H3. It also provides an explanation the observed differences in kinase activity, 
with Bdf1 revealing a weaker kinase activity than Bdf2. It is possible that Bdf1 needs acetylated 
H4 to unfold a stronger kinase activity compared to Bdf2 or that the kinase activity of Bdf1 is 
restricted to a specific serine-/threonine- or tyrosine-residue within H3 while the kinase activity of 
Bdf2 might target several residues. An intriguing fact is that these results may suggest a 
possible interplay between acetylation and histone phosphorylation by the CTK-homologous 
Bdf-proteins in yeast.  
 
4.3 Phosphorylation of H2B is essential for transcriptional activation 
 
One general question of this work was how the coactivator dTAF1 functions in vivo as histone 
kinase and especially how the documented kinase activity contributes to activation of 
transcription.  
It is known that histone phosphorylation can activate transcription, but most of these events were 
restricted to phosphorylation of histone H3 (Cheung et al. 2000a). Specific phosphorylation of 
H2B was shown before, but only in context of apoptotic mammalian cells (Ajiro 2000) and this 
phosphorylation event coincides with nucleosomal DNA fragmentation. The phosphorylation of 
mammalian H2B is occurring at serine 32 by an unidentified kinase and is probably dependent 
on caspase-induced signaling pathways. Compared to Drosophila H2B, mammalian H2B 
contains serines at position 32 and 36 (Figure 10).  
Are there any potential links between apoptotic pathways and histone modifications? A 
connection might exist since the dTAF1-protein used in this work was initially identified as a 
splice-variant of dTAF1, which was expressed in Drosophila embryo cells after induction of 
apoptosis (Kwoczynski 2002).  
 
4.3.1 TAF1 phosphorylates serine 33 in the NH2-terminal H2B tail in vivo 
 
The experiments described in chapter 2 show that TAF1 phosphorylates H2BS33 in vivo (Maile 
et al. 2004). Interestingly, serine 33 is the only evolutionary conserved position of serines or 
threonines in the NH2-terminus of metazoan H2Bs (Figure 10). The crystal structure of the 
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nucleosome from Xenopus laevis reveals that the respective serine-residue links the H2B NH2-
terminal tail, which binds DNA, to the histone-fold domain (Luger et al. 1997a, Luger and 
Richmond 1998). It might be possible that this exchange of the hydroxyl group on serine 33 with 
a bulkier negatively charged phosphate group might drastically affect H2B-tail interactions with 
DNA. This is particularly important because the H2B-tail is supposed to regulate nucleosome 
mobility. For example, deletion of the H2B-tail bypasses the requirement for the SWI/SNF 
nucleosome-remodeling complex in yeast (Recht and Osley 1999) and the NH2-terminal tail 
shows to be also critical for maintaining the position of histone octamers in in vitro sliding assays 
(Hamiche et al. 2001).  
These results display a model in which the TAF1-mediated phosphorylation of H2BS33 changes 
the overall conformation of the H2B NH2-terminal tail, which may result in the disruption of DNA-
histone interactions, leading to local decondensation of chromatin. This decondensation might 
be a trigger for chromatin remodeling and the formation of a chromatin structure that facilitates 
the assembly of other GTFs at a given promoter, a function that is primarily attributed to TFIID 
(Lemon and Tjian 2000, Orphanides and Reinberg 2002, Dikstein et al. 1996a). 
 
4.3.2 The role of TAF1-phosphorylated H2BS33 for cell cycle regulation 
 
Experiments show that cell cycle arrest of TAF1RNAi cells correlates with reduced transcription 
of string.  
The protein phosphatase String is predominantly expressed during G2-phase and activates the 
cell cycle by dephosphorylating Cdc2 (Lee et al. 1992, Figure 38). Therefore, the loss of stg from 
S2 cells by treatment with Stg-RNAi causes G2-M arrest (Pile et al. 2002), indicating that TAF1 
may regulate G2/M-phase progression by activating the transcription of stg. 
 XChIP experiments revealed that activation of stg coincides with TAF1-mediated 
phosphorylation of H2BS33. Similarly, transcription of string is repressed in SIN3-RNAi treated 
cells (Pile et al. 2002). However the results obtained in this work show that the stg-promoter 
remains associated with H2BS33P and dTAF1. This indicates that loss of phosphorylation of 
H2B serine 33 in TAF1RNAi-treated cells is directly due to the elimination of TAF1 rather than 
arrest in G2/M-phase (Figure 30).  
In addition to the kinase-activity, TAF1 has a histone acetyltransferase activity that acetylates H3 
lysine 14 and unidentified lysine residues in histone H4 in vitro (Mizzen et al. 1996). Analysis by 
XChIP detected acetylated histone H3 lysine 14 and histone H4 at the transcriptionally active 
Discussion    106 
     
 
 
stg-promoter in mock-treated RNAi cells but not at the inactive stg-promoter in TAF1RNAi-
treated cells (Figure 30).  
 
4.3.3 The role of TAF1-acetylation in stg transcription 
 
These results indicate that in case of stg-activation, several histone modifications might play a 
combinatory role at specific promoters and they suggest that the dTAF1-mediated 
phosphorylation of H2BS33 is essential for transcriptional activation of string/cdc25 and thus cell 
cycle progression. Furthermore, phosphorylation of H2BS33 and acetylation of H3 and H4 seem 
to be correlated with transcriptional activation in Drosophila, underlining that TAF1-CTK- and 
TAF1-HAT-activities may cooperate in transcriptional activation of some genes.  
Other components of TFIID also showed to have influence over the cell cycle in various 
organisms. Depletion of yeast TAF5, human TAF2 or a twofold reduction in TBP from chicken 
was shown to result in arrest in the G2/M-phase (Apone et al. 1996, Martin et al. 1999, Um et al. 
2001). Besides, as shown in this work with TAF1, also TBP is regulating expression of 
stg/cdc25, thus providing additional support for the results in this study, indicating that the H2B-
S33 kinase activity of TAF1 occurs in the context of TFIID (Um et al. 2001). Another interesting 
fact is that the depletion of yeast TAF1, which does not possess a CTK, and the inactivation of 
Figure 38. The transition from G2 phase to mitosis is triggered by the Cdc25-mediated activation 
(dephosphorylation) of the cyclinB/cdc2 complex. CyclinB/cdc2 is activated by phosphorylation of
threonine 162 and the dephosphorylation of threonine 14 - tyrosine 15. The complex is kept in an 
inactive state due to the phosphorylation of threonine 15, which is catalyzed by the kinase Wee1.
Cyclin B/cdc2 activation is triggered when Cdc25, a phospatase, dephosphorylates threonine 15. 
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the HAT-activity of TAF1 induce G1-phase arrest because of a reduced transcription of B- and 
D-type cyclins, respectively (Apone et al. 1996, Dunphy et al. 2000). That means that the loss of 
all TAF1 activities causes G2/M-phase arrest whereas the loss of TAF1 HAT-activity causes 
arrest in G1-phase, which suggests a more gene-specific requirement for the CTK- and HAT-
activities of TAF1. 
 
4.3.4 The role of TAF1-phosphorylation of H2BS33 in Drosophila 
development 
 
It was shown by XChIP-PCR-analysis, that phosphorylation of H2BS33 by CTK is essential for 
transcription of the gene giant. 
Additionally, acetylation was found at the transcriptionally silent gt-promoter since the HAT-
activity of the TAF1CTK-mutants was not disabled, which suggests that acetylation occurs 
independently of the phosphorylation of H2BS33 (Maile et al. 2004). Additionally, missing 
ubiquitination at the gt promoter is correlating with missing phosphorylation (F. Sauer, personal 
correspondence). 
These results point towards the theory that TAF1-mediated phosphorylation of H2BS33 is a 
dominant factor in the transcription of giant. It is possible that prior acetylation of histones at the 
gt promoter introduces phosphorylation of H2BS33 due to better binding of the kinase motif 
carrying DBD to the multiple-acetylated target region. Phosphorylation then changes the 
structure of the histone tail in a way to allow better binding of TAF1 or other transcription factors 
to the promoter. 
giant (gt) is a gap gene that codes for a transcriptional repressor, which is located in the nucleus. 
In keeping with its developmental group, lack of giant expression produces gaps in both anterior 
and posterior structures, specifically the labial and labral head structures and abdominal 
segments A5 through A7. Giant helps to define the domains of expression for the pair-rule genes 
even-skipped, paired and fushi tarazu and it also delimits the anterior boundary of early 
antennapedia expression. While giant is expressed in an anterior and a posterior stripe in early 
fly development, for example, GT RNA is first detected quite early in development during nuclear 
cycle 12, the expression pattern becomes increasingly complex over time (Eldon and Pirotta 
1991, Kraut and Levine 1991). This complex expression pattern during development is likely 
linked to an equal complex regulation of transcription. Therefore it is possible that besides TAF1-
mediated phosphorylation, other histone modifications might interfere with the transcriptional 
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regulation of giant in different developmental stages.  During the last years, it has become clear 
that there is interplay between core histone modifications. For example, the choice of 
methylation of H3 lysine 9 could be directed by phosphorylation of H3 serine 10: In 
Saccharomyces cerevisiae, Snf1 and GCN5 appear to work synergistically to mediate gene 
activation by phosphorylating H3 serine 10 and acetylating H3 lysine 14, respectively (Lo et al. 
2001). There might be even other TAF1-mediated histone modifications that are correlated with 
kinase-activity: TAF1 has been shown to contain histone-specific ubiquitin-activating/conjugating 
(E1/E2) activity for histone H1 (Pham and Sauer 2000). An intriguing cross-talk linking 
ubiquitination of H2B to methylation of H3 was shown also in yeast: Genetic experiments 
demonstrated a link between ubiquitination of H2B by Rad6/Ubc2 and the methylation of H3 on 
lysine 4 in budding yeast (Sun and Allis 2002). Recently, a novel histone-kinase, NHK-1 
(nucleosomal histone kinase-1), was discovered to phosphorylate H2A threonine 119 specifically 
in context of the nucleosome during mitosis in the Drosophila embryo (Aihara et al. 2004). 
Mammalian H2A lysine 119, which is next to the putative unique phosphorylation site in mammal 
H2A threonine 120, is well conserved and known to be modified by mono ubiquitination (Olson et 
al. 1976, Goldknopf et al. 1977), suggesting a possible interplay between both modification sites. 
With the gene giant, this study shows that the kinase activity of dTAF1 might also be involved in 
the transcriptional activation of developmental genes. It might be interesting to conduct further 
ChIP experiments to get more insight into the connections of dTAF1 histone kinase activity and 
the role of the functional interplay between histone modifications in the context of the genome.  
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5. Summary 
Activation of eukaryotic transcription involves an orchestrated interplay between transcription 
factors and the general RNA polymerase II (Pol II) transcription machinery (GTM), which 
consists of Pol II and general transcription factors (GTFs). 
The GTF TFIID consists of the TATA-box binding protein (TBP) and several TBP-associated 
factors (TAFs). The binding of TFIID to promoters can nucleate transcription. 
TAF1 is the largest subunit of TFIID and plays a central role within the nucleating function of 
TFIID in transcription. TAF1 mediates the binding of TFIID to promoters and interacts with 
enhancer-bound transcription factors and several GTFs. Additionally, TAF1 contains four 
enzymatic activities that are essential for viability of eukaryotes and mediate posttranslational 
modification of GTFs and histones. TAF1 is a bipartite protein kinase and contains an NH2-
terminal kinase domain (NTK) and a COOH-terminal kinase domain (CTK). A previous study 
demonstrated that the CTK phosphorylates serine-residue 33 in histone H2B (H2BS33). 
However, the role of TAF1-mediated phosphorylation in transcription regulation remained 
unknown. 
In this study, the functional importance of H2BS33 phosphorylation (H2BS33P) by TAF1 was 
investigated by using a combination of biochemical and in vivo assays.  
In vitro kinase assays uncovered the two essential kinase motifs in TAF1CTK, the ATP-binding 
motif and the serine/threonine-specific catalytic motif, and indicate that the TAF1 CTK has 
intrinsic kinase-activity. Western blot analysis using an antibody to H2BS33P revealed that 
H2BS33 is phosphorylated in Drosophila. RNA-interference (RNAi) assays, designed to 
attenuate TAF1 expression (TAF1RNAi), revealed that TAF1 is a major kinase for H2BS33 in 
Drosophila Schneider cells. 
Flow-cytometry analysis of TAF1RNAi cells indicated that loss of TAF1 expression results in cell 
cycle arrest in G2/M-phase. Screening the transcription of cell cycle genes in TAF1RNAi cells by 
using reverse-transcriptase-PCR demonstrated that the transcription of the cell cycle gene string 
(stg) is reduced in the absence of TAF1. 
Chromatin immunoprecipitation assays (XChIP) indicate that H2BS33P is detectable at the 
transcriptionally active stg promoter but not at the silent stg promoter in TAF1RNAi cells. These 
results demonstrate that phosphorylation of H2BS33 is involved in stg transcription. 
XChIP-assays using chromatin prepared from Drosophila embryos, which express a mutant 
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TAF1 lacking the CTK, revealed that CTK-mediated phosphorylation of H2BS33 plays an 
essential role in the activation of transcription of the Drosophila segmentation gene giant. 
In vitro kinase assays demonstrate that Bdf1 and Bdf2, the yeast homologues of the TAF1CTK, 
phosphorylate histones suggesting that the kinase activity of the TAF1CTK is phylogenetically 
conserved. The results of this work demonstrate that TAF1CTK is a major histone kinase of 
H2BS33 and that TAF1-mediated phosphorylation of H2BS33 plays an essential role in the 
transcription events during cell cycle progression and development. 
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6. Zusammenfassung 
Die Aktivierung eukaryotischer Transkription umfaßt eine geordnete Interaktion zwischen 
Transkriptionsfaktoren und der generellen RNA Polymerase II (Pol II) Transkriptionsmaschinerie 
(GTM), welche aus Pol II und generellen Transkriptions-Faktoren (GTFs) gebildet wird. 
Der GTF TFIID besteht aus dem TATA-Box-bindenden Protein (TBP) und mehreren TBP-
assoziierten Faktoren (TAFs). Die Bindung von TFIID an Promotoren kann Transkription 
nukleieren. TAF1 ist die größte Untereinheit von TFIID und spielt eine zentrale Rolle bei der 
nukleierenden Funktion von TFIID in Transkription. TAF1 vermittelt die Bindung von TFIID an 
Promotoren und interagiert mit Enhancer-gebundenen Transkriptionsfaktoren sowie mehreren 
GTFs. Desweiteren enthält TAF1 vier enzymatische Aktivitäten, welche essentiell für die 
Entwicklung von Eukaryoten sind und posttranslationelle Modifikationen von GTFs und Histonen 
vermitteln. TAF1 ist eine zweiteilige Proteinkinase und enthält eine NH2-terminale 
Kinasedomäne (NTK) sowie eine COOH-terminale Kinasedomäne (CTK). Eine frühere Studie 
zeigte daß die CTK Serin 33 in Histon H2B (H2BS33) phosphorylieren kann. Welche Rolle die 
TAF1-vermittelte Phosphorylierung in der Transkription spielt, blieb jedoch unbeantwortet. 
In dieser Studie wurde die funktionelle Bedeutung der Phosphorylierung von H2BS33 
(H2BS33P) durch TAF1 mittels Kombination von biochemischen Assays und Experimenten in 
vivo untersucht. 
Mit Hilfe von in vitro Kinase-Assays wurden die zwei essentiellen Kinasemotive in TAF1CTK, 
das ATP-bindende Motiv und das Serin/Threonin-spezifische katalytische Motiv, aufgedeckt und 
gezeigt, daß TAF1CTK intrinsische Kinaseaktivität besitzt. Western-Blot-Analysen mit 
Antikörpern gegen H2BS33P zeigen, daß H2BS33 in Drosophila phosphoryliert ist. RNA-
Interferenz Experimente (RNAi), welche eine Abschwächung der Expression von TAF1 
bewirkten, zeigen, daß TAF1 eine bedeutende Kinase für H2BS33 in Drosophila Schneider-
Zellen darstellt. 
Durchflußzytometrische Analysen von TAF1RNAi-Zellen ergaben, daß die Reduzierung der 
Expression von TAF1 einen Zellzyklusarrest in G2/M-Phase bewirkt. Ein Screening der 
Transkription von Zellzyklusgenen in TAF1RNAi-Zellen zeigte, daß die Transkription des 
Zellzyklusgens string (stg) in der Abwesenheit von TAF1 reduziert ist. 
Chromatin Immunopräzipitierungsassays (XChIP) detektierten H2BS33P am transkriptionell 
aktiven stg promoter, jedoch nicht am transkriptionell inaktiven stg promoter in TAF1RNAi-
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Zellen. Diese Ergebnisse demonstrieren, daß die Phosphorylierung von H2BS33 an der 
Transkription von stg beteiligt ist. 
XChIP-Assays mit Chromatin aus Drosophila Embryos, welche eine TAF1-Mutante ohne CTK 
exprimieren, deckten außerdem auf, daß die CTK-vermittelte Phosphorylierung von H2BS33 
eine essentielle Rolle bei der Transkriptionsaktivierung des Drosophila Segmentierungsgens 
giant spielt. 
In vivo Kinase-Assays zeigen daß Bdf1 und Bdf2, Homologe von TAF1CTK in Hefe, Histone 
phosphorylieren und legen nahe, daß die Kinaseaktivität von TAF1CTK phylogenetisch 
konserviert ist. 
Die Ergebnisse dieser Arbeit charakterisieren TAF1CTK als eine bedeutende Histonkinase von 
H2BS33 und zeigen daß die TAF1-vermittelte Phosphorylierung von H2BS33 eine bedeutende 
Rolle in der Transkription zellzyklus- und entwicklungsspezifischer Gene spielt. 
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